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Molecular regulation of the Ca2+ balance
Calcium (Ca2+) plays a major role in numerous important physiological processes. It has 
an important function in the generation and preservation of bone. As a second messenger 
it functions in intracellular signal transduction pathways in a variety of processes, from 
muscle contraction and neuronal transmission to fertilization, blood coagulation and cell 
proliferation.1,2 Consequently, tight regulation of total body Ca2+ levels and intracellular 
Ca2+ concentrations is of major importance. Disturbances in Ca2+ homeostasis have large 
implications for health, as demonstrated by heart failure, seizures, osteoporosis and kidney 
stones.3-5 In plasma, free Ca2+ concentrations are kept within a range of 1.1-1.3 mM,6,7 while 
cytosolic Ca2+ concentrations are only ~100 nM at resting state.2 This results in a large chemical 
gradient across the plasma membrane. Intracellular concentrations are kept at this low level 
by the actions of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) transporting 
cytosolic Ca2+ into the organelle and the plasma membrane Ca2+-ATPase (PMCA) and Na+/Ca2+ 
exchanger (NCX) responsible for Ca2+ transport out of the cell.2  
Overall the Ca2+ balance is maintained by the concerted action of intestinal Ca2+ absorption, 
storage in bone and reabsorption in the kidney.8 To ensure Ca2+ homeostasis, tight regulation 
of Ca2+ excretion via the urine is crucial. Of all Ca2+ filtered by the glomerulus, the majority 
(99%) is reabsorbed. Reabsorption of Ca2+ largely takes place through paracellular transport 
in the proximal part of the nephron (65-70%) and the thick ascending limb (TAL, 20-25%).9,10 
The final amount of Ca2+ excretion via the urine is determined in the distal part of the nephron, 
through a highly regulated process of transcellular Ca2+ reabsorption.9,11 Transcellular Ca2+ 
transport is specifically located in the second part of the distal convoluted tubule (DCT2) and 
connecting tubule (CNT), also known as the distal convolution. Here, at the apical membrane 
Ca2+ is taken up from the pro-urine via the epithelial Ca2+ channel transient receptor potential 
vanilloid 5 (TRPV5).11,12 After entry, Ca2+ is buffered by the Ca2+-binding protein calbindin-
D28k and the complex diffuses intracellularly towards the basolateral side.
13,14 Finally, Ca2+ is 
extruded towards the blood compartment by the ATP-dependent Ca2+-ATPase (PMCA1) and 
the Na+-Ca2+ exchanger type 1 (NCX1) (Figure 1).1,15-17
Coordinated control of renal transcellular Ca2+ transport 
The process of transcellular Ca2+ transport is tightly regulated by several hormones and other 
calciotropic factors. The most important regulators of Ca2+ homeostasis are the hormones 
1,25-dihydroxy vitamin D3 (1,25-(OH)2D3) and parathyroid hormone (PTH). In response to low 
Ca2+ levels in the blood, PTH is released into the circulation by the parathyroid gland, which 
senses blood Ca2+ levels via its Ca2+-sensing receptor (CaSR). Subsequently, PTH stimulates Ca2+ 
reabsorption in the kidney, both in TAL and distal convolution.5 In addition, PTH as well as 
low plasma Ca2+ levels, trigger the renal synthesis of 1,25-(OH)2D3 from its precursor, thereby 
enhancing intestinal Ca2+ absorption.18 In the kidney, 1,25-(OH)2D3 specifically increases 
transcellular Ca2+ transport in the distal convolution. 1,25-(OH)2D3 acts through the nuclear 
vitamin D receptor (VDR), which upon activation binds to vitamin D-responsive elements 
(VDREs) in target gene promoter regions.5,19 1,25-(OH)2D3 elevates the expression levels of all 
Ca2+ transport proteins identified  in the distal convolution including TRPV5, calbindin-D28k, 
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PMCA1 and NCX1, resulting in enhanced transcellular Ca2+ transport.20,21 PTH elevates expression 
levels of TRPV5, calbindin-D28k and NCX1, but not PMCA1.
22 In addition to 1,25-(OH)2D3 and PTH, 
other non-typical calciotropic hormones are implicated in the regulation of transcellular Ca2+ 
transport as well. Estrogen increases expression levels of TRPV5, calbindin-D28k, PMCA1 and 
NCX1, through the nuclear estrogen receptor detected in the distal convolution.23 In contrast, 
testosterone reduces expression levels.24 Furthermore, pH and dietary Ca2+ influence Ca2+ 
transport, as both metabolic acidosis and a high Ca2+ diet result in reduced expression levels 
of TRPV5 and calbindin-D28k.
20,25,26 Finally, recent evidence suggests that high levels of dietary 
Na+ increase the expression levels of TRPV5, calbindin-D28k and NCX1, to compensate for the 
accompanying reduced proximal Ca2+ reabsorption.27
Hence, the main Ca2+ transport proteins in the distal convolution are tightly regulated at the 
transcriptional level. Two mechanisms are responsible for this observation. In addition to direct 
stimulation of expression levels, studies using PTH and TRPV5 knockout animals suggest that 
Ca2+ itself, via influx through TRPV5, controls the expression of other Ca2+ transport proteins.26 
Moreover, activity and function of individual components of the Ca2+ transport machinery, 
comprising Ca2+ entry through TRPV5, intracellular shuttling and subsequently extrusion by 
PMCA1 and NCX1, could be directly regulated as well. 
ATPADP
Pi
Ca2+
Na+
Nucleus
ER
TRPV5
distal convolution
pro-urine
blood
apical
basolateral 
CB28k
PMCA1NCX1
Figure 1 - Transcellular Ca2+ transport in the distal convolution. Ca2+ entry from the pro-urine is facilitated 
by the Ca2+ channel TRPV5. NCX1 and PMCA1 are responsible for the extrusion of Ca2+ from the cell towards 
the blood against a steep concentration gradient, being driven by the Na+ gradient and hydrolysis of ATP, 
respectively. Intracellularly, Ca2+ can be transported via vesicles, through the endoplasmic reticulum (ER) or by 
binding to calbindin-D28k (CB28k).
11
Introduction
1
Apical Ca2+ entry: TRPV5 
Within the TRPV subfamily, the highly homologous and Ca2+-selective TRPV5 and TRPV6 
channels both play an important role in Ca2+ homeostasis. TRPV5 is the predominant isoform 
in kidney epithelial cells, and shows a distinct localization in the distal convolution segment 
of the kidney.28 The channel is localized at the apical membrane facing the tubule lumen 
and in vesicles observed in close proximity to the plasma membrane.29 The key role of TRPV5 
in transcellular Ca2+ transport was confirmed in TRPV5 knockout (TRPV5-/-) mice, showing 
significantly reduced Ca2+ transport levels in the distal convolution and severe hypercalciuria.30 
Recently, a different transgenic TRPV5 mouse model also exhibited hypercalciuria. These mice 
harbor a missense mutation (S682P) resulting in significantly decreased TRPV5 channel Ca2+ 
permeability. Both mice models demonstrate high levels of 1,25-(OH)2D3 to compensate for 
urinary Ca2+ loss by increasing absorption of Ca2+ in the intestine.30,31 Thus, the epithelial Ca2+ 
channel TRPV5 enables the entry of Ca2+ into the cells lining the distal convolution, and is, 
thereby, the postulated gatekeeper of transcellular Ca2+ transport in the kidney.
Molecular characteristics and basic interactions of the TRPV5 channel 
As a member of the TRP superfamily, TRPV5 consists of six putative transmembrane segments 
flanked by large cytoplasmic N- and C-terminal tails (Figure 2). TRP channels are suggested to 
assemble into tetramers with the hydrophobic loop between transmembrane 5 and 6 acting 
as a pore domain, together forming a cation selective channel.32,33 The TRPV5 channel exists in 
a constitutively open state, with the pore residue D542 being crucial for Ca2+ permeability.34 
Although structure and function of the cytosolic N- and C-terminal domains is generally quite 
diverse between TRP subfamilies,35 in the TRPV5 N-terminal tail six highly conserved ankyrin 
repeats have been identified. The ankyrin repeats comprise multiple protein/ligand interaction 
domains of ~33 residues with helix-loop-helix structures.36-38 Several factors, such as ATP and 
calmodulin, have been demonstrated to bind TRP ankyrin repeats. Although the TRPV5 channel 
N-terminus is involved in channel oligomerization39 and binding of calmodulin,40 the role of 
ankyrin repeats within this domain has not been identified so far.37,41 In the TRPV5 C-terminal 
tail a highly conserved TRP domain region is present, which could play a role in the formation 
of the closed channel conformation.42  Residue R606 within this TRP domain of TRPV5 has been 
implicated in sensing of phosphatidylinositol 4,5-bisphosphate (PIP2), inactivating the channel 
when PIP2 levels are depleted.
42 
Trafficking of the TRPV5 channel 
Next to the conserved elements, the function of TRPV5 is highly dependent on several specific 
regulatory sites especially within its C-terminus. For example, the C-terminal residue H712 is 
crucial for channel internalization.43 As a plasma membrane protein, TRPV5 is dependent on 
its trafficking towards the cell surface. Presence of TRPV5 on the plasma membrane is highly 
dynamic. TRPV5-containing vesicles reside in close proximity to the plasma membrane, ready to 
be inserted.29 Moreover, channels are constitutively internalized through processes mediated 
by clathrin-coated vesicles and caveolar vesicles, the latter being facilitated by caveolin-1.44,45 
After endocytosis, the majority of internalized TRPV5 is recycled, and transported back to the 
cell surface via interaction with Rab11a in recycling endosomes.45,46 Several other interactions 
that could play a role in TRPV5 trafficking have been identified as well. A heterotetrameric 
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complex of S100A10-annexin 2 is crucial for TRPV5 trafficking by binding to a conserved VATTV 
sequence in the C-terminus, of which the residue T599 is essential for binding.47 Other auxiliary 
proteins are the Na+/H+ exchanger regulatory factor 2 (NHERF2) (together with serum- and 
glucocorticoid-induced kinase 1, SGK1 and With No lysine (K) kinase 4, WNK4) and NHERF4, 
both interact with the PDZ motifs within the TRPV5 C-terminus.48-50 NHERF2 is suggested to link 
plasma membrane proteins such as the TRPV5 channel to the cytoskeleton,51 and plays a role in 
regulation of TRPV5 plasma membrane abundance. NHERF4 is a putative membrane scaffold 
protein for TRPV5 as well.48 Trafficking of TRPV5 is a highly regulated process, and is influenced 
by many factors, such as Ca2+ itself, pH, PIP2, Mg
2+, tissue kallikrein and hormones such as PTH 
and klotho.29 
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Figure 2 – Schematic representation of TRPV5. The TRPV5 channel consists of six putative transmembrane 
domains, a pore domain (in yellow) with the critical residue D542, and large cytoplasmic N- and C-termini. An 
N-glycosylation site is present at residue N358. The N-terminal region contains six highly conserved ankyrin 
repeats (in purple) and harbors two phosphorylation sites: S144 and S299. In green, the region implicated in 
channel oligomerizaton is indicated. The C-terminus is important in many regulatory processes. It contains the 
conserved TRP box region (LWRAQV) and TRP domain involved in sensing of PIP2 (key residue R606), which also is 
a hot spot for binding of several other factors: S100A10, Rab11a, NHERF4 and calmodulin (CaM). Two calmodulin 
binding sites have been identified at positions S696-H712 and Q587-S616. The regions A650-C653 and G701-F730 
(in pink) are implicated in Ca2+-dependent inactivation of the channel. At the end of the tail a PDZ motif is 
present, an interaction site for NHERF2. Two phosphorylation sites are localized in the C-terminus: S654 and T709. 
13
Introduction
1
Differential regulation of the TRPV5 channel 
The TRPV5 channel plays a key role in transcellular Ca2+ transport in the kidney. Therefore, 
TRPV5 activity, as controlled by the number of channels on the plasma membrane and single 
channel activity, is regulated by numerous factors.
Regulation by Ca2+/calmodulin - The TRPV5 C-terminus plays an important role in the regulation 
of channel activity via its sensitivity for intracellular Ca2+ levels. The regions A650-C653 and 
G701-F730 are implicated in Ca2+-dependent inactivation of the channel.52 Furthermore, the 
Ca2+-sensor calmodulin regulates TRPV5 activity by binding to the region S696-H712, while the 
region Q587-S616 is likely also involved in Ca2+-dependent TRPV5 regulation by calmodulin.53-55 
In vitro peptide binding studies indentified three additional putative calmodulin binding sites 
in TRPV5: V133-R154, Q310-F329 and P405-I428.55 By sensing intracellular Ca2+ levels, binding 
of calmodulin can provide the channel with an important negative feedback mechanism to 
protect the cells from elevated intracellular Ca2+ levels.54 In addition, TRPV5-mediated Ca2+ 
uptake is regulated by extracellular Ca2+ concentrations through activation of the CaSR on 
the plasma membrane. Activation of the CaSR eventually leads to protein kinase C (PKC)-
mediated phosphorylation of the residues S299 and S654 on the TRPV5 N- and C-termini and 
subsequently to an enhanced Ca2+ transport rate.56 In contrast, both intra- and extracellular 
Mg2+, a divalent cation with physical properties most closely to Ca2+, were reported to inhibit 
TRPV5 function.34,57
Regulation by pH - TRPV5 channels are also highly regulated by protons (H+). Both TRPV5 
trafficking and single channel activity are decreased by an acidic pH.58-60 Firstly, TRPV5 
membrane abundance is reduced upon extracellular acidification, due to the retrieval of TRPV5-
containing vesicles from the plasma membrane.58 Secondly, channel activity is decreased by 
both intra- and extracellular acidification. The TRPV5 residues E522 and K607 are implicated 
in pH sensing. Residue E552 is present in the extracellular loop close to the pore region, while 
K607 is located in the intracellular C-terminus. Binding of protons to these residues decreases 
channel activity due to conformational changes of the pore region, reducing the channel’s 
open probability, the probability of a channel being in the open state.59,60 The open probability 
of a channel together with channel conductance determines, the amount of current through 
the channel in the open state, the total single channel activity.59,60
Regulation by hormones - In addition to the regulation of TRPV5 gene expression, different 
hormones regulate TRPV5 channel activity by modulating channel trafficking and intrinsic 
channel activity.22,44,61 Firstly, PTH increases plasma membrane expression by delaying channel 
retrieval from the plasma membrane, via a pathway similar to the response reported for 
CaSR activation. Both the CaSR and the parathyroid hormone receptor type 1 (PTH1R) are 
G-protein-coupled receptors (GPCRs), and seem to act through identical pathways leading to 
PKC-mediated phosphorylation of the residues S299/S654 in the TRPV5 channel.44 Secondly, 
PTH increases TRPV5 channel activity by a very fast response. By binding to the PTH receptor, 
a cAMP-dependent cascade is activated, resulting in phosphorylation of residue T709 by 
protein kinase A (PKA).61 Through phosphorylation of residue T709, the inhibitory binding of 
calmodulin is reduced, which decreases the negative feedback regulation and subsequently 
increases channel activity.54 Additionally, TRPV5 is regulated via its N-linked glycan tree at 
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residue N358. The hormone klotho, specifically produced and secreted by DCT cells, enhances 
TRPV5-mediated Ca2+ entry through stabilization of the channel on the plasma membrane via 
this N-glycan.62
Regulation by proteases - Many proteases have been identified in urine, especially in patients 
suffering from kidney damage reflected by leakage of large plasma proteins through the 
disrupted glomerular basement membrane.63 Proteases can, however, also be produced along 
the nephron.64 Tissue kallikrein, a serine protease produced in the CNT, stimulates TRPV5 
activity. Binding of tissue kallikrein to the GPCR bradykinin receptor subtype 2 (B2R) increases 
abundance of TRPV5 channels on the plasma membrane in a process identical to activation 
of CaSR and PTH1R.64 In contrast, TRPV5 activity is inhibited by plasmin, a protease present 
in the urine of patients with Nephrotic Syndrome.63 Plasmin activates the protease-activated 
receptor-1 (PAR-1), a GPCR, inducing PKC-mediated phosphorylation of residue S144. In 
similarity to PTH, plasmin appears to modulate calmodulin binding through phosphorylation 
of a residue within a potential calmodulin binding site, although in this case leading to channel 
inhibition rather than activation.63 
Intracellular Ca2+ shuttling: calbindin-D28k
After TRPV5-mediated Ca2+ entry at the apical membrane of the epithelial cell, Ca2+ is 
shuttled intracellularly towards the basolateral membrane. Since Ca2+ is an important second 
messenger, chronic elevations in intracellular Ca2+ levels should be prevented in order to 
avoid disturbances of signal transduction pathways. Mathematical models indicated that the 
observed rate of transcellular Ca2+ transport is ~70 times higher than the capacity of free Ca2+ 
diffusion while maintaining normal physiological cytosolic concentrations.5,65,66 Therefore, 
several possible mechanisms have been proposed to facilitate intracellular Ca2+ shuttling. Firstly, 
Ca2+ can be transported via endocytic vesicles, which are formed due to disruption of local actin 
filaments upon Ca2+ influx (Figure 1). The vesicles fuse with lysosomes and are subsequently 
transported by microtubules.5 Secondly, Ca2+ can be taken up by the endoplasmic reticulum 
and thereby tunneled towards the basolateral membrane.67 Thirdly, Ca2+ diffuses towards the 
basolateral membrane bound to the Ca2+-binding protein calbindin-D28k, according to the so-
called “facilitated diffusion model”. Hereby, the free Ca2+ concentration is kept low while total 
cellular Ca2+ increases, enlarging the capacity for Ca2+ diffusion.5,66,67
Calbindin-D28k (gene name CALB1) is a ~28 kDa protein of the CALB family of proteins with six EF-
hand domains. Of the six EF-hand domains in calbindin-D28k, four are functional and bind Ca
2+ 
with different affinities. The high affinity site has a slow rate of Ca2+ binding (KD ~180-240 nM, 
Kon 1
.107 M-1 s-1), whereas the low affinity EF hands (KD ~410-510 nM) bind Ca
2+ 8 times faster.68,69 
In general, calbindin-D28k is a freely diffusible cytosolic protein, but it is also reported to bind 
several proteins including TRPV5. Thereby, calbindin-D28k is thought to function both as a Ca
2+-
buffer and sensor.13,69,70 Calbindin-D28k is generally expressed in cells handling high levels of Ca
2+ 
influx, such as neurons (especially Purkinje cells) and TRPV5-expressing tissues.13 Calbindin-
D28k
 knockout (calbindin-D28k
-/-) mice display normal serum concentrations for Ca2+, phosphate 
and PTH and normal urinary Ca2+ excretion. These mice only show a mild impairment in motor 
coordination/motor learning, most probably due to a disturbed calbindin-D28k function in 
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Purkinje cells in the brain.69,71,72 In mice, calbindin-D9k is expressed together with calbindin-
D28k in the distal convolution. In other organisms as well as humans, calbindin-D9k is expressed 
mainly in the intestine where it is implicated in an analogous process of intestinal transcellular 
Ca2+ absorption together with the epithelial Ca2+ channel TRPV6.14,70,73 Renal expression of 
calbindin-D9k in mice probably compensates for the loss of calbindin-D28k in calbindin-D28k
-/- 
mice. Calbindin-D28k
-/-/calbindin-D9k
-/- double knockout animals showed reduced bone length 
on a low Ca2+ diet. Urinary Ca2+ and PTH levels were not measured.74 In addition, double 
knockout animals for calbindin-D28k and vitamin D receptor (VDR), which express no calbindin-
D28k and only 10% of calbindin-D9k in the kidney, demonstrate an aggravated rachitic skeletal 
phenotype, higher urinary Ca2+ excretion, more severe secondary hyperparathyroidism and 
thus higher PTH levels when compared to VDR-/- mice.72 Thus, calbindin-D28k plays an important 
role in renal transcellular Ca2+ transport.
In the distal convolution of the kidney, calbindin-D28k co-localizes  with TRPV5 on the luminal side 
of the membrane, where it buffers Ca2+ entering the cell through the channel. Fast buffering of 
Ca2+ by calbindin-D28k at the channel mouth can slow down the Ca
2+-dependent inactivation 
of TRPV5, allowing higher rates of Ca2+ influx. A similar mechanism was observed for voltage-
gated Ca2+ channels in nerve cells.13,69 Calbindin-D28k translocates to the luminal membrane 
when intracellular Ca2+ levels are low, but only in the presence of TRPV5. Thereby TRPV5 and 
calbindin-D28k could coordinately facilitate Ca
2+ transport. However, the mode of interaction 
between calbindin-D28k and TRPV5 remains to be elucidated.
13 Phenotypes of hypercalciuria as 
observed in TRPV5-/- mice are not aggravated in TRPV5-/-/calbindin-D28K
-/- mice, confirming the 
role of TRPV5 as gatekeeper the process of renal transcellular Ca2+ transport.75 
Basolateral Ca2+ extrusion: PMCA1 and NCX1
At the basolateral side of the distal convolution cell, the Ca2+ transporters PMCA1 and NCX1 
are present to extrude Ca2+ towards the blood compartment. NCX1 is the predominant 
mechanism of extrusion, accounting for ~70% of total Ca2+ transported over the basolateral 
membrane.15,16,28 NCX1 has a lower affinity for Ca2+ as compared to PMCAs, but a much 
higher transport capacity (turnover number between 2,500 and 5,000 s-1 versus 10-50 s-1 for 
PMCAs).76,77 Hence, PMCA1 is probably responsible for fine-tuning of cytosolic Ca2+ levels.15 In 
contrast to the entry step, extrusion of Ca2+ takes place across a steep concentration gradient, 
making it very energy consuming. PMCA1 directly consumes ATP through hydrolysis in its 
catalytic center, while NCX1 function is dependent on the Na+ gradient established by the 
Na+-K+ ATPase. A concerted action of PMCA and NCX in maintaining intracellular Ca2+ levels has 
been proven in other cells as well, such as neurons and vascular endothelial cells.78,79 
Physiological role of PMCAs
PMCAs are present in all eukarytic cells where they function to maintain low intracellular Ca2+ 
levels. Four mammalian PMCA isoforms exist (PMCA1-4), as well as over 20 splice variants. 
PMCA1 and PMCA4 are ubiquitously expressed, while PMCA2 and PMCA3 are expressed 
almost exclusively in excitable tissues.80-82 In kidney, primarily PMCA1b and PMCA4b are 
present.16,17 PMCA1b is the principal efflux mechanism for intestinal transcellular Ca2+ transport 
mediated by TRPV6 and calbindin-D9k. Therefore, PMCA1b is considered as the major PMCA in 
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distal convolution transcellular Ca2+ transport as well.83,84 Of all nephron segments, the distal 
convolution shows the highest levels of PMCA protein, implicating its key role in transcellular 
Ca2+ transport.17 The physiological role of the PMCAs was studied by the generation of 
different knockout animals. Homozygous PMCA1 knockout (PMCA1-/-) mice are embryonic 
lethal, whereas heterozygous mutants do not show any disturbances, suggesting a crucial 
housekeeping role. PMCA4 mutant mice do not show any apparent phenotype, although male 
PMCA4-/- mice show infertility, which suggests a more specified role for this isoform.85 As far 
as we know there is no data available on urine and serum Ca2+ levels in PMCA1 or PMCA4 
knockout mice.
Molecular characteristics of the PMCA pump 
PMCAs are part of the large superfamily of P-type ATPases and consist of ten transmembrane 
domains, two large intracellular loops (between TM2-3 and TM4-5), and cytosolic N- and 
C-termini (Figure 3). The N-terminus is the most variable region between the four isoforms. 
In analogy to the SERCA nomenclature, the intracellular loop between TM2 and TM3 together 
with the N-terminus, forms the so-called actuator “A-domain”, which is one of the two binding 
sites for activator acidic phospholipids. The intracellular loop between TM4 and TM5 contains 
the catalytic “P-domain” that contains the aspartate residue forming the acyl phosphate 
intermediate and “N-domain” containing the conserved lysine crucial for binding of ATP. PMCAs 
transport one Ca2+ for every hydrolyzed ATP, with a KD of 10-20 µM in resting state to 0.2-0.5 µM 
upon activation.80,81,86 
All four PMCA isoforms are subjected to alternative splicing, which occurs at site A and C. Splice 
site A lies within the first intracellular loop within the “A-domain” and site C in the C-terminal 
14-3-3 K
CaM
ATPA-domain
P-domain
N-domain
N
C
intracellular space
extracellular space 
D
Figure 3 - Topology of the plasma membrane Ca2+-ATPase (PMCA1). PMCA1 contains ten transmembrane 
domains, intracellular N- and C-termini and two large cytoplasmic domains between TM2-3 and TM4-5. The 
N-terminus and cytoplasmic domain between TM2-3 comprise the actuator A-domain for binding of activating 
acidic phospholipids. The cytoplasmic loop between TM4-5 contains both the catalytic P-domain with the 
aspartate (D) for formation of the acyl phosphate intermediate and the N-domain containing the lysine (K) for 
binding of ATP. The N-terminus is involved in binding of the 14-3-3 protein. Calmodulin (CaM) binds to a variable 
region due to alternative splicing (in purple) in the C-terminus, thereby releasing inhibitory interactions with the 
two cytosolic loops. Another splice region is present in the first cytosolic loop, however for PMCA1 alternative 
splicing has never been observed at this site. 
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calmodulin binding site, although PMCA1 is never spliced at site A. Splice variants have specific 
distributions during development and in different tissues of the body and are dedicated for 
their function there.77,81 Differences between splice variants are demonstrated for PMCA4a 
and PMCA4b (differentially spliced at site C), the latter being much slower in activation and 
inactivation rates, indicating it is specialized for handling slow changes in Ca2+ levels in non-
excitable cells.82,87 Therefore the so-called “b” variant of PMCA1 as found in kidney is well suited 
for its continuous role in Ca2+ extrusion.
Regulation of the PMCA pump
In order to function, PMCAs need to be activated, as Ca2+ affinities in resting state are too low to 
initiate transport. The main regulator of PMCA function is calmodulin. The calmodulin binding 
region has an auto-inhibitory function on the PMCA pump via its binding to the two large 
cytoplasmic loops. Upon binding, calmodulin removes the calmodulin binding domain from 
the cytoplasmic loops, thereby releasing the catalytic domain from auto-inhibition. Binding of 
calmodulin decreases the KD from 10-20 µM to less than 1 µM.
15,81,82 Activation by calmodulin 
is slow and differs among the splice variants. In general the so-called “a” splice variants show 
lower calmodulin affinities and higher calmodulin-independent basal activities as compared 
to the “b” variants.15,81,82 In addition to calmodulin, PMCAs are activated by acidic phospholipids 
and polyunsaturated fatty acids, which can bind to two regions within the PMCA pump, one in 
the calmodulin binding domain and the other in the first cytosolic loop. This way the KD for Ca
2+ 
is decreased to ~100 nM.81 Other processes regulating PMCA function are PKA/PKC-mediated 
phosphorylation of residues in the C-terminus, proteolytic cleavage of part of the C-terminus 
and dimerization via the C-terminal tails.15,82,88 Regulatory mechanisms are strongly dependent 
on the specific PMCA isoform. For example, some isoforms are activated by PKC (PMCA4b) 
whereas others are unaffected (PMCA4a)82.
Physiological role of NCX1
While PMCAs are considered to fine-tune cytosolic Ca2+ concentrations, NCX1 is the main 
extruder of Ca2+ in the process of transcellular Ca2+ transport. NCX1 belongs to the SLC8 
superfamily of cation/Ca2+ exchangers, next to NCX consisting of YRBG, CAX, NCKX and CCK 
proteins.89 Na+/Ca2+ exchangers comprise a fast and high-capacity Ca2+ transporting system. 
They transport Ca2+ in a rate of three Na+ ions for one Ca2+ ion using the physiological Na+ 
gradient over the plasma membrane.15 Under specific circumstances, NCX1 also functions 
in the reverse-mode, allowing influx of Ca2+.90,91 The NCX family consists of three members: 
NCX1, NCX2 and NCX3, of which NCX1 is the main isoform expressed in kidney. NCX1 is highly 
expressed in cardiac myocytes as well, where its role and regulation in Ca2+ extrusion during 
relaxation and diastole have been extensively studied.15,92 NCX1 knockout (NCX1-/-) mice are 
embryonic lethal,93 prohibiting the study of the physiological effects of NCX1 in the kidney.
Molecular characteristics of the NCX1 exchanger
The three NCX proteins are structurally very similar. NCX1 is predicted to consist of ten 
transmembrane helices (Figure 4). The first five transmembrane domains are separated from 
the last five transmembrane domains by a large cytosolic loop of ~500 residues. The short 
N- and C-termini are directed towards the extracellular space. NCX1 has a single N-linked 
glycosylation site.90,94,95 In addition, NCX1 proteins contain two highly conserved internal 
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repeats, the so-called α-repeats that are implicated in ion binding and transport. In the large 
intracellular loop two Ca2+ binding domains are present (CBD1 and CBD2).90 The second Ca2+ 
binding domain contains a region that is subjected to alternative splicing of six exons named 
A, B, C, D, E and F, leading to the generation of many splice variants. Exons A and B are mutually 
exclusive. Exon A is generally expressed in excitable tissues, whereas exon B is present in other 
tissues including kidney. The other four exons are cassette exons that can all be transcribed or 
spliced out, although all identified isoforms so far contain exon D.90,96-98 In kidney three splice 
variants have been identified, NCX1.2 (exons B, C and D), NCX1.3 (exons B and D) and NCX1.7 
(exons B, D, and F). NCX1.3 is considered the main NCX present in the kidney.96,97,99 A second 
alternative splice region was found in the 5’-untranslated region of the gene, regulating 
protein expression.90,99,100 
Regulation of the NCX1 exchanger
By providing the driving force for Ca2+ transport, the Na+ gradient is an important regulator 
of NCX1 function. Mathematical models indicate that amiloride enhances Ca2+ transport by 
increasing the driving force for NCX1, as intracellular Na+ levels are reduced due to inhibition 
of the epithelial Na+ channel ENaC at the apical membrane.90,101,102 In addition to Na+, also 
intracellular Ca2+ regulates NCX1 function. The Ca2+ binding domain 1 (CBD1) is the primary 
Ca2+-sensor, detecting subtle differences in cytosolic Ca2+ and subsequently undergoing 
large structural changes causing activation of the exchanger. The CBD2 undergoes only small 
structural changes upon Ca2+ binding at high intracellular Ca2+ concentrations.103,104 Due to 
the splice region within CBD2, regulation by Ca2+ is isoform specific. The renal NCX1.3 splice 
variant is more responsive to intracellular Ca2+ than the cardiac isoform NCX1.1.105-107 Another 
regulatory element within the NCX1 intracelullar loop domain is the so-called XIP (exchanger 
inhibitor peptide) region, which is localized close to the fifth transmembrane segment. This 
XIP region is implicated in the regulation by Na+ and acidic phospholipids and might also be 
involved in the regulation by Ca2+ via calmodulin binding.108-110 However, calmodulin interaction 
with NCX1 has not been demonstrated.
Also required for NCX1 function is ATP, by stimulating NCX1 via the formation of PIP2 from 
phosphatidylinositol (PI).102,111-113 PIP2 enhances the activity of many plasma membrane 
proteins and ion channels, as was also observed for PMCA and TRPV5.42,81 In contrast to these 
transporters, regulation of NCX through phosphorylation processes remains controversial. 
NCX1 proteins are reported to be stimulated through phosphorylation via PKA- and PKC-
mediated pathways, but results are variable, suggesting that regulation could be indirect, being 
mediated by other proteins in multi-protein complexes.114-116 In addition, phosphorylation was 
shown to have different effects on the different NCX1 splice variants. Isoforms containing exon 
A showed significantly increased Ca2+ transport after activation of PKA, whereas expression 
levels of exon B containing isoforms were not affected.105
Basolateral transporters: Trafficking and interactions with cytoskeletal proteins 
The process of PMCA and NCX1 trafficking is not studied in great detail. However, interactions 
with several auxiliary proteins have been demonstrated. The large cytosolic loop of NCX 
interacts with several proteins including the 14-3-3 protein,117 ankyrin,118 the filamentous 
actin network,119 caveolin 3 (in the heart),120,121 and caveolin 1 and 2 (in neuronal cells).122 
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These interactions suggest the formation of multi-protein complexes within specific micro-
domains.15,123 Interestingly, the XIP peptide, a sequence present in the NCX1 protein, was 
found to inhibit PMCAs, which might implicate cross-regulatory functions on NCX and PMCA 
regulation.124 PMCAs have also been shown to interact with components of the cytoskeleton. 
The 14-3-3 protein plays an inhibitory role on pump activity by binding to the PMCA1 
N-terminus and might also be implicated in chaperoning and trafficking of the PMCA Ca2+-
pump.125 Furthermore, a PDZ domain-binding motif is located at the C-terminus of all “b”-splice 
variants, but none of the “a”-splice variants. As for NCX1, interactions with the cytoskeleton 
allow PMCAs to cluster into functional multi-protein complexes.82 
Outline of this thesis
Transcellular Ca2+ transport is regulated by the concerted action of entry through the TRPV5 
channel, buffering by calbindin-D28k and extrusion via PMCA1 and NCX1. Being considered 
the gatekeeper of transcellular Ca2+ transport, the TRPV5 channel has been intensively 
studied. Although functional aspects of most regions within the TRPV5 channel have been 
identified, the role of the ankyrin repeats abundantly present in the N-terminal domain has 
not been clarified to date. Therefore, the role of the TRPV5 N-terminus on channel function, 
tetramerization and trafficking has been studied in chapter 2. In addition to regulation by 
its structural features, several hormonal factors have been identified to regulate TRPV5 
XIP
N
C
CBD1
CBD2
Ca2+
Ca2+
α1
α2 intracellular space
extracellular space 
Figure 4 - Topology of the Na+-Ca2+ exchanger (NCX1). NCX1 consists of ten transmembrane domains, 
extracellular N- and C-termini and a large cytoplasmic domain between TM5-6. Two highly conserved α-repeats 
are present. The N-terminus contains a single glycosylation site. The cytoplasmic loop consists of two Ca2+ 
binding domains (CBD1 and CBD2), of which part of CBD2 is an alternative splicing region. In addition, the so-
called XIP region is located close to TM5. 
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function. These are the classical calciotropic hormones 1,25-(OH)2D3 and PTH, as well as more 
atypical hormones such as estrogen and testosteron. TRPV5 function is also regulated by 
other factors, such as proteases. Thus, many other yet unknown factors could play a role in the 
regulation of transcellular Ca2+ transport via the TRPV5 channel as well. In chapter 3 a novel 
potential regulator of transcellular Ca2+ transport and TRPV5 activity, the β-adrenergic agonist 
dobutamine, was studied. 
To understand the effects of regulation of the individual components in the highly coordinated 
process of transcellular Ca2+ transport, the molecular interplay of the various elements needs 
to be studied in detail. Comprehensive studies of renal transcellular Ca2+ transport are enabled 
by a novel primary distal convolution cell model as presented in chapter 4. Distal convolution 
tubule fragments were isolated from mice specifically expressing enhanced Green Fluorescent 
Protein (EGFP) in these nephron segments, rendering a unique distal convolution cell model 
with the Ca2+ transport characteristics and regulatory pathways remained intact. By being 
responsible for Ca2+ extrusion, also PMCAs and NCX1 play a key role in determining total flux 
of Ca2+ in the distal convolution. The role and regulation of basolateral extrusion of Ca2+ in 
transcellular Ca2+ transport in the kidney is poorly described so far. Therefore in chapter 5, 
NCX1 was cloned from mice kidney and its general function and regulation were characterized. 
In addition, calmodulin was studied as a regulator of renal NCX1 function. Finally, the results 
and implications of the studies reported in chapters 2 to 5 are summarized and discussed in 
chapter 6.  
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Abstract
The epithelial Ca2+ channel transient receptor potential vanilloid 5 (TRPV5) constitutes the 
apical entry site for active Ca2+ reabsorption in the kidney. The TRPV5 channel is a member of the 
TRP family of cation channels, which are composed of four subunits together forming a central 
pore. Regulation of channel activity is tightly controlled by the intracellular amino (N)- and 
carboxy (C)-termini. The TRPV5 C-terminus regulates channel activity by various mechanisms, 
but knowledge regarding the role of the N-terminus remains scarce. To study the role of 
the N-terminus in TRPV5 regulation, we generated different N-terminal deletion constructs. 
We found that deletion of the first 32 residues did not affect TRPV5-mediated 45Ca2+ uptake, 
whereas deletion up to residue 34 and 75 abolished channel function. Immunocytochemistry 
demonstrated that these mutant channels were retained in the endoplasmic reticulum and in 
contrast to wild-type TRPV5 did not reach the Golgi apparatus, explaining the lack of complex 
glycosylation of the mutants. A limited amount of mutant channels escaped the endoplasmic 
reticulum and reached the plasma membrane, as shown by cell surface biotinylation. These 
channels did not internalize, explaining the reduced but significant amount of these mutant 
channels at the plasma membrane. Wild-type TRPV5 channels, despite significant plasma 
membrane internalization, showed higher plasma membrane levels compared with the 
mutant channels. The assembly into tetramers was not affected by the N-terminal deletions. 
Thus, the N-terminal residues 34-75 are critical in the formation of a functional TRPV5 channel 
because the deletion mutants were present at the plasma membrane as tetramers, but lacked 
channel activity. 
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Introduction
The epithelial Ca2+ channel TRPV5, the gatekeeper of active Ca2+ reabsorption in the kidney, 
is a member of the TRP superfamily. TRP channels are involved in many different biological 
processes ranging from sensory physiology, contributing to taste, olfaction, and vision to 
muscle proliferation and Ca2+ and Mg2+ homeostasis of the body.1,2 Based on their sequence and 
structural homology, the mammalian TRP channel superfamily is divided into six subfamilies: 
TRPA (ankyrin), TRPC (canonical), TRPM (melastatin), TRPP (polycystin), TRPML (mucolipin) 
and TRPV (vanilloid). All TRP proteins have a common topology, including six transmembrane 
segments flanked by large cytoplasmic N- and C-terminal domains. They are suggested to 
assemble into tetramers, the hydrophobic loop between transmembrane 5 and 6 forming a 
putative core domain, ultimately leading to the formation of a cation-selective channel.1,3
Despite this common topology, the structure and function of the cytosolic N- and C-terminal 
domains between the different TRP subfamilies are quite diverse.4 The N-terminus of the 
TRPM subfamily holds four TRPM homology regions (MHRs), which are essential for proper 
functioning of these channels.5-8 Highly conserved ankyrin repeats are present in the N-termini 
of TRPC, TRPV and TRPA channels. Ankyrin repeats are composed of multiple protein/ligand 
interaction domains of ~33 residues each with a highly conserved helix-loop-helix structure.9,10 
ATP and calmodulin, have been demonstrated to bind TRP ankyrin repeats; however, more 
binding factors remain to be identified.10,11 Within the C-terminus, a highly conserved short 
hydrophobic stretch, called the TRP box region, has been identified in TRPC, TRPM, and TRPV 
families.12 The TRP box region is located just after the sixth transmembrane segment and might 
serve as a coiled-coil zipper keeping the channel in a closed conformation.13 The C-terminus of 
the TRPM subfamily harbors a coiled-coil region, which is involved in channel tetramerization 
and is critical for channel activation.7,8,14-16 The members TRPM6 and TRPM7 contain a unique 
α-kinase domain at the far end of the C-terminus, which regulates channel activity by a variety 
of molecular mechanisms.17,18 
From the subfamily of TRPV channels, TRPV1-4 play a role in sensory signaling, whereas the 
Ca2+-selective and highly homologous TRPV5 and TRPV6 channels are crucial players in Ca2+ 
homeostasis. Like the other members of this TRPV subfamily the C-terminus of TRPV5 is 
relatively short as compared with the N-terminus. However, various molecular mechanisms 
regulate TRPV5 channel activity via the C-terminus. In contrast, information regarding the 
role of the N-terminus in TRPV5 function is more limited. One report revealed a critical role 
for a N-terminal protein kinase C (PKC) phosphorylation site in tissue kallikrein-mediated 
TRPV5 stimulation.19 This site was also necessary for PKC phosphorylation triggered by 
parathyroid hormone (PTH).20 Additionally, calmodulin has been demonstrated to bind the 
TRPV5 N-terminus;21 however, the role in channel function has not been identified. Finally, 
residues 64-77 appeared essential for oligomerization of different N-termini within the TRPV5 
tetramer.22 Because TRPV5 is a rate-limiting factor in active Ca2+ reabsorption, understanding 
the molecular regulation of this Ca2+ channel is essential to elucidate the mechanisms of renal 
Ca2+ handling. The aim of our study was to gather more information regarding the role of the 
TRPV5 N-terminus in channel regulation. 
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Experimental Procedures
Molecular biology - Constructs containing N-terminally HA-tagged rabbit TRPV5 in pCB6 were 
obtained as described previously.23 This vector was used to develop HA- and FLAG-tagged 
N-terminal deletion constructs. First, using in vitro mutagenesis the restriction site BspEI was 
inserted directly after the HA-tag. Second, a FLAG-tagged TRPV5 construct was generated by 
replacing the HA-tag by the FLAG tag using restriction sites KpnI and BspEI. Third, using PCR 
the different N-terminal TRPV5 truncants were subcloned in the original vectors containing 
HA- and FLAG-tagged TRPV5 via restriction sites BspEI and XbaI. The tapasin-EGFP construct 
was a kind gift from the lab of Dr. K. Jalink (Amsterdam). 
Cell culture and transfection - HEK293 cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM, Bio Whittaker Europe, Vervier, Belgium) containing 10% v/v fetal calf serum (PAA, Linz, 
Austria), 2 mM L-glutamine, 10 μl/ml non-essential amino acids at 37°C in a humidity-controlled 
incubator with 5% v/v CO2. For biochemical experiments cells were transiently transfected with 
the appropriate plasmids using polyethyleneimine (PEI, PolySciences Inc) with a DNA:PEI ratio 
of 6:1. For patch clamp experiments, cells were transiently transfected with the appropriate 
plasmids using Lipofectamine® 2000 (Invitrogen). Transfected cells were used after 24 h.
45Ca2+ uptake - Radioactive Ca2+ uptake was determined using TRPV5-expressing HEK293 cells 
seeded on poly-L-lysine (Sigma) coated 24-well plates. Cells were pretreated for 20 min with 25 
µM BAPTA-AM, subsequently washed with PBS and incubated for 5 min in KHB buffer (110 mM 
NaCl, 5 mM KCl, 1.2 mM MgCl2, 0.1 mM CaCl2, 10 mM sodium acetate, 2 mM NaH2PO4, 20 mM 
HEPES pH 7.4, adjusted with NaOH) and finally incubated for 10 min with 45CaCl2 (1 µCi/ml) in 
KHB buffer with voltage-gated Ca2+ channel inhibitors (10 µM felodipine, 10 µM verapamil). To 
block TRPV5-mediated 45Ca2+ uptake, cells were incubated with 10 µM ruthenium red during 
the 5 and 10 min incubation steps. After multiple washing steps with ice-cold stop buffer (110 
mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 10 mM Na-acetate, 0.5 mM CaCl2, 1.5 mM LaCl3 and 20 mM 
HEPES pH 7.4, adjusted with NaOH) the uptake of 45Ca2+ was measured. 
Electrophysiology - Patch clamp experiments were performed as described previously24 in the 
tight seal, whole cell configuration at room temperature using an EPC-9 patch-clamp amplifier 
computer controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany).
Immunocytochemistry - TRPV5-expressing cells were grown on coverslips. Culture medium 
was removed, and cells were washed with cold PBS and subsequently fixed for 30 min at 
room temperature with 4% w/v formaldehyde in PBS. After washing twice with PBS, cells 
were treated with permeabilization buffer (0.2% v/v Triton X-100 in PBS with 0.1% w/v BSA) 
for 15 min. Then, cells were treated with 50 mM NH4Cl for 15 min and washed with PBS and 
once with permeabilization buffer. Goat serum dilution buffer (16% v/v donkey or goat serum 
(Jackson ImmunoResearch Laboratories, West Grove, PA) and 0.2% v/v Triton X-100 in PBS) 
was applied before incubations with primary and secondary antibodies. Primary antibodies 
were diluted 1:200 in goat serum dilution buffer and incubated at 4°C overnight. Secondary 
antibodies, also diluted 1:200 in goat serum dilution buffer, were conjugated to Alexa Fluor 
dyes (Invitrogen). Secondary antibody incubations were for 1 h at 37°C. Cells were imaged by 
confocal microscopy (Olympus FV1000). 
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Cell surface biotinylation and internalization assay - HEK293 cells were transfected with different 
TRPV5 constructs in pCB6 using PEI. After 2 days cell surface proteins were biotinylated for 30 
min at 4°C using sulfo-NHS-LC-LC-biotin or sulfo-NHS-SS-biotin (0.5 mg/ml; Pierce, Etten-Leur, 
the Netherlands) as described previously.25 In short, cells were kept at 4°C or incubated for 30 min 
at 37°C to allow endocytosis from the plasma membrane. TRPV5 internalization was measured 
by treating cells with fresh 100 mM 2-mercaptoethanesulfonic acid sodium salt (mesna) for 3 
times 20 min at 4°C. After treatment with 120 mM iodoacetic acid to quench mesna, cells were 
lysed in 150 mM NaCl, 5 mM EGTA, 50 mM Tris, pH 7.5 adjusted with HCl, 1% v/v Triton and 
protease inhibitors at 4°C and centrifuged at 14,000 x g for 10 min. Finally, biotinylated proteins 
in the supernatant were precipitated using neutravidin-coupled beads (Pierce), and analyzed 
by immunoblotting using anti-HA antibodies (2367, Cell Signaling Technology). Anti-β-actin 
(A5441, Sigma) was used to detect non-specific labeling of intracellular proteins.
Co-immunoprecipitation - HEK293 cells expressing both HA-TRPV5 and FLAG-TRPV5 were lysed 
in 150 mM NaCl, 5 mM EGTA, 50 mM Tris, pH 7.5 adjusted with HCl, 0.5% v/v Nonidet P-40, and 
protease inhibitors: 1 mM PMSF, 10 µg/ml leupeptin, 1 µg/ml pepstatin, 5 µg/ml aprotinin at 
4°C. After centrifugation at 16,000 x g for 15 min at 4°C, the supernatant containing 3 µg of 
total protein was added to 30 μl equivalents of protein A/G plus-agarose beads (Santa Cruz 
Biotechnology), which were preincubated for 3 h at room temperature with 2 μl of polyclonal 
anti-FLAG antibody raised in rabbit (F7425, Sigma) in 0.7 ml of IPP500 (500 mM NaCl, 10 mM 
Tris pH 8.0 adjusted with HCl, 0.5% v/v Nonidet P-40, 1 mM PMSF, 10 µg/ml leupeptin, 1 µg/
ml pepstatin, 5 µg/ml aprotinin). As a control for non-specific antibody binding 2 μl of rabbit 
anti-GFP antibody (home-made) was bound to protein A/G plus-agarose beads. The beads 
were washed three times with the lysis buffer described above. Cell lysate and antibody-bound 
beads were incubated overnight at 4°C. Subsequently, the beads were washed with lysis buffer 
and proteins were eluted in Laemmli as described previously.26
Oligomerization assay - HA-tagged TRPV5, TRPV5-Δ1-38 and TRPV5-Δ1-75 were expressed in 
HEK293 cells. Cell lysates were mixed with 2x perfluorooctanoic acid (PFO) sample buffer (100 
mM Tris, 20% v/v glycerol, 8% w/v PFO (Sigma-Aldrich), 0.005% w/v bromophenol blue, pH 
8.0, adjusted with NaOH) and run on a 4-12% Tris-glycine acrylamide gel (Invitrogen) in 25 mM 
Tris, 192 mM glycine, 0.5% w/v PFO (pH 8.5, adjusted with NaOH) at 4°C. Subsequently TRPV5 
proteins were detected by immunoblotting using anti-HA antibodies. 
Molecular modeling - The crystal structure of delta endotoxin Cry8Ea1 (Protein Data Base 
ID code 3EB7) was used as a template to generate a model of the beginning of the TRPV5 
N-terminus (residues 10 to 46). Sequence homology for this region was 35%. YASARA was 
employed for modeling. 
Statistical analysis - In all experiments, data are expressed as mean ± S.E. Statistical comparison 
was determined using a one-way ANOVA followed by the Newman-Keuls multiple comparison 
test. p values < 0.05 were considered significant. 
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Results
TRPV5 lacking the first 38 N-terminal residues is not functional 
To analyze the role of the N-terminus in the regulation of the TRPV5 channel, several channel 
deletion constructs were generated each missing parts of the N-terminus. To study the role of 
the ankyrin domains in TRPV5 function, deletion constructs TRPV5-Δ1-75 and TRPV5-Δ1-161 
were developed missing ankyrin domains 1 and 1-3, respectively (Figure 1A). Additionally, 
three constructs lacking the first 25, 32 and 38 N-terminal residues, but with intact ankyrin 
domains were generated (Figure 1A). Human embryonic kidney (HEK) 293 cells were 
transfected with these constructs to study protein expression and function using 45Ca2+ uptake 
assays. Immunoblotting of wild-type TRPV5 (TRPV5-WT) demonstrated a double band (Figure 
1B), representing a core and complex glycosylated form.23 Removal of the first 38 or 75 amino 
acids completely prevented complex glycosylation, whereas this was only slightly reduced for 
TRPV5-Δ1-32 (Figure 1B). Unfortunately, deletion mutants TRPV5-∆1-25 and TRPV5-Δ1-161 
showed severely reduced protein expression compared with TRPV5-WT, so these constructs 
were not included in the functional analysis (data not shown). The activity of the deletion 
mutants was measured by the influx of radioactive 45Ca2+ into TRPV5-expressing HEK293 cells. 
Removal of the first 32 amino acids of the N-terminus did not affect TRPV5-mediated 45Ca2+ 
influx (Figure 1C). In contrast, removal of the first 38 or 75 amino acids abolished TRPV5 activity 
because the 45Ca2+ influx levels were not different from the TRPV5 blocker ruthenium red (Figure 
1C). To investigate further the mechanism by which removal of the N-terminus abolishes TRPV5 
function, we used TRPV5-Δ1-38 because this was the minimal deletion eliminating channel 
activity. Patch clamp analysis was implemented to study whether TRPV5-∆1-38 was permeable 
to Na+. In contrast to TRPV5-WT, the TRPV5-Δ1-38 mutant did not exhibit Na+ currents different 
from mock-transfected cells (Figure 1D,E).
TRPV5-Δ1-38 is retained in the endoplasmic reticulum 
Because a lack of complex glycosylation can be a direct result of retention in the endoplasmic 
reticulum, the localization of TRPV5-Δ1-38 was visualized using immunocytochemistry. In 
short, HEK293 cells coated on coverslips were transfected with TRPV5-WT or TRPV5-Δ1-38. 
To investigate the presence in the Golgi apparatus, cells were stained with the Golgi marker 
α-giantin. TRPV5 localization was determined using an antibody against the HA-tag. TRPV5-WT 
appeared mainly in vesicles and specifically co-localized with α-giantin (Figure 2A). In contrast, 
TRPV5-Δ1-38 was not localized to vesicles and did not specifically overlap with the Golgi 
marker (Figure 2A). To study whether TRPV5-Δ1-38 was retained in the endoplasmic reticulum, 
EGFP-fused tapasin, an endoplasmic reticulum resident protein was co-expressed. In contrast 
to TRPV5-WT, TRPV5-Δ1-38 co-localized with the endoplasmic reticulum protein tapasin-EGFP 
(Figure 2B).
Plasma membrane regulation of TRPV5-Δ1-38 is affected 
The presence of TRPV5-WT channels at the plasma membrane can not be visualized 
by immunocytochemistry. Therefore, other biochemical experiments like cell surface 
biotinylation were used to investigate the expression of TRPV5 at the plasma membrane.27 
Because TRPV5-Δ1-38 was retained in the endoplasmic reticulum we investigated whether this 
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mutant still reached the plasma membrane. Cell surface proteins of cells expressing TRPV5-
WT or TRPV5-Δ1-38 were biotinylated and subsequently precipitated with neutravidin-agarose 
beads. TRPV5 protein expression in whole cell lysate and biotinylated fraction was determined 
using immunoblotting. Strikingly, both TRPV5-WT and TRPV5-Δ1-38 were present at the 
plasma membrane, although the latter to a lower extent (Figure 3A). This was confirmed by 
quantification of protein levels (Figure 3B). Previous studies indicated a key role of the N-glycan 
at residue N358 in TRPV5 retrieval from the plasma membrane.28 To study whether the lack 
of complex glycosylation of TRPV5-Δ1-38 affected channel plasma membrane trafficking, we 
performed an internalization assay. Consequently, all proteins at the cell surface were probed 
Figure 1 – Channel activity of TRPV5-WT and N-terminal deletion mutants. A) Schematic overview of 
the TRPV5 protein domains. First residue of the different predicted ankyrin domains is depicted. B) Protein 
expression of TRPV5-WT and mutants. C) 45Ca2+ influx in HEK293 cells transiently expressing TRPV5-WT 
(n=11), TRPV5-Δ1-32 (n=11), TRPV5-Δ1-38 (n=11) and TRPV5-Δ1-75 (n=9). TRPV5-mediated 45Ca2+ uptake was 
blocked with 10 µM ruthenium red (RR). *,p < 0.05 versus TRPV5-WT control. D) I-V relationship measured 
from 400-ms voltage ramps in the whole-cell configuration in nominally divalent-free solution for TRPV5-
WT (solid line), TRPV5-Δ1-38 (dashed line) and mock (dotted line). E) Average current densities at 80 mV in 
TRPV5-WT (n=8), TRPV5-Δ1-38 (n=11) and mock (n=8) transfected HEK293 cells. *,p < 0.05 versus TRPV5-WT. 
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Figure 2 – Subcellular localization of TRPV5-WT and the N-terminal deletion mutant TRPV5-Δ1-38. A) 
Immunofluorescence staining of HA-tagged TRPV5-WT and TRPV5-Δ1-38, respectively, in the presence of the 
Golgi marker α-giantin. B) Co-expression with the endoplasmic reticulum marker tapasin fused to EGFP.
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Figure 3 – Plasma membrane expression and internalization of TRPV5-WT and -Δ1-38. A) Plasma 
membrane expression of TRPV5-WT and TRPV5-Δ1-38 in transiently transfected HEK293 cells assessed by cell 
surface biotinylation. B) Quantification of cell surface expression of TRPV5-WT (n=7) and TRPV5-Δ1-38 (n=7). 
*,p < 0.05 versus TRPV5-WT. C) Internalization of TRPV5-WT and TRPV5-Δ1-38 as measured by the biotinylated 
fraction after mesna cleavage with and without a 30-min chase. D) Quantified amounts of TRPV5-WT (n=5) and 
TRPV5-Δ1-38 (n=5) channels internalized after a 30-min chase normalized against TRPV5 levels in whole cell 
lysate (no mesna). *,p < 0.05 versus no chase.
remove all biotin bound to remaining cell surface proteins. Treatment with mesna removed 
~80% of all biotin for both TRPV5-WT and TRPV5-Δ1-38 (Figure 3C,D). A 30-min chase at 37°C 
resulted in a significant elevation of TRPV5-WT protein amounts (Figure 3C,D). These channels 
were internalized and, therefore, resistant to mesna treatment. In contrast, a 30-min chase for 
cells expressing TRPV5-Δ1-38 did not affect the biotinylated fraction, indicating that these 
channels did not internalize (Figure 3C,D).
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Tetramerization of TRPV5-Δ1-38 
Tetrameric assembly of TRPV5 is necessary to establish a functional channel because the central 
Ca2+-selective pore is formed by the hydrophobic pore-forming loops of the four subunits 
and is located between transmembrane domain 5 and 6.23 To study whether the retention 
of TRPV5-Δ1-38 in the endoplasmic reticulum and the absence of function at the plasma 
membrane are due to the inability to tetramerize, co-immunoprecipitation was performed. 
Therefore, we transfected HEK293 cells with HA-tagged and FLAG-tagged N-terminal deletion 
mutants (Figure 4A). Subsequently, FLAG-tagged proteins were precipitated using anti-FLAG 
antibody-bounded beads (Figure 4A). Then, these immune complexes were examined for 
the presence of HA-tagged TRPV5 proteins. TRPV5-WT and all deletion mutants were co-
precipitated (Figure 4A), demonstrating that oligomerization of the TRPV5 channels was not 
affected by deletion of the first 75 residues. Next PFO-PAGE was implemented to investigate 
whether TRPV5-Δ1-38 forms a tetrameric complex at the plasma membrane. Perfluorooctanoic 
acid (PFO) is a mild detergent, retaining oligomeric structures, and was successfully applied on 
other TRP channels.29 Biotinylated fractions and whole cell lysates of TRPV5-WT, TRPV5-Δ1-38 
and TRPV5-Δ1-75 were analyzed by PFO-PAGE and subsequent immunoblotting. All subjected 
proteins were present in four different oligomeric states, demonstrating tetramerization of the 
truncated channels at the plasma membrane.
Residues Q31 and D34 are essential for proper TRPV5 function 
To identify the precise part of TRPV5 critical for proper channel functioning, the residues 
surrounding amino acid 32 were investigated (Figure 5A). First, two additional deletion 
Figure 4 – Tetramerization of the TRPV5 Δ1-38 N-terminal deletion mutant. A) FLAG-tagged and HA-tagged 
TRPV5-WT and N-terminal deletion mutants were immunoprecipitated (IP) using the anti-FLAG antibody and 
subsequently co-immunoprecipitated TRPV5 channels were determined using the anti-HA antibody. Of note, 
antibodies used for precipitation are visible on immunoblot as depicted by the arrows. n.a., no antibody; n.s.a., 
control antibody for non-specific binding. B) Cell surface expression of TRPV5 tetramers was determined by 
submitting biotinylated fractions to PFO-PAGE analysis.
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Figure 5 – Identification of key residues in N-terminal region of TRPV5. A) Multiple alignment of rabbit, 
human, rat and mouse TRPV5 protein sequences, respectively. Conserved residues Q31 and D34 are indicated. B) 
45Ca2+ influx in HEK293 cells transiently expressing TRPV5-WT (n=11), TRPV5-Δ1-32 (n=11), TRPV5-Δ1-34 (n=11), 
TRPV5-Δ1-36 (n=11) and TRPV5-Δ1-38 (n=11). TRPV5-mediated 45Ca2+ uptake is blocked by addition of 10 µM 
ruthenium red (RR). *,p < 0.05 versus TRPV5-WT control. Protein expression was determined by immunoblotting 
(insert) C) 45Ca2+ influx by TRPV5-WT (n=12), the double point mutant TRPV5-Q31A-D34A (n=11) and triple point 
mutant TRPV5-QQE-AAA (n=12). *,p < 0.05 versus TRPV5-WT control. D) Model of TRPV5 N-terminus showing 
residues 10-46 using YASARA. Mutated residues are indicated.
mutants were generated, TRPV5-Δ1-34 and TRPV5-Δ1-36. TRPV5 function was determined by 
introducing TRPV5-WT and the different deletion mutants into HEK293 cells, and subsequent 
the amount of 45Ca2+ influx was measured. Significant 45Ca2+ influx was observed for TRPV5-
WT and TRPV5-Δ1-32 (Figure 5B). In contrast, deletion mutants TRPV5-Δ1-34, -Δ1-36 and 
-Δ1-38 were not permeable for Ca2+ because they did not exhibit any TRPV5-mediated 45Ca2+ 
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influx (Figure 5B). Immunoblotting demonstrated the absence of complex glycosylation of 
TRPV5-Δ1-34, -Δ1-36 and -Δ1-38 (Figure 5B). Next, single point mutations were introduced in 
the TRPV5 protein to identify the residues critical for channel function. Based on alignments 
of the rabbit TRPV5 sequence with other species the conserved residues Q31 and D34, located 
around the N-terminal region essential for TRPV5 function, were selected (Figure 5A). To 
determine the effect of these residues in TRPV5 function the amino acids were mutated into an 
alanine and subsequently studied by assessing the 45Ca2+ influx. 45Ca2+ influx was significantly 
reduced in the double point mutant Q31A-D34A (Figure 5C). Furthermore, this mutant lacked 
complex glycosylation. TRPV5 modeling using the YASARA bioinformatics program suggested 
the presence of these critical residues within a helix (Figure 5D). Alanine substitution of three 
similar residues outside the helix (Q40, Q41 and E42), rendering a triple point mutant (QQE-
AAA), did not affect TRPV5 function (Figure 5C). 
30°C incubation recovers function of TRPV5-Δ1-38 and TRPV5-Q31A-D34A 
Retention of proteins at the endoplasmic reticulum, as was observed for TRPV5-Δ1-38, is often 
a result of protein misfolding.30 Incubation at lower temperatures is known to rescue proteins 
that are retained in the endoplasmic reticulum, allowing them to pass the endoplasmic 
quality control system.31,32 To investigate whether this procedure can recover the function of 
TRPV5-Δ1-38 and TRPV5-Q31A-D34A, HEK293 cells were transfected with these constructs and 
subsequently cultured at 30°C for 18 h. TRPV5 channel activity was measured by the influx of 
radioactive 45Ca2+. Activity of the TRPV5-Δ1-38 mutant channel was nearly recovered (Figure 
6A). Remarkably, 45Ca2+ influx was restored in the Q31A-D34A mutant, and immunoblotting 
demonstrated a double band (Figure 6A,B), indicating recovery of complex glycosylation.
Figure 6 – Activity of TRPV5-WT, TRPV5-Δ1-38 and TRPV5-Q31A-D34A in cells cultured at reduced 
temperature. A) 45Ca2+ influx in HEK293 cells transiently expressing mock construct (n=9), TRPV5-WT (n=9), 
TRPV5-Δ1-38 (n=9) and TRPV5-Q31A-D34A (n=9) cultured for 18 h at 37°C and 30°C respectively. *,p < 0.05 
versus TRPV5-WT. B) Protein expression of TRPV5-WT, TRPV5-Δ1-38 and TRPV5-Q31A-D34A as determined by 
immunoblotting.
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Discussion
This study demonstrated the instrumental role of the TRPV5 N-terminus in channel activity 
based on the following findings. Deletion of the first 38 residues of the N-terminus abolished 
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TRPV5 activity. The TRPV5-Δ1-38 protein exhibited no complex glycosylation and appeared 
to be retained in the endoplasmic reticulum. Hence, plasma membrane expression of 
TRPV5-Δ1-38 was strongly reduced. However, the TRPV5-Δ1-38 mutant is still able to form 
tetramers at the plasma membrane. Thus, although TRPV5-Δ1-38 channels reach the plasma 
membrane, they are not active, suggesting that the first 38 residues of the N-terminus are 
critical for the formation of a functional channel.
Mutation or removal of N-terminal regions abrogates function of many TRP channels 
studied,8,33-36 however the underlying mechanism remains poorly understood. Within the 
TRPV subfamily, N-terminal deletion mutants or splice variants of TRPV1, TRPV4 and TRPV6 
were investigated. Deletion of ankyrin repeats 1 and 3 in TRPV4 and ankyrin repeat 3 in 
TRPV6 disabled channel function. These channels could not tetramerize anymore.34,35 This 
suggests that certain ankyrin domains within the N-terminus are critical for proper channel 
tetramerization. Assembly dysfunction of TRPV4 resulted in retention in the endoplasmic 
reticulum, whereas the intracellular localization of the N-terminal TRPV6 mutant was not 
different from the wild-type channel.34,35 In TRPV1, deletion of the first 114 and more residues 
abrogated channel function.33 Interestingly, this is exactly the start of the first ankyrin repeat.9 
Plasma membrane expression was not different from the wild-type channel.33 Our study 
demonstrated that N-terminal deletion mutants were retained in the endoplasmic reticulum. 
Removal of the first ankyrin repeat (TRPV5-Δ1-75) did not affect channel tetramerization. Thus, 
elimination of essential ankyrin repeats disables the formation of tetramers, whereas deletion 
of other parts of the N-terminus abrogates channel function due to a different molecular 
mechanism. 
Functional and biochemical experiments revealed that removal of the first 38 residues of the 
TRPV5 N-terminus resulted in loss of channel function and lack of complex glycosylation. 
Furthermore, most of the TRPV5-Δ1-38 mutant was retained in the endoplasmic reticulum and 
did not reach the Golgi apparatus, which is in line with the lack of complex glycosylation. Quality 
control within the endoplasmic reticulum recognizes and retains misfolded proteins or protein 
complexes.30 Strikingly, some TRPV5-Δ1-38 complexes were not retained by the endoplasmic 
reticulum quality control and reached the plasma membrane. PFO-PAGE demonstrated that 
these mutants formed tetramers at the plasma membrane, however functional analysis did 
not show any current for these TRPV5-Δ1-38 tetramers. The absence of activity of TRPV5-Δ1-38 
tetramers at the plasma membrane together with the retention of the majority of protein in 
the endoplasmic reticulum indicates that the TRPV5-Δ1-38 subunits were probably not folded 
correctly. Thus, an intact TRPV5 N-terminus is not required for channel tetramerization, but the 
N-terminal residues 34 to 75 are probably essential for correct protein folding and thus normal 
channel function. The assembly of misfolded proteins into oligomers has been observed by 
others.37,38
Besides the role of the TRPV5 N-terminus in channel function, we made some other interesting 
observations during this study. First, the co-occurrence of TRPV5-Δ1-38 tetramerization and 
retention in the endoplasmic reticulum indicates that tetramerization of TRPV5 channels takes 
place in the endoplasmic reticulum. Oligomerization of proteins is indeed known to take place 
in the endoplasmic reticulum and is a prerequisite to pass quality control of the endoplasmic 
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reticulum.30,39 Second, several TRPV5-Δ1-38 mutants escaped the endoplasmic reticulum 
quality control eventually appearing at the plasma membrane. These channels did not display 
any complex glycosylation, indicating that this small subset of channels reached the plasma 
membrane without being processed by the Golgi apparatus. Protein targeting to the plasma 
membrane independent from the Golgi apparatus has been observed by others.40 Finally, we 
observed that the plasma membrane retrieval of TRPV5-Δ1-38 mutant was delayed. This could 
be related to the absence of complex glycosylation, which has been implicated in the retrieval 
of TRPV5 channels from the plasma membrane.28 This delayed retrieval overestimates the 
amount of TRPV5-Δ1-38 proteins that reaches the plasma membrane. 
In 2003, it was demonstrated that TRPV5 has a tetrameric stoichiometry, which results in a 
functional channel with an assumed ring-like structure around a central pore.23 A few years 
later, Chang et al. demonstrated interactions between GST-fused TRPV5 N-termini and between 
GST-fused TRPV5 N- and C-termini.22 The N-terminal residues 64-77 were necessary for these 
interactions and were therefore described as a multimerization domain. We demonstrated 
that deletion of residues 1-75 abolished channel function and that these channels were still 
able to form tetramers. Thus, although the TRPV5 N-termini interact, they are not critical for 
tetramerization of the channel. The TRPV5-Δ1-75 mutant lacks the multimerization domain 64-
77, possibly hindering proper folding into a functional channel. The role of the multimerization 
domain 64-77 in a TRPV5 tetramer remains to be investigated. 
In addition, we pinpointed the N-terminal residues essential for proper channel function. 
Therefore, TRPV5 protein sequences from several species were aligned and within the first 38 
N-terminal residues only several residues appeared to be conserved. Residues Q31 and D34 
were close or within the N-terminal region essential for TRPV5 function. Furthermore, modeling 
with delta endotoxin Cry8Ea1, displaying low sequence homology with the TRPV5 N-terminus, 
suggested that these residues were located in the center of a helix. Alanine substitution of Q31 
and D34 rendered a non-functional TRPV5 mutant, lacking complex glycosylation. Mutation of 
three similar residues, Q40, Q41 and E42, just outside the putative helix did not affect channel 
function. This indicates that the region around residues 31-34 might be essential for correct 
folding of the channel or binding of other factors. 
Finally, TRPV5-Δ1-38 and TRPV5-Q31A-D34A mutants were rescued at reduced temperature, 
pointing to misfolding as the reason for retention at the endoplasmic reticulum and inactivity 
at the membrane. For the TRPV5-Q31A-D34A mutant complex glycosylation was restored 
as well, suggesting recovery of trafficking through the Golgi apparatus. Thus, the putative 
helix around residues Q31A-D34A is of major structural importance, affecting both channel 
processing and function. 
This report demonstrated the essential role of the TRPV5 N-terminus in channel function. 
Deletion of the N-terminus from residue 34 and further abrogated channel function and 
resulted in endoplasmic retention. Interestingly, we found that the first 75 residues of TRPV5, 
containing the first ankyrin repeat, are not necessary for channel tetramerization. The role of 
other ankyrin repeats in TRPV5 tetramerization remains to be established. 
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Abstract
Epinephrine (Epi) and norepinephrine (NE) are present in the pro-urine. β-adrenergic receptor 
(β-AR) blockers administered to counteract sympathetic overstimulation in patients with 
congestive heart failure (CHF) have a negative inotropic effect, resulting in reduced cardiac 
contractility. Positive inotropes, β1-AR agonists, are used to improve cardiac functions. Active 
Ca2+ reabsorption in the late distal convoluted and connecting tubules (DCT2/CNT) is initiated 
by Ca2+ influx through the transient receptor potential vanilloid type 5 (TRPV5) Ca2+ channel. 
Although it was reported that β-ARs are present in the DCT2/CNT region, their role in active 
Ca2+ reabsorption remains elusive. Here we revealed that β1-AR, but not β2-AR is localized with 
TRPV5 in DCT2/CNT. Subsequently, treatment of TRPV5-expressing mouse DCT2/CNT primary 
cell cultures with the β1-AR agonist dobutamine showed enhanced apical-to-basolateral 
transepithelial Ca2+ transport. In human embryonic kidney (HEK293) cells, dobutamine 
was shown to stimulate cAMP production, signifying functional β1-AR-expression. Fura-2 
experiments demonstrated increased activity of TRPV5 in response to dobutamine, which 
could be prevented by the PKA inhibitor H89. Moreover, non-phosphorylable TRPV5-T709A 
and phosphorylation-mimicking TRPV5-T709D mutants were unresponsive to dobutamine. 
Surface biotinylation showed that dobutamine did not affect plasma membrane abundance of 
TRPV5. In conclusion, activation of β1-AR stimulates active Ca2+ reabsorption in DCT2/CNT; an 
increase in TRPV5 activity via PKA phosphorylation of residue T709 possibly plays an important 
role. These data explicate a calciotropic role in addition to the inotropic property of β1-AR. 
47
Activation of the β1-AR  stimulates TRPV5 activity
3
Introduction
Ca2+ plays a pivotal role in bone skeletal development and acts as a second messenger in 
excitatory cells; thus maintenance of Ca2+ homeostasis is vital for the body.1 Ca2+ balance is 
tightly regulated by three primary organs: the gastrointestinal tract, bone, and the kidney.1 
Ca2+ absorbed from the intestine is stored mostly in bone (99%) whereas the rest is either 
conjugated with other charged molecules or freely circulating in blood.2 The latter portion 
of Ca2+ is filtered in the glomerulus of the kidney and is reabsorbed to the circulation by the 
proximal tubule (PT, 65%), thick ascending limb of Henle’s loop (TAL, 20%), and DCT2/CNT 
(14%).3 Mechanisms of Ca2+ reabsorption in these three segments are of different origin: 
passive Ca2+ reabsorption through the paracellular space in the PT and TAL, dependent on the 
electrochemical gradient, whereas active transcellular Ca2+ reabsorption in the DCT2/CNT is 
energetically driven by ATP hydrolysis.1 Ca2+ transport in the TAL and DCT2/CNT is subject to 
regulation by several factors including G protein-coupled receptors (GPCRs).1 Agonists of two 
members of GPCRs i.e., Ca2+-sensing receptor (CaSR) and parathyroid hormone (PTH) receptor 
type 1, inhibit and stimulate Ca2+ reabsorption in TAL and in DCT2/CNT, respectively.4-6 
Active Ca2+ reabsorption in the DCT2/CNT is a crucial fine-tuning event determining final 
urinary Ca2+ excretion and consists of three consecutive steps: apical entry through the 
transient receptor potential vanilloid type 5 (TRPV5) Ca2+ channel, intracellular buffering and 
translocation to basolateral membrane by calbindin-D28k, and extrusion into the blood by the 
Na+/Ca2+ exchanger 1 (NCX1) and plasma membrane Ca2+ ATPase type 1b (PMCA1b).1,7,8 TRPV5-
mediated Ca2+ influx is the rate-limiting step for the active renal Ca2+ reabsorption as shown by 
hypercalciuria and osteopenia in TRPV5-deficient mice.3 Among six members of the vanilloid 
TRP family, TRPV5 is the most Ca2+-selective channel possessing a constitutive inward rectifying 
property at low intracellular Ca2+ concentrations and physiological membrane potentials. 
9-11 Therefore, the amount of Ca2+ influx through the channel depends on channel activity 
and plasma membrane abundance.3 TRPV5 activity and plasma membrane abundance are 
regulated by various factors, including GPCRs. For example, activation of bradykinin receptor 
type 2 (B2R) and PTH receptor type 1 (PTH1R) initiate phosphorylation of TRPV5 through PLC/
DAG/PKC and adenylyl cyclase/cAMP/PKA signaling cascades, respectively.6,12 
Epinephrine (Epi) and norepinephrine (NE) have diverse hormonal and neurotransmitter 
functions in the body. Epi and NE were shown to be present in pro-urine filtered from blood, 
but were also found to be synthesized by renal glomeruli/tubules and released from renal 
sympathetic nerves.13 Epi and NE can act through several members of GPCR adrenergic 
receptors: α1-AR, α2-AR, and three β-ARs. In kidney, α1-AR is expressed in arterioles whereas 
α2-AR is located predominantly in proximal tubules.14 α1-AR and α2-AR are responsible for 
stimulation of renal vasoconstriction and Na+ reabsorption, respectively.14 β-ARs can be divided 
into three subtypes: β1-AR, β2-AR, and β3-AR.15,16 β1 and β2-ARs are reportedly expressed in 
rat and mouse DCT, whereas β3-AR is not detectable in the kidney.17-20 The roles of β1- and β2-
ARs are well known respectively for myocardial contraction and vasodilation, whereas β3-AR is 
important for lipolysis.18,21 β-AR blockers (β-blockers) are frequently administered to counteract 
sympathetic overstimulation in patients with congestive heart failure (CHF), resulting in 
reduced cardiac contractility.22 Positive inotropes, β1-AR agonists, are used to improve cardiac 
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functions.22 Upon stimulation by Epi and NE, β-ARs activate Gα by the exchange of GDP for GTP, 
which can further enhance the activity of adenylyl cyclase (AC) and phospholipase C (PLC), 
mediators of cAMP/protein kinase A (cAMP/PKA)- and diacyl glycerol/protein kinase C (DAG/
PKC)-dependent phosphorylation, respectively.20
Even though Epi and NE are secreted in the pro-urine, to our knowledge, no effects of these 
hormones through signaling via β-ARs on renal active Ca2+ transport have been reported. We 
hypothesized that β-ARs regulate active Ca2+ reabsorption in DCT2/CNT. Thus, the present 
study aims to investigate i) co-localization of β1- and β2-AR with TRPV5 in DCT2/CNT; ii) the 
effect of β-AR activation by a β-AR agonist on active Ca2+ reabsorption; and iii) the molecular 
mechanism of TRPV5 activation by β-AR.
Experimental Procedures
Immunohistochemistry - Mouse kidney sections were incubated for 16 h at 4°C with rabbit 
polyclonal antibody against β1-AR (1:100) or β2-AR (1:300) (NB100-92439 and NBP1-68227, 
Novus Biologicals). To visualize the receptors, an enhancer step was performed using a 
biotinylated  goat anti-rabbit  antibody. Biotin was then coupled to streptavidin-HRP and 
visualized with Thyramid (TSA Fluorescein System, NEL701A001KT, Perkin Elmer). TRPV5 
staining was described previously.4 Negative controls, i.e. conjugated antibodies solely, were 
devoid of any staining.
Isolation of DCT2/CNT using COPAS sorting and primary cell culture - Transgenic mice expressing 
EGFP under the TRPV5 promoter were generated as described.23 Mice were maintained on a 
SSNIFF rodent complete diet (SSNIFF, Soest, Germany) with free access to water. The animal 
ethics board of Radboud University Nijmegen approved all of the experimental procedures. 
The process of renal tubular sorting by COPAS (Union Biometrica) has been described.24 
Approximately 4,000-10,000 tubules from one mouse were pelleted (800 x g, 5 min, 4°C) prior 
to culture or mRNA isolation as described below. For primary culture 2,000 fluorescent tubules, 
a mixture of tubules from two mice, were resuspended into warmed cell culture medium 
(Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F12, Invitrogen) with supplements 
as described24 and seeded onto 0.33 cm2 polycarbonate Transwell® inserts (Corning Costar) 
previously coated with rat-tail collagen (16 µl per insert of 0.75 mg/ml collagen in 95% v/v 
ethanol with 0.25% v/v acetic acid). Volumes used in the apical and basolateral compartments 
were 100 µl and 600 µl, respectively. Cells were cultured at 37°C in 5% v/v CO2-95% v/v 
atmospheric air and the medium was refreshed every day. 
45Ca2+ transport measurement - For radioactive 45Ca2+ transport experiments, primary cells 
cultured on Transwell® inserts as described above were used. Cells were used 7 to 8 days 
after seeding; the day prior to the experiment transepithelial electrical resistance (TEER) was 
measured using an epithelial volt-ohmmeter (EVOM, World Precision Instruments). Cells were 
pretreated by adding 5 µM indomethacin to the culture medium for 30 min. Culture medium 
was removed and cells were washed once with physiological salt solution (PSS: 140 mM NaCl, 
2 mM KCl, 1 mM K2HPO4, 1 mM MgCl2, 1 mM CaCl2, 5 mM D-glucose, 5 mM L-alanine, 5 µM 
indomethacin, 10 mM HEPES/Tris, pH 7.4.). The apical compartment contained 100 µl and the 
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basolateral compartment contained 600 μl. Physiological salt solution was replaced with the 
same volumes of the pre-warmed identical solution with and without 10 μM dobutamine 
hydrochloride (sc-203031, Santa Cruz Biotechnology); the apical medium contained 3 µCi/ml 
45Ca2+. Ten microliters of basolateral medium was collected at time points 0, 15, 30, 60, 120 
and 180 min and analyzed for radioactivity in a PerkinElmer Life Sciences liquid scintillation 
counter. Unidirectional flux from the apical side to the basolateral side (JA→B) was calculated as 
described previously.25 
Semi-quantitative real-time PCR - To evaluate mRNA expression, RNA was extracted from 
pellets of 1,000 tubules isolated by COPAS using TRIzol® Reagent (Invitrogen) according 
to the manufacturer’s protocol. The obtained RNA was reverse-transcribed by Moloney 
murine leukemia virus reverse transcriptase (Invitrogen). cDNA was used to determine 
mRNA expression levels by real-time PCR of Adrb1 (β1-AR) and Adrb2 (β2-AR). As controls 
Trpv5 and Slc12a1 (Na-K-Cl cotransporter 2, NKCC2) were included. The housekeeping 
gene Gapdh was used as an endogenous control. Primers targeting the genes of interest 
were designed using Primer3 and are listed in Table 1. Normal PCR using AmpliTaq Gold® 
(Invitrogen) was performed on HEK293 cDNA to check for β1-AR and β2-AR expression 
(primers: ADRB1 F, CCCAGAAGCAGGTGAAGAAG R, CCCAGCCAGTTGAAGAAGAC, ADRB2 F, 
GGCAGCTCCAGAAGATTGAC, R, TGGAAGGCAATCCTGAAATC), products were visualized on a 
1.5% w/v agarose gel. 
Table 1 - Mus Musculus oligonuceotide sequences used in real-time PCR 
Gene Forward primer (5’-3’) Reverse primer (5’-3’)
Adrb1 GATCTGGTCATGGGATTGCT AAGTCCAGAGCTCGCAGAAG
Adrb2 CCTTAACTGGTTGGGCTACG GCTCTTGAAAGGCAATCCTG
Trpv5 CTGGAGCTTGTGGTTTCCTC TCCACTTCAGGCTCACCAG
Slc12a1 GGCTTGATCTTTGCTTTTGC CCATCATTGAATCGCTCTCC
Gapdh TAACATCAAATGGGGTGAGG GGTTCACACCCATCACAAAC
Adrb1, β1-adrenergic receptor gene; Adrb2, β2-adrenergic receptor gene; Trpv5, transient receptor potential 
vanilloid type 5 gene; Slc12a1, Na-K-Cl cotransporter 2 gene (NKCC2); Gapdh, glyceraldehyde-3-phosphate 
dehydrogenase gene.
Cell culture and transfection - HEK293 cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM, Bio Whittaker) containing 10% v/v fetal calf serum (PAA), 2 mM L-glutamine, 10 μL/
mL non-essential amino acids at 37°C in a humidity controlled incubator with 5% CO2. Cells 
were transiently transfected with the appropriate plasmids using polyethyleneimine (PEI, 
PolySciences Inc) with a DNA:PEI ratio of 1:6 for biochemical or live-cell imaging experiments. 
Cell surface biotinylation and immunoblotting - HEK293 cells (9 × 104 cells/cm2) were plated and 
transfected with 5 μg TRPV5-HA pCINeo/IRES-EGFP or pCINeo/IRES-EGFP in 10-cm dishes. At 
24 h after transfection cells were re-seeded on poly-L lysine (Sigma) coated 6-well plates. At 
48 h after transfection, cells were incubated for 1 h with 10 μM dobutamine or vehicle. Cells 
were homogenized in 1 ml of lysis buffer as described previously using the NHS-LC-LC-biotin 
(Pierce).6 Finally, biotinylated proteins were precipitated using neutravidin beads (Pierce). 
TRPV5 expression was analyzed by immunoblotting for the precipitates (plasma membrane 
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fraction) and for the total cell lysates using the anti-HA antibody.6
Intracellular Ca2+ and cAMP measurements using Fura-2 AM and EPAC-EGFP-mCherry - For 
combined [Ca2+]i and cAMP measurements, HEK293 cells were seeded onto coverslips (Ø 25 
mm) and co-transfected with the cAMP sensor (exchange protein directly activated by cAMP, 
(EPAC)-EGFP-mCherry,26 kindly provided by Dr. K. Jalink) for cAMP measurements, and the 
appropriate TRPV5 pCINeo/IRES-EGFP construct from which the sequence encoding EGFP was 
deleted. After 24 h, cells were loaded with 3 μM Fura-2 AM (Molecular Probes) and 0.01% v/v 
Pluronic F-129 (Molecular Probes) in DMEM medium at 37°C for 20 min. After loading, cells were 
washed with PBS and allowed to equilibrate at 37°C for another 10 min in HEPES-Tris buffer 
(in mM: 132.0 NaCl, 4.2 KCl, 1.4 CaCl2, 1.0 MgCl2, 5.5 D-glucose and 10.0 HEPES/Tris, pH 7.4). 
Changes in [Ca2+]i and cAMP were simultaneously monitored, using a modified Fura-2 protocol 
allowing simultaneous measurements of Ca2+ and cAMP.10 Briefly, the cAMP sensor EPAC 
EGFP-mCherry was excited at 488 using a monochromator. Fluorescence emission light was 
directed by a 525DRLP dichroic mirror (Omega Optical Inc.) through a 535af26 emission filter 
(EGFP fluorescence) and a 565ALP emission filter (mCherry fluorescence) onto a CoolSNAP HQ 
monochrome CCD-camera. The integration time of the CCD-camera was set at 200 ms with a 
sampling interval of 5 s. All measurements were performed at room temperature. Quantitative 
image analysis was performed with Metamorph 6.0 (Molecular Devices Corporation). For each 
wavelength, the mean fluorescence intensity was monitored in an intracellular region and, for 
purpose of background correction, an extracellular region of identical size. After background 
correction, the fluorescence emission ratio of 340 nm and 380 nm excitation was calculated to 
determine the [Ca2+]i while the fluorescence emission ratio of the red and green fluorescence 
of the cAMP sensor was used to determine changes in cellular cAMP content. 
Statistical analysis - If not specified otherwise, the data are expressed as mean ± S.E. The 
significant differences between the means of two groups were analyzed by unpaired Student’s 
t test using the measurements per cell/sample (n≥9) of at least three independent experiments. 
The level of statistical significance is p < 0.05. All data were analyzed using GraphPad Prism. 
Results
β1-AR and β2-AR are expressed in DCT2/CNT
To investigate the role of β1-AR and β2-AR on active Ca2+ reabsorption in DCT2/CNT, 
immunohistochemical staining was performed on frozen mouse kidney sections. Stainings 
showed co-localization of β1-AR with TRPV5 in DCT2/CNT segments, but not β2-AR (Figure 
1A,C). β1-AR and β2-AR antibody specificity was evaluated by negative controls of secondary 
antibody only (Figure 1B, neg ctrl panel) and staining of liver tissue (Figure 1B, liver panel) 
reported to be negative for both β1-AR and β2-AR.27,28 mRNA expression of β1-AR (Adrb1) and 
β2-AR (Adrb2) in DCT2/CNT cells isolated from pTRPV5-EGFP mice using the COPAS Biosorter, 
was determined by real-time PCR. Results showed that both β1-AR and β2-AR are enriched 
in DCT2/CNT compared with total kidney cortex material, although the expression level 
of β1-AR is considerably higher (Figure 2A), especially compared with the negative control 
NKCC2 (Slc12a1) normally expressed in TAL. TRPV5 expression was used as a positive control. 
Altogether, these results indicated that β1-AR is expressed at the DCT2/CNT part of the 
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nephron together with TRPV5. At the cellular level, only part of the β1-AR signal did co-localize 
with TRPV5, suggesting expression in both apical and basolateral areas (Figure 1C).
Dobutamine stimulates transcellular Ca2+ transport in mouse DCT2/CNT
To examine the role of β1-AR stimulation on Ca2+ reabsorption in the distal part of the 
nephron, primary DCT2/CNT tubules were cultured on Transwell inserts for 7/8 days allowing 
the formation of tight monolayers (transepithelial electrical resistance of 603±80 Ω·cm2 1 
day prior to the experiment). Transepithelial transport of Ca2+ from the apical to basolateral 
compartment was measured by apical addition of 45Ca2+ in the presence or absence of 10 µM 
dobutamine, a specific β1-AR agonist, in both the apical and basolateral solution. Transport 
of Ca2+ was significantly increased by 10 μM dobutamine (19±2 and 30±4 nmol·hr-1·cm-2 for 
control and dobutamine, respectively, p < 0.05) after 60 min (Figure 2B). 
β1-AR agonist stimulates cAMP production in HEK293 cells
To study the role of the Ca2+ channel TRPV5 in β1-AR-mediated activation of transcellular Ca2+ 
transport, we examined the effect of dobutamine in HEK293 cells, which were reported to 
express β1-AR.29 First, the expression of β1- and β2-AR in HEK293 cells was confirmed (Figure 
3). Identity of the observed bands was verified by sequencing of the respective PCR products. 
Because β1-AR activation leads to cAMP production18 the β1-AR-mediated TRPV5 Ca2+ influx 
β1-AR
TRPV5
merge merge
TRPV5
β2-AR
merge
TRPV5
β2-ARβ1-AR
TRPV5
merge 20 µm20 µm 10 µm 10 µm
A C
B
β1-ARmerge merge
β2-ARβ1-AR
neg ctrl
β2-ARβ1-AR
liver
Figure 1 – β1-AR and β2-AR expression in mouse kidney. A) Localization of β1-AR, β2-AR, and TRPV5 is 
depicted by immunohistochemistry on mouse kidney tissue. B) Negative controls of secondary antibody 
only and stainings of liver tissue are shown. C) Higher magnification immunohistochemistry pictures of the 
localization of β1-AR, β2-AR, and TRPV5 are shown.
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in HEK293 cells transfected with the cAMP sensor 
EPAC and TRPV5 was studied as described under 
“Experimental Procedures”. The EPAC and Fura-2 ratios 
were measured before (t=0 min, t0) and after (t=3 min, 
t3) dobutamine treatment (10 μM) (Figure 4A,D). The 
EPAC ratio plotted at t0 and t3 indicated a significant 
increase in cAMP levels after a 2-min incubation with 
dobutamine as measured by a 5.1±0.1% increase in 
the EGFP:mcherry ratio due to loss of the FRET signal 
upon binding of cAMP (Figure 4B). Fura-2 ratios 
were increased by 19.5±0.3% upon stimulation by 
dobutamine (Figure 4E).  The dobutamine-induced 
increase in EPAC and Fura-2 ratio was dose-dependent (Figure 4C,F), implying that β1-AR 
signaling can functionally stimulate TRPV5 activity in HEK293 cells.
Dobutamine does not change TRPV5 protein abundance at the plasma membrane
Ca2+ influx through TRPV5 is regulated by plasma membrane abundance and activity of the 
channel.3 The effect of dobutamine on TRPV5 plasma membrane expression was assessed 
in HEK293 cells transiently transfected with TRPV5 using cell surface biotinylation. A 60-min 
incubation with 10 μM dobutamine did not affect plasma membrane abundance of TRPV5 
(Figure 5A,B). Total expression of TRPV5 in the dobutamine-treated cells did not differ from 
control as well (Figure 5A).
Dobutamine stimulates TRPV5-mediated Ca2+ uptake in HEK293 cells via PKA 
phosphorylation of T709 residue
TRPV5 channel activity is known to be stimulated by cAMP/PKA-mediated pathways.6 HEK293 
cells were transfected with TRPV5 and loaded with the Fura-2 Ca2+-sensor to measure Ca2+ 
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Figure 2 – Effect of β1-AR agonist (10 μM dobutamine) on transepithelial Ca2+ transport in mouse DCT2/
CNT primary cultured monolayers. A) mRNA enrichment of β1-AR (Adrb1) and β2-AR (Adrb2) in isolated 
mouse DCT2/CNT cells compared with total kidney cortex; TRPV5 (Trpv5) was used as positive control, NKCC2 
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Figure 3 – Expression of β1- and β2-AR in 
HEK293 cells. + and - signify PCR products 
of reverse-transcribed and non-reverse-
transcribed mRNA, respectively. Product 
sizes were 346 bp for β1-AR and 328 bp for 
β2-AR.
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Figure 4 – Effect of β1-AR agonist dobutamine on cAMP production and Ca2+ uptake in HEK293 cells 
transiently transfected with TRPV5 and EPAC sensor. A) Averaged EPAC trace upon the addition of 10 
μM dobutamine (Dob) (n=60 cells). B) EPAC ratios before (t0) and after (t3) dobutamine stimulation. *,p < 
0.05 compared with t0 (n=60 cells). C) Dose-response curve of the effect of dobutamine treatment on cAMP 
production as measured by EPAC ratios (t3 compared with t0) (n=28-76 cells/condition). D) Averaged Fura-2 trace 
upon the addition of 10 μM dobutamine (Dob) (n=59 cells). E) Fura-2 ratios demonstrated before (t0) and after 
(t3) dobutamine stimulation. *,p < 0.05 compared with t0 (n=59 cells). F) Dose-response curve of the effect of 
dobutamine treatment on Ca2+ uptake as measured by Fura-2 ratios (t3 compared with t0) (29-70 cells/condition).
Figure 5 – Effect of β1-AR agonist on plasma membrane abundance of TRPV5. A) TRPV5-transfected HEK293 
cells were treated for 60 min with or without 10 μM dobutamine. NHS-LC-LC-biotin was added to medium for 
30 min before the cells were lysed, and the biotinylated (plasma membrane) fraction was pulled down using 
neutravidin-agarose beads. Representative immunoblot for TRPV5 analyzed for plasma membrane and total 
expression. CTRL, control; Dob, dobutamine-treated. B) Calculated immunoblot densities (n=9).
54
Chapter 3
3
uptake. After a 1-min incubation with dobutamine, Ca2+ uptake reached maximal activation, ~2 
times elevated compared with basal uptake levels (Figure 6A). Interestingly, these stimulatory 
effects were prevented when the cells were preincubated (30 min) with the PKA inhibitor, 
H89 (Figure 6A,B), indicating that β1-AR activation is mediated by PKA phosphorylation 
of the TRPV5 channel. Previously, threonine residue 709 on the C-terminus of TRPV5 was 
identified as the sole TRPV5 PKA phosphorylation site.10 To study the effects of dobutamine 
on phosphorylation of TRPV5 at this residue, TRPV5-WT, non-phosphorylated mutant TRPV5-
T709A, and the TRPV5-T709D mutant mimicking phosphorylation at this residue were used. 
The stimulatory effect of dobutamine was absent in the non-phosphorylable TRPV5-T709A 
mutant and the phosphorylation-mimicking TRPV5-T709D mutant, the latter already showing 
activation, indicating that the T709 residue is crucial for β1-AR-mediated PKA phosphorylation 
(Figure 6C,D).
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Figure 6 – Effect of β1-AR agonist on TRPV5-dependent Ca2+ uptake. A) Averaged Fura-2 traces of mock (n=10 
cells), TRPV5-WT transfected preincubated with PKA inhibitor, H89, 10 μM (n=26) and without (n=12) upon the 
addition of 1 μM dobutamine. B) Fura-2 levels before (open bars) and after (filled bars) dobutamine stimulation 
of mock-transfected (n=10 cells), TRPV5-WT (n=12), and H89-treated TRPV5-WT (n=26) *,p < 0.05 compared with 
untreated mock. #,p < 0.05 compared with the respective dobutamine untreated (t0). C) Averaged Fura-2 traces 
of TRPV5-T709A (n=21) and TRPV5-T709D (n=20 cells) mutants upon the addition of dobutamine compared 
with TRPV5-WT (n=12). D) Fura-2 levels demonstrated before (open bars) and after (filled bars) dobutamine 
stimulation of TRPV5-WT (n=12 cells), TRPV5-T709A (n=21), and TRPV5-T709D (n=20) #,p < 0.05 compared with 
untreated WT.
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Discussion
The present study indicates that activation of β1-AR stimulates TRPV5-mediated Ca2+ 
transepithelial transport via PKA phosphorylation of the Ca2+ channel. Our conclusion relies 
on the following findings: i) β1-AR co-localizes with TRPV5 in mouse DCT2/CNT; ii) the β1-AR 
agonist dobutamine stimulates cAMP production and TRPV5-mediated Ca2+ uptake in HEK293 
cells; iii) dobutamine increases the TRPV5 channel activity which can be prevented by the PKA 
inhibitor H89 and mutation of the channel at the T709 residue; iv) dobutamine stimulates the 
apical-to-basolateral transepithelial Ca2+ flux in the mouse primary DCT2/CNT culture.
To our knowledge, the expression profile and the consequences of activation of β-ARs in 
mouse DCT2/CNT have not been characterized. Boivin and colleagues elaborately investigated 
β1- and β2-ARs in rat kidney by immunohistochemistry.17 In their study, β2-AR is faintly present 
in DCT and undetectable in CNT,17 while in our study β2-AR did not co-localize with TRPV5 in 
the mice DCT2/CNT. For β1-AR, Boivin et al. showed co-localization with calbindin-D28k on the 
apical membrane17 in line with our finding that β1-AR co-localizes with TRPV5, although we did 
not observe a clear apical localization. 
Gesek and White demonstrated that the immortalized mouse DCT cell line expresses both 
β1- and β2-ARs.30 In the present study, both receptors were detected by PCR in material 
from DCT2/CNT as isolated by the COPAS biosorter. Considering the lower amounts of β2-
AR detected in highly enriched DCT2/CNT material, combined with the absence of β2-AR in 
immunohistological stainings in DCT2/CNT, we conclude that β2-AR seems not present in the 
DCT2/CNT. Gesek and Friedman showed that isoproterenol stimulated both cAMP production 
and Na+ uptake, but not Ca2+ influx into the cells.31 However, they selected thiazide-sensitive 
DCT1 cells, which contain no TRPV5, resulting in very low Ca2+ transport rates.20,24,31 In contrast, 
in the present study, DCT2/CNT tubules were selectively sorted from TRPV5-expressing cells. In 
the polarized mouse primary DCT2/CNT culture we demonstrated that dobutamine stimulates 
apical-to-basolateral transepithelial Ca2+ transport. Due to generally lower expression levels of 
β1-AR, in primary cultures compared with the in vivo situation, relatively high concentrations 
of dobutamine were applied (10 µM) to stimulate transepithelial Ca2+ transport maximally.
HEK293 cells are generally used as a model for studying molecular mechanism of TRPV5-
mediated Ca2+ uptake because they lack endogenous expression of this Ca2+ channel,32 
allowing transfection of exogenous wild-type or residue-specific TRPV5 mutants. In addition, 
due to overexpression of TRPV5 faster and stronger effects are to be expected compared 
with primary cultures. Moreover, the cells were reported to express β1-AR, which could be 
stimulated by a non-specific β-AR agonist isoproterenol, showing enhanced cAMP synthesis.29 
Here, we show that the intracellular level of cAMP is increased within minutes after addition 
of dobutamine, indicating that β1-AR was functionally expressed in HEK293 cells and that the 
cells are suitable for studying β1-AR-initiated intracellular signaling. Accordingly, dobutamine 
was demonstrated to stimulate Ca2+ uptake in TRPV5-expressing HEK293 cells with maximal 
activation at 2 min. This rapid action of the agonist is likely nongenomic as exemplified by 
the hormonal action of PTH on TRPV5 activity that exerted similar maximal stimulation within 
2 min. It is reported that TRPV5 activation is stimulated by the cAMP-dependent PTH1R 
signaling pathway leading to PKA-mediated phosphorylation of TRPV5 on the C-terminus 
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of the channel.6 Moreover, Topala and colleagues showed that the activation of the Ca2+-
sensing receptor (CaSR) induces TRPV5-mediated Ca2+ peak current in <1 s.4 They elaborated 
that the CaSR-agonist neomycin mediated PKC phosphorylation of the residues S299 and 
S654. Interestingly, Gkika and co-workers demonstrated that long-term (1-h) stimulation of 
bradykinin receptor type 2 (B2R) with tissue kallikrein resulted in increased plasma membrane 
accumulation of TRPV5.12 In the present study, however, 1-h dobutamine incubation did not 
affect plasma membrane abundance or total expression of TRPV5. Altogether, activation of β1-
AR enhanced TRPV5 activity via cAMP-dependent PKA phosphorylation of the TRPV5 channel 
at residue T709 in the intracellular C-terminus. 
Apart from the classic cAMP-dependent signaling mechanism of β-ARs, β1-AR has been 
reported to be PLC-dependent.20 In the study by Kang and colleagues, a non-specific 
β-AR agonist isoproterenol stimulated Mg2+ uptake in isolated mouse DCT1 cell culture.20 
Isoproterenol is known to bind preferentially to β1-AR and to a lesser extent to β2-AR. In the 
latter study, both PKA and PLC inhibitors inhibited the stimulatory effects of isoproterenol. 
Phorbol 12-myristate-13-acetate (PMA), a DAG analog, had no effect on Mg2+ reabsorption, but 
potentiated effects of isoproterenol.20 There is no report of dobutamine action on signaling 
mechanisms other than the cAMP-dependent pathway and the PKA inhibitor H89 completely 
blocked the dobutamine action. Thus, the β1-AR signaling pathway in the present study seems 
to be mediated solely by the cAMP/PKA. 
The present study indicates a novel calciotropic role of dobutamine in renal DCT2/CNT in 
addition to the positive inotropic effect in cardiac myocytes. In addition, β-blockers widely 
used in treatment of CHF might have adverse effects on maintaining body Ca2+ homeostasis. 
CHF initiates when the heart fails to supply sufficient blood to match the body demand due 
to reduced cardiac contractility.21,33 Heart rate is accelerated,34 leading to a decreased effective 
circulating volume, which in turn triggers the renin-angiotensin-aldosterone system in the 
kidney.35 As a result of CHF, patients develop secondary aldosteronism leading to increased 
fecal and urinary Ca2+ excretion.36 In addition, patients are generally treated with loop diuretics 
and often suffer from vitamin D deficiency.36,37 Moreover, hypercalciuria and osteopenia have 
been implicated in patients with advanced CHF awaiting cardiac transplantation.36,38 Hence, 
potential calciotropic effects of β-blockers might further increase chances of developing 
hypocalcemia in these patients. In addition, β-blockers are used to resolve hypercalcemia 
among other symptoms in hyperthyroidism.39,40 The mechanism of action of β-blockers in 
hyperthyroidism is unclear, but principally appears to antagonize overstimulated β-AR-
mediated signaling. Interestingly, the Ca2+-lowering effect of propranolol (nonselective 
β-blocker) was proposed to be caused by a direct effect on bone or renal Ca2+ handling.40
In conclusion, the present study demonstrates that dobutamine, a β1-AR agonist, stimulates 
TRPV5 activity via a PKA-dependent pathway. PKA activation results in phosphorylation of 
the T709 residue and consequently enhances TRPV5 activity. Epi and NE, by activating TRPV5 
activity, could potentially be involved in normal physiological renal Ca2+ handling in the DCT2/
CNT. Therefore, β-adrenergic receptor agonists and blockers, increasingly administered to 
patients, potentially exert adverse calciotropic effects.
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Abstract
Fine-tuning of renal calcium ion (Ca2+) reabsorption takes place in the distal convoluted and 
connecting tubules (distal convolution) of the kidney via transcellular Ca2+ transport, a process 
controlled by the epithelial Ca2+ channel transient receptor potential vanilloid 5 (TRPV5). 
Studies to delineate the molecular mechanism of transcellular Ca2+ transport are seriously 
hampered by the lack of a suitable cell model. The present study describes the establishment 
and validation of a primary murine cell model of the distal convolution. Viable kidney tubules 
were isolated from mice expressing enhanced Green Fluorescent Protein (EGFP) under the 
control of a TRPV5 promoter (pTRPV5-EGFP), using Complex Object Parametric Analyser and 
Sorting (COPAS) technology. Tubules were grown into tight monolayers on semi-permeable 
supports. Radioactive 45Ca2+ assays showed apical-to-basolateral transport rates of 13.5±1.2 
nmol/hr/cm2, which were enhanced by the calciotropic hormones parathyroid hormone and 
1,25-dihydroxy vitamin D3. Cell cultures lacking TRPV5, generated by crossbreeding pTRPV5-
EGFP with TRPV5 knockout mice (TRPV5-/-), showed significantly reduced transepithelial 
Ca2+ transport (26% of control), for the first time directly confirming the key role of TRPV5. 
Most importantly, using this cell model, a novel molecular player in transepithelial Ca2+ 
transport was identified: mRNA analysis revealed that ATP-dependent Ca2+-ATPase 4 (PMCA4) 
instead of PMCA1 was enriched in isolated tubules and downregulated in TRPV5-/- material. 
Immunohistochemical stainings confirmed co-localization of PMCA4 with TRPV5 in the distal 
convolution. In conclusion, a novel primary cell model with TRPV5-dependent Ca2+ transport 
characteristics was successfully established, enabling comprehensive studies of transcellular 
Ca2+ transport. 
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Introduction
Ca2+ reabsorption in the kidney is a critical step in maintaining total body Ca2+ homeostasis. 
Most of the Ca2+ filtered through the glomerulus is reabsorbed along the nephron, since only 
1-2% of the Ca2+ is excreted in urine. Ca2+ reabsorption occurs largely through paracellular 
transport in the proximal part of the nephron (65-70%) and the thick ascending limb (TAL, 20-
25%).1 However, in the distal part of the nephron, the final concentration of Ca2+ in the urine is 
determined by the regulated process of active transcellular Ca2+ reabsorption.1-3
The distal convolution comprises the second part of the distal convoluted tubule (DCT) 
and connecting tubule (CNT). Here, the epithelial Ca2+ channel transient receptor potential 
vanilloid 5 (TRPV5) is located at the apical cell membrane and allows influx of Ca2+ from the 
pro-urine into the cell.4 After entry into the cell, Ca2+ is transported towards the basolateral 
side, via the Ca2+-binding protein calbindin-D28k and is extruded into the blood by the ATP-
dependent Ca2+-ATPase (PMCA1) and the Na+-Ca2+ exchanger (NCX1).5,6 NCX1 is considered 
to be the predominant mechanism of extrusion, accounting for ~70% of the extruded Ca2+.7-9 
Ca2+ influx through the Ca2+ channel TRPV5 is tightly regulated by many factors, most importantly 
the calciotropic hormones 1,25-dihydroxy vitamin D3 (1,25-(OH)2D3) and parathyroid hormone 
(PTH), both regulating TRPV5 expression.10,11 PTH directly stimulates activity of TRPV5 via cAMP 
signaling and subsequent phosphorylation of the channel by Protein Kinase A (PKA).12 TRPV5 
activity is inhibited through Protein Kinase C-dependent phosphorylation by plasmin, present 
in the urine of patients with Nephrotic Syndrome.13 Other factors regulate TRPV5 plasma 
membrane abundance and subsequent activity, such as the hormone klotho and tissue 
kallikrein. Klotho is co-expressed in the distal part of the nephron, regulating the function 
of TRPV5 by modifying its N-glycan, leading to stabilization of the channel on the plasma 
membrane.14,15 Calciotropic hormones also regulate other components of transcellular Ca2+ 
transport. Calbindin-D28k and NCX1 levels are upregulated by PTH and 1,25-(OH)2D3 in vivo
10,11 
and PMCA1 expression was found to be increased by 1,25-(OH)2D3 in a Madin-Darby canine 
kidney (MDCK) cell model16 as well as in vivo.10 
The exact mechanism of the interplay between the apical influx, intracellular movement 
and basolateral extrusion in transcellular Ca2+ transport has not been clarified to date and is 
difficult to study due to the lack of a polarized cell model with Ca2+ transporting characteristics 
closely resembling the in vivo situation. Available cell models such as the MDCK cell line show 
very low Ca2+ transport rates.16,17 Other cell models which have higher Ca2+ transport levels, 
are the murine distal convoluted tubule cell line (mpkDCT),18 primary DCT/CNT cells isolated 
by microdissection18 and the rabbit kidney connecting tubule and cortical collecting duct 
primary culture.19 However, the utility of these cell models is limited. Firstly, the existing mouse 
mpkDCT cell line is not responsive to the important calciotropic hormone PTH, indicating that 
essential pathways might be missing.18 Second, microdissection of tubular fragments is too 
laborious for isolation of large numbers of tubule fragments to perform extensive primary cell 
culture studies. Thirdly, a mouse model is preferable over rabbit, in part because of the ready 
availability of primers and knockout animals. In the current study, we present a novel primary 
cell culture of the mouse distal convolution, showing TRPV5-dependent transcellular Ca2+ 
transport. By a combined approach of transgenic mice expressing enhanced Green Fluorescent 
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Protein (EGFP) under the control of a TRPV5 promoter,20 and the Complex Object Parametric 
Analyser and Sorter (COPAS) technology, distal convolution segments could be automatically 
sorted. This approach enables us to obtain large amounts of high quality and functional tubule 
segments. The primary cell model facilitates the study of different key players in transcellular 
Ca2+ transport. For example, we here exploit the model to demonstrate that PMCA4, and not 
PMCA1, may be the key Ca2+ ATPase involved in renal hormone regulated transcellular Ca2+ 
reabsorption.
Experimental Procedures
Transgenic mice - Transgenic mice expressing EGFP under control of the TRPV5 promotor 
(pTRPV5-EGFP) were generated as described by Hofmeister et al., 2009.20 TRPV5-/- mice 
were crossbred with pTRPV5-EGFP mice in order to generate pTRPV5-EGFP/TRPV5-/- mice. 
Mice were housed with free access to an SSNIFF rodent complete diet (SSNIFF, Soest, 
Germany) and water. The animal ethics board of Radboud University Nijmegen approved 
all the experimental procedures. Genotype was assessed by PCR, using primers:  Forward: 
ATGGTGAGCAAGGGCGAGGAGCT and Reverse: GCCGAGAGTGATCCCGGCCGCGGT to select for 
EGFP expression. Mice homozygous or heterozygous for EGFP could not be distinguished so 
both were selected. TRPV5-/- mice were genotyped as described previously.21
Immunohistochemistry - Immunohistochemistry for TRPV5 was performed as described.22 
Mouse kidney sections were incubated for 16 h at 4°C with guinea pig anti-TRPV5 antiserum 
(1:50). Anti-guinea pig secondary Alexa Fluor® 594 conjugated antibodies (1:300, A-11076, 
Molecular Probes, Eugene, USA) were used to visualize TRPV5 proteins. For PMCA4 co-stainings 
sections were treated as described with the addition of anti-PMCA4 (1:200 Abcam, ab2783). 
The PMCA4 proteins were visualized with a secondary antibody anti-mouse Alexa Fluor® 488 
(1:300, A-11029, Molecular Probes, Eugene, USA). Negative controls of conjugated antibodies 
solely, were devoid of any staining.
Isolation of distal convolution using COPAS biosorter - Distal convolution segments were isolated 
using the COPAS Biosorter (Union Biometrica, Holliston, MA) as described by Markadieu et al. 
and optimized for the distal convolution.23 In short: mice aged 4-6 weeks were anesthetized 
(ketamine 0.1 mg/g body weight and xylazine 0.01 mg/g) and perfused with ice-cold KREBS 
buffer. The kidney cortex was dissected, minced, and subjected to three subsequent digestion 
steps: incubation in 7 ml of digestion solution composed of 1 mg/ml collagenase type 1 
(Worthington Biochemical Corporation, Lakewood, NJ) and 0.9 mg/ml hyaluronidase (H3884, 
Sigma) in KREBS buffer, for 15 min, 6-8 min and 5-7 min at 37°C respectively,23 with each 
digestion followed by filtration. The tubule suspension was filtered through a 100-µm sieve and 
collected on a 40-µm sieve (BD Biosciences, Breda, the Netherlands). The material remaining 
on the 100-µm sieve was subjected to additional digestion steps as described above. Tubules 
collected from the three digestions were mixed, kept on ice and sorted by the COPAS Biosorter. 
Tubules were sorted using the enhanced mode configuration, sort region parameters: vertex: 
x 100 a.u., y 14 a.u.; polygon: x 100 a.u., y 14 a.u.. Using this protocol, an estimated 2,000 EGFP-
expressing tubules were sorted per hour, and between 4,000 and 10,000 tubules per mouse 
were collected. Isolated tubules were kept on ice until all were sorted, after which the tubules 
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were pelleted (800 x g, 5 min, 4°C).
Real-time PCR - mRNA from distal convolution tubules was extracted using TRIzol® Reagent 
(Invitrogen). Briefly, pellets of 1,000 COPAS sorted tubules were treated with 100 µl TRIzol®, and 
mRNA was extracted using chloroform and isopropanol as described in the manufacturer’s 
protocol. Reverse Transcription reaction was performed using M-MLV Reverse Transcriptase 
(Invitrogen) according to manufacturer’s protocol, except that RNasin® (Promega) was used as 
an RNase inhibitor. Real-time PCR was performed with the use of iQ SYBR Green Supermix (Bio-
rad) using exon-overlapping primer sets (Table 1). Gapdh was used as a housekeeping gene. 
Table 1 - Primers sets used for real-time PCR analysis
Gene Position within ORF Forward primer (5’-3’) Reverse primer (5’-3’)
Gapdh 293-312, 453-434 TAACATCAAATGGGGTGAGG GGTTCACACCCATCACAAAC
Slc12a1 1001-1020, 1103-1084 GGCTTGATCTTTGCTTTTGC CCATCATTGAATCGCTCTCC
Pvalb 46-65, 146-127 CGCTGAGGACATCAAGAAGG CCGGGTTCTTTTTCTTCAGG
Slc23a3 1070-1089, 1191-1172 CTTCGGCCACTGGCATTCTG GATGGCAAGGTAGGAGATGG
Trpv5 924-943, 1011-993 CTGGAGCTTGTGGTTTCCTC TCCACTTCAGGCTCACCAG
Calb1 211-230, 308-289 GACGGAAGTGGTTACCTGGA ATTTCCGGTGATAGCTCCAA
Kl 914-933, 1018-999 GGTTGCCCACAACCTACTTT TGGGAGCTTAAGGCGATAGA
Slc8a1 1857-1876, 2052-2033 CTCCCTTGTGCTTGAGGAAC CAGTGGCTGCTTGTCATCAT
Atp2b1 2454-2473, 2546-2527 GTCACCGGCCTTACGTGTAT TCCAGCCCTCTGACATTTCT
Atp2b4 541-560, 682-663 CTTAATGGACCTGCGAAAGC ATCTGCAGGGTTCCCAGATA
Scnn1a 1585-1604, 1712-1693 CATGCCTGGAGTCAACAATG CCATAAAAGCAGGCTCATCC
Aqp2 154-173, 511-492 CACGCTCCTTTTCGTCTTCT GGTCAGGAAGAGCTCCACAG
Slc12a1, NKCC2; Pvalb, parvalbumin; Slc12a3, NCC; Calb1, calbindin-D28k, Kl, klotho; Slc8a1, NCX1 (exon B specific 
primers); Atp2b1, PMCA1; Atp2b4, PMCA4; Scnn1a, ENaC.
Primary cell culture - Two thousand fluorescent tubules were pelleted, and suspended into a 
pre-warmed cell culture medium (DMEM/Ham’s F12, Invitrogen, #11039) supplemented with 
60 nM sodium selenite, 5 µg/ml transferrin, 2 mM L-glutamine, 50 nM dexamethasone, 1 nM 
triiodothyronine, 10 ng/ml epidermal growth factor, 2% v/v fetal calf serum, 6 µg/ml insulin, 
13 mM D-glucose, 0.5 mM sodium pyruvate, 20 µg/ml ciproxin, and 5 mM HEPES/NaOH pH 
7.3.23 Tubules were seeded onto 0.33 cm2 polycarbonate Transwell® inserts (Corning Costar, cat. 
#3413) previously coated with rat tail collagen (16 µl per insert of 0.75 mg/ml collagen in 95% 
v/v ethanol with 0.25% v/v acetic acid). Volumes used in apical and basolateral compartments 
were 100 µl and 600 µl, respectively, according to the manufacturer’s recommendations. 
Tubules were cultured at 37°C in 5% v/v CO2 and the medium was refreshed every day. 
Ca2+ concentration measurements - Medium from apical and basolateral compartments was 
collected and diluted 4 times in Milli-Q water. Standards were prepared using 0.5 mM CaCl2 
standard (Hach, 21277-16). Five microlitres of sample was mixed with 200 µl freshly mixed 
buffer: 10% v/v Ca2+ buffer (3.5 M 2 amino-2-methylpropan-1-ol, pH 10.7 with HCl) and 10% 
v/v chromogen (0.15 mM phthalein purple, 6.89 mM 8-hydroxyquinoline, 0.06 M HCl) in Milli-Q 
water. Absorbance at 570 nm was measured using a microplate spectrophotometer (Bio-rad, 
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Benchmark Plus).
45Ca2+ transport assays - The epithelial resistance was measured one day prior to the assay. 
Seven to eight days after seeding, monolayers were preincubated with 5 µM indomethacin in 
culture medium for 30 min. Assays were conducted at 37°C, all buffers were pre-warmed. Cells 
were washed with physiological salt solution (PSS) containing 140 mM NaCl, 2 mM KCl, 1 mM 
K2HPO4, 1 mM MgCl2, 1 mM CaCl2, 5 mM D-glucose, 5 mM L-alanine, 5 µM indomethacin, 10 mM 
HEPES/Tris, pH 7.4. Subsequently, apical buffer was replaced with PSS (100 µl) containing 3 µCi/
ml 45Ca2+. Basolateral buffer (600 µl) was replaced with PSS. Buffers were supplemented with 
either the desired compounds or solvent: 10 µM forskolin (Sigma), 100 nM PTH (Sigma). To study 
transport in the absence of Na+, in PSS 140 mM NaCl was replaced by equal amounts of NMDG. 
Cells were incubated at 37°C. Ten microlitre samples were taken apically and basolaterally at 
time-point 0; basolateral samples were taken at subsequent time points: 15, 30, 60, 120 and 
180 min and analysed for radioactivity using a liquid scintillation counter. Transport rate was 
calculated from the slope of the linear part of the time range, t=0-120 min. 
Immunoblotting - Immunoblotting of TRPV5 protein was performed on kidney lysates from 
wild-type and TRPV5-/- mice (100 µg total protein per sample). The membrane was incubated 
in 1:50 diluted rabbit anti-TRPV5 antibody (generated by O. Bonny et al.) in PBS overnight at 
4°C. Next the membrane was incubated with anti-rabbit secondary antibody conjugated with 
HRP and visualized with ECL plus. The membrane was then stripped and exposed to anti-actin 
antibody (1:500, Sigma).
Immunocytochemistry - Tubules were cultured on Transwell® inserts as described above. 
At day 7, monolayers were pre-treated for 10 h with 100 nM 1,25-(OH)2D3 and prepared for 
immunocytochemistry as described.23 Filters were incubated overnight at 4°C in 1:250 diluted 
anti-TRPV5 (raised in rabbit, generated by O. Bonny et al.) in goat serum dilution buffer (16% v/v 
goat serum in PBS pH 7.4). Next, filters were washed with PBS and incubated for 1 hr at room 
temperature in 1:300 diluted Alexa Fluor® 594 conjugated anti-rabbit IgG (Molecular Probes, 
A11012) in goat serum dilution buffer in the dark. Filters were mounted on coverslips using 
Mowiol (Polysciences Europe GmbH, Eppelheim, Germany). Images were obtained using an 
Olympus FV1000 Confocal Laser Scanning Micropscope using a x60 oil-immersion objective. 
Statistical analysis - Results are expressed as mean ± S.E. of at least three independent 
experiments and at least three different sortings from different mice. Significance of the results 
was determined by one-way ANOVA, followed by Bonferroni post-test in case of significance. 
Except for 45Ca2+ experiments and quantification of PMCA4 stainings, these results were 
evaluated by the unpaired Student’s t test. p values < 0.05 were considered significant. 
Results
Isolation of EGFP-expressing distal convolution segments
To isolate distal convolution tubule fragments, kidneys from mice expressing EGFP under the 
control of the TRPV5 promoter were used.20 Expression of EGFP in the distal convolution was 
confirmed by the co-localization of EGFP with immunohistochemical staining of TRPV5 (Figure 
1A). To collect substantial amounts of EGFP-expressing distal convolution fragments, mice 
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kidneys were isolated, digested and applied to the COPAS Biosorter. Tubule fragments were 
selected based on EGFP expression levels (fluorescence) and particle size (Figure 1B). 
RNA was isolated from 1,000 sorted fragments to evaluate purity, which was assessed by real-time 
PCR measurements of mRNA expression levels of specific tubular markers. Control fragments, 
representing total cortex material, were sorted based on size only. Expression levels of the 
distal convolution markers TRPV5, calbindin-D28k (CB28k) and NCX1 were markedly enriched 
(17-25 fold) in the fluorescence-sorted fragments when compared to the control samples of 
the total cortex material (Figure 2A). Expression of klotho, a regulator of TRPV5-dependent Ca2+ 
transport in the distal convolution,14 was 7-fold higher in the sorted distal convolution tubules. 
Interestingly, PMCA1 was not significantly enriched in our distal convolution material, whereas 
expression of PMCA4 was found to be increased 18-fold. Impurity of the isolated preparation 
with other tubular segments was assessed using markers for neighbouring segments. The 
Na-K-Cl cotransporter (NKCC2), a marker for TAL, was not enriched. The specific DCT markers 
parvalbumin (PV) and the Na-Cl co-transporter (NCC) were expressed 3- and 7-fold higher, 
respectively, in the sorted tubules compared to the control material (Figure 2A). 
Transepithelial Ca2+ transport across distal convolution monolayers
Functional characteristics of Ca2+ transport in the isolated distal convolution cells were studied 
by generating polarized primary cell monolayers. Primary cultures were obtained by seeding 
2,000 sorted tubule fragments onto 0.33 cm2 transwell inserts. The basolateral membrane 
of the cells will attach on the transwell surface and subsequently the tubule structure will 
open and grow into a tight cell monolayer. Transepithelial electrical resistance (TEER) of the 
cell monolayer increased to 755±62 Ω·cm2 on day 6 (Figure 2B) and remained stable for at 
Figure 1 - Characterization of EGFP-sorted tubules. 
A) Co-localization of EGFP (green) and TRPV5 (red) in a 
section of the renal cortex in pTRPV5-EGFP mice. The 
lower panel is the merged red and green images above. 
B) 1,000 tubules were sorted within a defined window, 
enabling collection of the fragments of proper size and 
EGFP expression levels. Each dot represents one tubule 
fragment as detected by the COPAS.
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least 3 days. Within the same time frame, a lumen negative potential difference of -38±2 mV 
developed across the monolayer (Figure 2C). During culturing, apical and basolateral media 
were refreshed and collected every 24 h. After 7 days the Ca2+ concentration in the apical 
compartment dropped from 1.0 mM to 0.3 mM (Figure 2D). 
Stimulation of transepithelial Ca2+ transport by calciotropic hormones
As the cultured monolayers demonstrate transcellular Ca2+ transport, we tested the 
responsiveness of the primary cultures to calciotropic hormones. A 45Ca2+ flux assay was used 
to study the regulation of transepithelial Ca2+ transport in our primary distal convolution 
cultures. After 7-8 days of culturing, monolayers were pre-treated with 5 µM indomethacin for 
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Figure 2 – Characterization of distal convolution cell monolayers. A) Real-time PCR was performed on mRNA 
samples extracted from 1,000 fluorescently sorted tubules as compared to tubules sorted based on size only 
(total cortex material). Results are normalized to Gapdh housekeeping gene and presented relative to control of 
non-fluorescently sorted material. Results are given as mean ± SE, n=5. *,p < 0.0001, p < 0.01 for PV as compared to 
total cortex material. B) Development of transepithelial resistance ( x cm2) was assessed over 8 days of culturing. 
Resistance was measured after every 24 h using an epithelial Volt-Ohm meter. Results are given as mean ± SE, 
n=6-44 for days 2 to 8 respectively. C) Potential differences (mV, lumen negative) were measured in parallel to 
transepithelial resistance every 24 h. Results are expressed as mean ± SE, n=3-31 for days 2 to 8 respectively. D) 
During culturing medium containing 1 mM of Ca2+ was changed and collected every 24 h. Ca2+ concentrations 
(mM) in 24 h conditioned medium were determined for apical (closed circles) and basolateral compartments 
(open circles). Results are expressed as mean ± SE, n=5-16, for days 2 to 8. *,p < 0.001 as compared to day 2.
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Transepithelial Ca2+ transport across distal convolution monolayers is mediated by TRPV5 
In order to assess whether Ca2+ transport in the distal convolution derived monolayers is 
mediated by TRPV5, TRPV5 knockout (TRPV5-/-) mice were crossbred with pTRPV5-EGFP mice 
in order to generate pTRPV5-EGFP/TRPV5-/- mice. Kidneys were subsequently processed, and 
tubules sorted and cultured in parallel with pTRPV5-EGFP expressing fragments. Real-time 
PCR analysis showed that the expression levels of the key players in Ca2+ transport, namely 
calbindin-D28k, klotho, and NCX1 were significantly reduced in TRPV5
-/- distal convolution tubule 
fragments compared to wild-type tubules (Figure 4A). Interestingly, PMCA1 expression levels 
were not changed, whereas PMCA4 levels were significantly lower in kidneys of TRPV5-/- mice. 
As a control for sorting of identical distal convolution tubule fragments for TRPV5+/+ and TRPV5-
/-, mRNA levels of PV, NCC, the epithelial sodium channel (ENaC) and aquaporin 2 (AQP2) were 
analysed and were found unchanged (Figure 4A). Absence of TRPV5 protein in TRPV5-/- mice 
was confirmed by immunoblot (Figure 4B). After 7 days of culturing, TRPV5 protein expression 
could be detected on the apical membranes of cell monolayers derived from wild-type tubules 
by immunocytochemistry. Despite pre-treatment for 10 h with 1,25-(OH)2D3, positive staining 
for TRPV5 was absent in TRPV5-/- derived cell monolayers (Figure 4C). Expression of EGFP from 
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Figure 3 – Stimulation of Ca2+ transport in distal convolution cultures by PTH and 1,25-OH2D3. A) The Ca
2+ 
transport rate was assessed in tubules cultured for 7-8 days by measuring transport (nmol/cm2) of 45Ca2+ from the 
apical side to the basolateral compartment in the presence of 1 mM Ca2+ at time points up to 180 min. Results 
are presented as mean ± SE, n=23-32 respectively for time points 0-180 min. B) Ca2+ transport was assessed 
in the presence of 10 µM forskolin (n=11) and 100 nM PTH (n=13) as well as in cells treated for 24 h with 100 
nM 1,25-(OH)2D3 (n=5), all both in apical and basolateral medium. Results were normalized for cell monolayers 
treated with solvent control and presented as mean ± SE. *,p < 0.05 as compared to untreated monolayers.
30 min, in order to inhibit prostaglandin synthesis.24 Next, cell cultures were washed once with 
physiological salt solution (PSS) and the apical side was subsequently exposed to PSS containing 
3 µCi/ml 45Ca2+, all in the presence of 1 mM Ca2+. An apical-to-basolateral Ca2+ transport rate 
of 13.5±1.2 nmol/hr/cm2 was measured (Figure 3A) during the first 2 h. Ca2+ transport was 
significantly enhanced in the presence of forskolin (10 µM, in apical and basolateral medium) 
(Figure 3B). The calciotropic hormone PTH (100 nM) had a similar stimulatory effect on Ca2+ 
transport across the distal convolution cultures. Furthermore, cell monolayers treated for 24 h 
with 1,25-(OH)2D3 (100 nM) showed over 2 times more Ca
2+ transport compared to untreated 
cultures. 
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the TRPV5 promoter region was similar for wild-type and TRPV5-/- cultures. Most importantly, 
a marked reduction in transepithelial Ca2+ transport was observed in TRPV5-/- primary cultures 
compared to wild-type cultures (4±1 nmol/hr/cm2 versus 17±2 nmol/hr/cm2, respectively, p < 
0.05) (Figure 4D). Moreover, Ca2+ concentrations in the apical culture medium did not decrease 
during culturing of TRPV5-/- tubules as was previously described above for wild-type (data not 
shown).
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Figure 4 – Ca2+ transport in distal convolution cultures is TRPV5-mediated. A) pTRPV5-EGFP mice were 
crossbred with TRPV5-/- mice, generating pTRPV5-EGFP/TRPV5-/- mice. In parallel with wild-type tubules, 1,000 
tubules from the knockout were sorted and mRNA was isolated. Results were normalized to Gapdh and 
expression levels were calculated against wild-type. Results are expressed as mean ± SE, n=5. *,p < 0.01 as 
compared to wild-type. B) TRPV5 protein expression in wild-type and TRPV5-/- kidney lysates; actin was used 
as a loading control. C) Tubules from pTRPV5-EGFP and pTRPV5-EGFP/TRPV5-/- mice were isolated and cultured 
in parallel. TRPV5 protein expression (red) was detected by immunocytochemistry in monolayers cultured on 
transwell inserts for 7 days. pTRPV5-EGFP expression (green) was visualized using excitation at 488 nm. D) Ca2+ 
transport (nmol/cm2/hr) in monolayers derived from wild-type and TRPV5-/- tubules was measured by apically 
applying 45Ca2+. Results are presented as mean ± SE, n=5. *,p < 0.001 as compared to wild-type.
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PMCA4 is proposed to be the key Ca2+-ATPase responsible for transepithelial Ca2+ transport 
in the distal convolution
PMCA4, but not PMCA1 mRNA, was demonstrated to be enriched in distal convolution tubule 
material. In addition, PMCA4 mRNA levels were significantly reduced in TRPV5-/- tubules similar 
to the identified key players of transepithelial Ca2+ transport. To confirm the role of PMCA4 
in transepithelial Ca2+ transport in the distal convolution, expression of PMCA4 protein was 
assessed by immunohistochemical staining of wild-type and TRPV5-/- kidney tissues. PMCA4 
exclusively co-localized with TRPV5 in the distal convolution, where it was expressed at 
the basolateral side (Figure 5A). In TRPV5-/- kidney tissues, PMCA4 expression levels were 
significantly reduced, as determined by quantification of the PMCA4 signal compared to wild-
type mice (Figure 5A,B). To study the basolateral extrusion mechanism in the distal convolution, 
45Ca2+ transport was measured in the presence and absence of Na+, thereby disrupting efflux of 
Ca2+ through NCX1 and leaving transport by PMCAs intact. In the absence of Na+ (replaced by 
NMDG+) a significant drop of 49% in Ca2+ transport was observed as compared to an identical 
physiological buffer with NaCl (Figure 5C).
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Figure 5 - PMCA4 is proposed as the key Ca2+-ATPase in the distal convolution. A) Co-localization of PMCA4 
(green) and TRPV5 (red) in a section of the renal cortex of both wild-type and TRPV5-/- mice. B) Quantification 
of the PMCA4 protein expression levels as assessed by immunohistochemistry in TRPV5-/- mice under equal 
conditions of exposure and compared to wild-type. Results are expressed as mean ± SE, n=47 different tubules 
for wild-type and n=39 for TRPV5-/-. *,p < 0.0001 as compared to wild-type. C) Ca2+ transport was assessed in 
the presence (NaCl) and absence (NMDG) of Na+ (n=11), all both in apical and basolateral medium. Results are 
expressed as mean ± SE. *,p < 0.01 as compared cell monolayers assessed in the presence of Na+.
Discussion
By the combined use of the COPAS technology and pTRPV5-EGFP mice, we established a novel 
primary cell model of the distal convolution that allows examination of the molecular aspects 
of transcellular Ca2+ transport. Distal convolution characteristics were confirmed in the sorted 
tubules, since mRNA expression levels of all known key players in transcellular Ca2+ transport 
were significantly enriched. Secondly, when seeded on semi-permeable transwell inserts, distal 
convolution fragments developed tight monolayers and demonstrated robust transepithelial 
Ca2+ transport after 7 days, which could be enhanced by the calciotropic hormones PTH and 
72
Chapter 4
4
1,25-(OH)2D3. Thirdly, expression of TRPV5 protein was demonstrated at the apical membranes 
after 7 days of culturing and its role as gatekeeper of Ca2+ transport was confirmed by using cell 
cultures derived from TRPV5-/- animals, demonstrating greatly reduced Ca2+ transport levels. 
Finally, making use of the unique properties of this primary cell system, we propose PMCA4, 
but not PMCA1, as the main PMCA isoform playing a role in hormone-regulated transcellular 
Ca2+ transport.
Using the COPAS Biosorter in combination with mice expressing EGFP under the control of a 
TRPV5 promoter region, viable distal convolution tubule fragments were easily and reproducibly 
collected, especially when compared to tubules obtained by manual microdissection.18 
Contamination with TAL was negligible, as observed by low expression levels of NKCC2. Based 
on the expression of PV and NCC, only minor contribution of DCT1 fragments was anticipated. 
Furthermore, our distal convolution cell model showed a Ca2+ transport rate noticeably higher 
than in microdissected primary DCT cultures and the mpkDCT cell lines.18 
Importantly, key regulatory pathways remained intact in the cultured primary tubules, as 
was observed from stimulation of Ca2+ transport by the calciotropic hormones 1,25-(OH)2D3 
and PTH. This is in contrast to the pre-existing mpkDCT cell lines, in which no response to 
PTH treatment was observed.18 Short-term responses to PTH have been reported to be 
mediated through a cAMP/PKA and PKC phosphorylation pathway25,26 and are likely to act 
on the TRPV5 channel. It has been reported that PTH can act on the TRPV5 channel through 
both pathways.12,27 Hence, the observed increase in transepithelial Ca2+ transport in response 
to PTH is probably caused by activation of the TRPV5 channel. Moreover, our finding that 
forskolin and PTH equally enhanced Ca2+ transport in our primary culture, suggests a role 
for the cAMP pathway in the response to PTH. Furthermore, regulation of Ca2+ transport by 
1,25-(OH)2D3 suggests that regulatory mechanisms on a transcriptional level are also preserved. 
1,25-(OH)2D3 is known to control mRNA expression levels of TRPV5, calbindin-D28k and NCX1, as 
was demonstrated in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice, which are not able 
to synthesize 1,25-(OH)2D3 from its inactive metabolite.
10 The conservation of the machinery 
for regulated transepithelial Ca2+ transport in our culture model, i.e. the relevant receptors, 
second messenger coupling, as well as effector transport proteins, allows for detailed studies 
of transcellular Ca2+ transport and its regulation. It can be expected that other, yet unknown, 
regulatory pathways will be preserved in the primary cells as well. Hence, we obtained a highly 
responsive novel primary distal convolution culture exhibiting robust Ca2+ transport rates, with 
the advantage of using the genetically well-defined and easily maintainable mouse models 
enabling us to make new discoveries pertaining to transcellular Ca2+ transport. 
By using distal convolution tubules isolated from TRPV5-/- mice, we demonstrated for the first 
time that Ca2+ transport in the distal part of the nephron is mainly dependent on the presence 
of TRPV5, substantiating the claim that TRPV5 is the gatekeeper of transcellular Ca2+ transport 
in the distal convolution. In addition, the absence of TRPV5 greatly affects expression of other 
known key players in Ca2+ transport, including calbindin-D28k and NCX1
21,28 and the novel 
candidate PMCA4. 
The basolateral extrusion mechanism was studied using Na+-free conditions, in order to 
block NCX1 function. A 49% drop in Ca2+ transport, as compared to a 74% drop in TRPV5-/- 
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tubules is in perfect agreement with the previously proposed ratio in which two-thirds of Ca2+ 
is extruded by NCX1 and one-third by PMCAs.7-9 Interestingly, PMCA1, generally thought to 
be the major Ca2+ transporting ATPase in the distal convolution,7,9 was not enriched in our 
distal convolution tubule fragments. Previously, PMCA1 and PMCA4 proteins were reported 
to be expressed in murine DCT cells.29 The other two PMCA proteins, PMCA2 and PMCA3, are 
present in low amounts in kidney, but not in DCT cells.29 In our DCT2/CNT tubule fragments, 
PMCA4 expression was enhanced in an order similar to TRPV5 and NCX1, suggesting a 
functional role of this transporter in transepithelial Ca2+ transport in the distal convolution. 
Moreover, immunohistochemistry demonstrated PMCA4 expression on the basolateral side 
of TRPV5-expressing cells. The proposed role of PMCA4 in transepithelial Ca2+ transport is 
supported by mRNA expression levels in tubule fragments from TRPV5-/- mice and protein 
levels in immunohistochemical stainings, where PMCA4 expression was significantly 
decreased, similar to the other key players in renal transcellular Ca2+ transport (calbindin-D28k 
and NCX1). In contrast, PMCA1 mRNA levels were not changed in these tubules. Expression 
levels of components of transepithelial Ca2+ transport have previously been shown to be 
co-regulated. Our findings are in agreement with previous studies showing that calbindin-
D28k and NCX1 were concomitantly downregulated in TRPV5
-/- animals.21 These animals lack 
high levels of Ca2+ influx through absence of TRPV5, suggesting that Ca2+ influx regulates 
expression of the other Ca2+ transporting proteins, including PMCA4. This is not due to altered 
PTH and 1,25-(OH)2D3 levels, since PTH levels were unchanged and 1,25-(OH)2D3 levels were 
even higher in TRPV5 knockout animals (which would lead to increased expression levels of 
Ca2+ transport proteins, rather than the decreased levels found in this study).21 Furthermore, 
whereas independent animal studies (e.g. in klotho knockout mice, 25-hydroxyvitaminD3-1α-
hydroxylase knockout mice, and parathyroidectomized rats) confirmed that TRPV5, calbindin-
D28k and NCX1 expression levels were all co-regulated, PMCA1 levels were not regulated 
under these conditions.10,11,30 Kip et al. demonstrated the importance of the PMCA4 gene in 
Ca2+ transport in an MDCK cell model by PMCA4 anti-sense knockdown.9 Characterization of 
PMCA1 and PMCA4 knockout animals indicated that knockout of PMCA1 is embryonic lethal, 
whereas PMCA4 knockout mice appear healthy but have more subtle abnormalities, such as 
male infertility and osteopenia due to increased osteoclasts on the bone surface.31,32 As far as 
we know there is no data available on urine and serum Ca2+ levels in PMCA4 knockout mice. 
Altogether, PMCA4 appears to be the major Ca2+-ATPase in the distal convolution involved 
in transcellular Ca2+ transport, whereas PMCA1 has a more general housekeeping function. 
Further studies using knockout mice models are necessary to elucidate the precise interplay of 
NCX1, PMCA4 and PMCA1 in transcellular Ca2+ transport. However, compensatory mechanisms 
should be taken into account when using these mice models.
In conclusion, the use of the pTRPV5-EGFP mice and the COPAS to sort EGFP-expressing distal 
convolution, repeatedly and consistently led to the establishment of highly responsive novel 
primary cultures with many characteristics of the intact distal convolution cells. In addition, by 
crossbreeding pTRPV5-EGFP mice with knockout animals, high-quality transgenic cell models 
can be established relatively easily, as we have done for TRPV5. This enables more detailed 
studies of transcellular Ca2+ transport and regulation, such as the mechanisms of Ca2+ entry by 
TRPV5 and Ca
2+ extrusion. As we now discovered PMCA4, and not PMCA1, as a co-regulated 
component of transepithelial Ca2+ transport in the distal convolution.
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Abstract
Fine-tuning of renal calcium (Ca2+) reabsorption takes place in the late distal convoluted and 
connecting tubules (DCT2/CNT) of the kidney via transcellular Ca2+ transport. The Na+/Ca2+ 
exchanger 1 (NCX1) is responsible for ~70% of basolateral Ca2+ extrusion. Since the other 
major Ca2+ transporters in the process of renal transcellular Ca2+ transport, TRPV5, and the 
plasma membrane Ca2+ ATPases PMCA1/4, are regulated by the Ca2+-sensor calmodulin and 
as multiple calmodulin binding sites were predicted in the renal splice variant NCX1.3 in silico, 
we investigated whether calmodulin is a regulator of NCX1.3. In this study, we demonstrated a 
stimulatory action of calmodulin on the renal isoform of NCX1 (NCX1.3), resulting in enhanced 
exchanger activity as studied by uptake of Ca2+ by function of the exchanger in the reverse-
mode. In addition, overexpression of calmodulin increased NCX1.3 protein levels, indicating 
stabilization of NCX1.3 by binding of calmodulin. Interestingly, this process appeared to be 
largely Ca2+-independent, while the effect on exchanger activity was dependent of Ca2+ 
binding to calmodulin. Mutation of key residue L696 within a potential calmodulin binding 
site abolished stimulation of NCX1.3 activity, whereas the positive effect of calmodulin on 
NCX1 protein levels and binding of calmodulin to NCX1.3 remained intact. Hence, calmodulin 
increases NCX1.3 activity through binding to the region in close proximity to residue L696.
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Introduction
The Na+/Ca2+ exchanger 1 (NCX1) is widely expressed in the body and generally controls 
intracellular calcium (Ca2+) levels by extruding Ca2+ from the cell. However, in the kidney NCX1 
is also part of a highly regulated process of transcellular Ca2+ reabsorption, thereby regulating 
final loss of Ca2+ via the urine and thus overall Ca2+ balance.1,2 In the late distal convoluted and 
connecting tubules (DCT2/CNT) of the nephron, the epithelial Ca2+ channel transient receptor 
potential vanilloid 5 (TRPV5) is responsible for entry of Ca2+ from the tubular lumen.3 Thereafter, 
Ca2+ is shuttled towards the basolateral side,4,5 where it is extruded towards the blood by the 
ATP-dependent plasma membrane Ca2+-ATPases (PMCA1/4) and the Na+-Ca2+ exchanger 
(NCX1).6 NCX1 is considered to be the predominant extrusion mechanism, accounting for 
~70% of the extruded Ca2+,7-9 thereby playing a key role in the process of renal transcellular 
Ca2+ reabsorption. 
Three NCX isoforms exist: NCX1, NCX2 and NCX3, which are structurally highly similar.8,10 NCX 
consists of 10 transmembrane segments and a large regulatory cytosolic loop. The cytosolic loop 
contains two Ca2+-binding domains (CBD1 and CBD2), of which the CBD2 region is subjective 
to alternative splicing.10,11 NCX1 splice variants have a tissue-specific distribution. NCX1 was 
first cloned from cardiac tissue (NCX1.1), where its crucial role in myocyte contraction has been 
extensively studied.12,13 However, studies on the function and regulation of the kidney specific 
variants are limited. In kidney, different NCX variants have been identified, NCX1.2 (exons BCD), 
NCX1.3 (exons BD) and NCX1.7 (exons BDF).14-16 For NCX1.2 and NCX1.3 a role in Ca2+ transport 
has been shown in immortalized mouse distal convoluted tubule (DCT) cells.16 NCX1.3 is 
considered to be the predominant variant and is often described as the renal NCX1.11,17,18 
Transcellular Ca2+ transport in the kidney is a tightly regulated process, modulated by several 
hormones and other factors implicated in Ca2+ homeostasis. The calciotropic hormones 
1,25-dihydroxy vitamin D3 (1,25-(OH)2D3) and parathyroid hormone (PTH) being the most 
important.19 Both were found to elevate expression levels of the identified Ca
2+ transporting 
proteins: TRPV5, calbindin-D28k and NCX1, resulting in increased transcellular Ca
2+ transport.20-22 
Hence, expression levels of the different components appear to be coordinately regulated. In 
addition, extensive research led to the identification of many factors directly regulating TRPV5 
channel function.23 The Ca2+-sensing protein calmodulin was found to be a crucial regulator of 
TRPV5 by providing it with a negative feedback mechanism in case of high intracellular Ca2+ 
levels.24 In addition, calmodulin is well known to release the PMCA pump from auto-inhibition, 
thereby being essential for PMCA1/4 functioning.25 Li et al. identified a predicted calmodulin 
binding site in the so-called XIP (exchanger inhibitory peptide) region of NCX1. However, this 
region was shown to bind calmodulin as a peptide only, and interestingly XIP peptides were 
shown to inhibit NCX and PMCA function. Interaction of calmodulin with NCX1 has never been 
observed so far.26,27 
The aim of the present study was to investigate which NCX1 variants are expressed in Ca2+ 
transporting epithelia in the kidney and to gain more insight in the role of calmodulin on 
renal NCX1 function by determining the binding of calmodulin to NCX1 and identification of 
potential calmodulin binding sites.
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Experimental Procedures
Cloning of NCX1 variants from mice kidney and generation of NCX1 mutant constructs - To generate 
NCX1 cDNA, total mice kidney mRNA was extracted using TRIzol® (Invitrogen) and processed 
using RQ1 DNase and M-MLV Reverse Transcriptase (Invitrogen) using RNasin® (Promega, 
Madison, WI, USA) as a RNase inhibitor, according to the manufacturer’s protocols. NCX primers 
(Table 1) were designed based on NCBI Reference Sequence: NM_011406.2, with the addition 
of a sequence for restriction digest using MluI and AscI respectively. PCR was performed using 
Phusion® High-fidelity DNA polymerase (Invitrogen). Products were isolated from agarose gel, 
MluI and AscI digested and ligated into the pCINeo-IRES-EGFP vector. Subsequently, pCINeo-
mNCX1.2-IRES-EGFP, pCINeo-mNCX1.3-IRES-EGFP and pCINeo-mNCX1.7-IRES-EGFP plasmid 
DNAs were recovered from transformed E.coli clones. pCINeo-mNCX1.3-IRES-EGFP constructs 
with specific mutations were obtained using the QuikChange site-directed mutagenesis kit 
(Agilent, Amstelveen, the Netherlands) according to the manufacturer’s protocol. All obtained 
constructs were verified by sequencing of the NCX1 open reading frame and applied restriction 
sites. 
Table 1 - Oligonucleotide sequences applied in (real-time) PCR
Gene Application Forward primer (5’-3’) Reverse primer (5’-3’)
Slc8a1 Cloning ATGCTTCGATTAAGTCTCCCA TTAGAAGCCCTTTATGTGGCA
Slc8a1 PCR splice site AGAGCATTGGCATCATGGA CAGTGGCTGCTTGTCATCAT
GAPDH Real-time PCR GGAGTCAACGGATTTGGTCGTA GGCAACAATATCCACTTTACCAGAGT
Slc8a1 Real-time PCR CTCCCTTGTGCTTGAGGAAC CAGTGGCTGCTTGTCATCAT
Slc8a1, murine Na+/Ca2+ exchanger 1 gene (NCX1); GAPDH, human glyceraldehyde-3-phosphate dehydrogenase 
gene. 
PCR/gel electrophoresis - PCR was performed using homemade Taq polymerase (1 µl) in 10 mM 
Tris-HCl, 50 mM KCl, 0.01% v/v gelatin, 2.5 mM MgCl2, 1 mM dNTPs and 0.2 µM of each primer 
(Table 1). Late DCT and connecting tubule (DCT2/CNT) cDNA was isolated by fluorescent 
sorting.28 PCR products were run on a 2% w/v agarose gel.   
Cell culture and transfection - HEK293(T) cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM, Bio Whittaker Europe, Vervier, Belgium) containing 10% v/v fetal calf serum 
(PAA, Linz, Austria), 2 mM L-glutamine, 10 μl/ml non-essential amino acids at 37°C and 5% 
v/v CO2. Cells were transiently transfected using Lipofectamine® 2000 (Invitrogen, 2 μl/μg 
DNA). For co-transfection of pCINeo-NCX1.3-IRES-EGFP with pCINeo-IRES-EGFP or pCINeo-
rCaM-IRES-EGFP, constructs were used in a ratio of 1:1.5. pCINeo-rCaM-IRES-EGFP constructs 
containing the rat calmodulin (CaM) and calmodulin with all four Ca2+ binding EF-hands being 
mutated, Δcalmodulin (ΔCaM), were obtained by subcloning from the pBF vector.29-31
Intracellular Ca2+ measurements using Fura-2 - After 24 hour transfection, HEK293 cells were 
re-seeded onto fibronectin-coated coverslips (Ø 25 mm). Twenty-four hours later, cells were 
loaded with 3 μM Fura-2 AM (Molecular Probes, Eugene, OR, USA) and 0.01% v/v Pluronic F-129 
(Molecular Probes, Eugene, OR, USA) in KREBS buffer (in mM: 5.5 KCl, 147 NaCl, 1.2 MgCl2, 1.5 
CaCl2, 10 D-glucose, 10 HEPES-NaOH, pH 7.4) at 37°C for 20 min. Then cells were washed with 
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KREBS, allowed to equilibrate for 10 min and placed on a 37°C stage of an inverted microscope 
(Axiovert 200 M, Zeiss, Jena, Germany), continuously being perfused with 37°C KREBS buffer. 
Sixty seconds after start of the measurements, perfusion buffer was changed to KREBS 
containing 1 μM thapsigargin (Sigma). At 220 s buffer was changed to KREBS with NaCl replaced 
by 147 mM N-methyl-d-glucamine (NMDG) in presence of thapsigargin. Details of monitoring 
[Ca2+]i using Fura-2 and quantitative image analysis have been described previously.
32 In short, 
the Fura-2 probe is excited at 340 and 380 nm, with a sampling interval of 3 s. After background 
correction, the fluorescence emission ratio of 340 and 380 nm excitation was calculated.
45Ca2+ uptake assays - HEK293T cells were re-seeded into poly-L-lysine (Sigma) coated 24-well 
plates. Na+-dependent uptake of 45Ca2+ was measured generally using the assay as described 
by Iwamoto et al.33 Cells were preincubated for 30 min with physiological buffer (in mM: 4 
KCl, 147 NaCl, 2 MgCl2, 1.0 CaCl2, 10 D-glucose, 0.1% w/v BSA, 10 HEPES, 10 Tris-HCl, pH 7.4) 
containing 1 mM ouabain (MP Biomedicals, Santa Ana, CA, USA), 48 h after transfection. Finally, 
cells were incubated in identical buffer (37°C) with NaCl replaced by 147 mM NMDG containing 
trace amounts of 45Ca2+ (0.8 μCi/ml) for 30 s. Then, cells were washed 3 times with ice-cold stop 
buffer (in mM: 120 NMDG, 10 LaCl3, 10 HEPES, 10 Tris-HCl, pH 7.4), subsequently cells were 
lysed with 0.05% w/v SDS. Radioactivity was measured and uptake of 45Ca2+ was calculated. 
Real-time PCR - cDNA was prepared as described above. Real-time PCR was performed using 
iQ SYBR Green Supermix (Bio-rad, Veenendaal, the Netherlands). Human GAPDH was used as a 
housekeeping gene. Primer sequences are presented in Table 1.
Calmodulin precipitation assay - Calmodulin-coupled agarose beads (Sigma) were incubated 
for overnight rotating at 4°C with transiently transfected HEK293T lysates (lysis buffer in mM: 
150 NaCl, 50 Tris-HCl, pH 7.5, 0.5% v/v Triton X-100 and protease inhibitors with addition of 
either 1 CaCl2 or 2.5 EGTA). After extensive washing using the lysis buffer indicated above but 
with 0.1% v/v Triton X-100, proteins were eluted from the beads using 2x Laemmli sample 
buffer and subsequently analyzed using immunoblotting. 
Immunoblotting - NCX1 protein expression was analyzed using transiently transfected HEK293T 
cell lysates (in 150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH 7.5 using HCl, 1% v/v Triton X-100  and 
protease inhibitors), immunoblotted using 1:500 diluted mouse anti-NCX1 antibody (ab6495, 
Abcam, Cambridge, UK) for overnight at 4°C. Secondary anti-mouse antibodies conjugated 
with HRP were used and visualized using femto ECL (Thermo scientific, Waltham, MA, USA). 
Statistical Analysis - Results are expressed as mean ± S.E. Significance of the results was 
determined by one-way ANOVA using the measurements per cell/sample (n≥6) of at least 
three independent experiments, followed by Bonferroni post-test in case of significance. p 
values < 0.05 were considered significant. All data were analyzed using GraphPad Prism.
Results
Cloning of NCX1.2, NCX1.3 and NCX1.7 from mice kidney
In the kidney three different splice variants were reported to be expressed: NCX1.2 (exons B,C,D), 
NCX1.7 (exons B,D,F) and NCX1.3 (exons B,D), the latter being considered the predominant 
82
Chapter 5
5
variant. An overview of the renal splice variants is presented in Figure 1A. All three reported 
renal variants were obtained when cloning NCX1 from mouse kidney: NCX1.2, NCX1.3 and 
NCX1.7 as identified by complete sequencing. Sequences correspond to GenBank accession 
numbers XM_006523942, XM_006523944, XM_006523940, respectively. By comparing PCR 
products using primers flanking the alternative splice region, NCX1.3 was confirmed as the 
predominant NCX1 variant in the kidney DCT2/CNT segments (Figure 1B), while other variants 
could be observed as well. The identity of the NCX1.3 band was further confirmed by a SspI 
restriction digest, specifically digesting exon B (data not shown).
A
B
N
CX
1.
3
N
CX
1.
7
N
CX
1.
2
to
ta
l k
id
ne
y
DCT2/CNTbp
448
339
264
exon F
exon B exon Dexon C
---RRGLK GGFTLT GQPIFRKVHARDHPIPSTVITISNCX1.7
---RRGLK ALLLNEL GGFTLT NCX1.2
---RRGLK GGFTLTNCX1.3
Figure 1 - Cloning of NCX1.2, NCX1.3 and NCX1.7 
from mice kidney cDNA. A) The alternative splice 
region of NCX1 consists of the mutually exclusive 
exons A/B (expressed in excitable/non-excitable 
tissues respectively), and the cassette exons C, D, E and 
F. B) NCX1.3 (exons BD, PCR product of 304 bp), NCX1.7 
(exons BDF, 373 bp product) and NCX1.2 (exons BCD, 
326 bp product) were cloned from mice kidney cDNA, 
of which NCX1.3 seems to be the predominant form in 
both total kidney as well as DCT2/CNT material.
NCX1.3 cloned from mice kidney is functional in HEK293 cells
To study the function of NCX1.3 cloned from mice kidney, HEK293 cells were transiently 
transfected with the pCINeo-mNCX1.3-IRES-EGFP construct. Depending on the electrochemical 
gradient, NCX can either extrude Ca2+ from the cell (forward-mode) or take up extracellular Ca2+ 
(reverse-mode). The intracellular Ca2+-sensor Fura-2 was used to demonstrate reverse-mode 
NCX1.3 activity. First, Ca2+ was released from the intracellular stores by perfusing the cells with 
KREBS buffer containing the SERCA inhibitor thapsigargin (1 μM). As a result, untransfected cells 
showed a clear rise in intracellular Ca2+ concentration, whereas NCX1.3-expressing cells did not 
demonstrate this response (Figure 2A,B). In order to study NCX1 activity, at 220 s, the reverse-
mode function was induced by switching the perfusion buffer to Na+-depleted medium, in 
which Na+ was replaced by NMDG. In NCX1.3 overexpressing cells a clear rise in [Ca2+]i was 
observed while no effect was observed in untransfected cells, demonstrating reverse-mode 
functioning of NCX1.3 (Figure 2A,B). 
Regulation of NCX1.3 by PKA/PKC phosphorylation and intracellular Ca2+
Regulation of NCX1.3 activity was studied by the uptake of radioactive 45Ca2+ during reverse-
mode function induced by switching to Na+-depleted medium for 30 s. Firstly, general 
characteristics of the murine NCX1.3 variant were studied. The NCX1 inhibitor for the reverse-
mode function SN-6 (50 μM)34,35 inhibited NCX1.3 function by 32±8% when cells were pre-
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treated for 30 min. Pre-treatment with TPA (100 nM) or forskolin (10 μM), to induce activation 
of PKC and cAMP/PKA-mediated pathways, respectively, did not affect NCX1.3 activity (Figure 
3A).  Since, NCX1 is known to be regulated by intracellular Ca2+ levels through its two Ca2+-
binding domains, we investigated the effect of lowering intracellular Ca2+ using BAPTA-AM 
(25 μM) or EGTA-AM (25 μM).10,36,37 Application of either buffer significantly decreased NCX1.3 
activity with 54±8%; or 25±9%, respectively (Figure 3B).
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Figure 2 - Fura-2 analysis of NCX1.3 shows Ca2+ influx under reverse-mode conditions. A) Average Fura-2 
traces in arbitrary units (a.u.) of HEK293 cells untransfected (in grey) and transfected (in black) with NCX1.3. At 
60 seconds the perfusing buffer was switched to thapsigargin (Thap, 1 μM) containing buffer in order to release 
intracellular Ca2+ stores. At 220 s buffer was switched from NaCl to NMDG still in the presence of thapsigargin, 
inducing reverse-mode functioning of the NCX. B) Averaged Fura-2 levels at t=220 (open bars) and t=320 s 
(closed bars). *,p < 0.0001 in comparison to t=220 (n=93-94). Thap, thapsigargin; a.u., arbitrary units.
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Figure 3 - Regulation of NCX1.3 as measured by influx of 45Ca2+. A) HEK293T cells were transfected with mock 
construct or NCX1.3 (DMSO/ETOH controls). Uptake of 45Ca2+ was measured in cells pre-treated for 30 min with 
50 μM SN-6, 100 nM TPA (both in DMSO) or 10 μM forskolin (in ETOH) in physiological buffer containing NaCl and 
ouabain. Reverse-mode of NCX1.3 was induced upon switching to NMDG containing medium for 30 s. B) NCX1.3 
transfected HEK293T cells were pre-treated for 30 min with BAPTA-AM and EGTA-AM (25 μM). *,p < 0.0001 as 
compared to mock, #,p < 0.01 as compared to DMSO/ETOH control (n=9). CTRL, control.
Overexpression of calmodulin results in higher NCX1.3 mediated Ca2+ uptake
Calmodulin is an important regulator of both TRPV5 and PMCA, together with NCX1 the key 
components of transcellular Ca2+ transport. In order to study the effect of calmodulin on 
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NCX1.3 function, calmodulin was transiently overexpressed in HEK293T cells together with 
NCX1.3. A significant increase in Ca2+ influx (from 165±5 to 216±8 pmol/s/mg) was observed 
due to overexpression of calmodulin. Interestingly, the calmodulin mutant, that is not able 
to bind Ca2+ (Δcalmodulin), had a significantly reduced stimulatory effect with a Ca2 influx of 
193±7 pmol/s/mg (Figure 4A). NCX1.3 mRNA levels were not affected by overexpression of 
calmodulin or Δcalmodulin as shown by real-time PCR analysis (Figure 4B). Immunoblotting 
of lysates from HEK293T cells cultured in parallel to the cells used for 45Ca2+ uptake studies, did 
demonstrate almost two times higher levels of NCX1.3 protein in response to overexpression 
of both calmodulin and Δcalmodulin (Figure 4C). When HEK293T cells overexpressing NCX1.3 
were lysed in the presence of Ca2+ (1 mM CaCl2), we clearly observed binding of NCX1.3 to 
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cells were co-transfected with mock/NCX1.3 and mock/calmodulin/mutated calmodulin (mock/CaM/ΔCaM) 
expressing constructs. NCX1.3 activity was measured by uptake of 45Ca2+ in reverse-mode function. *,p < 0.05 
as compared to CTRL, #,p < 0.05 as compared to + CaM (n=15). B) Real-time PCR analysis of NCX1.3 mRNA 
levels in HEK293T cells co-expressing NCX1.3 (CTRL) and mock/CaM/ΔCaM constructs (n=6). C) Representative 
immunoblot analysis for NCX1 on protein lysates isolated from HEK293T cells co-expressing mock/NCX1.3 
(CTRL) and mock/CaM/ΔCaM constructs as cultured in parallel to cells used in 45Ca2+ uptake assays (n=10). D) 
Representative immunoblot for NCX1, showing binding of NCX1.3 to CaM as analyzed using CaM-coupled 
agarose beads. Mock/NCX1.3 expressing HEK293T cells were lysed in the presence of Ca2+ (1 mM) or EGTA (2.5 
mM) and subsequently applied to the beads, protein lysates were used as input controls. E) Quantification of 
immunoblot densities for NCX1 binding to CaM beads, corrected for input and normalized versus Ca2+ containing 
control. *,p < 0.01 as compared to in 1 mM Ca2+ (n=9). CaM, calmodulin.
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calmodulin-coupled agarose beads (Figure 4D). Co-expressed EGFP was used as a negative 
control and could not be detected (data not shown). Binding was decreased to 61±12% in the 
presence of EGTA (2.5 mM) as calculated by quantification of immunoblot densities (Figure 
4D,E). Additionally, in the presence of Ca2+ a ~115 kDa band was observed for NCX1.3, whereas 
in the presence of EGTA a band was shown at ~140 kDa. Samples of protein lysates before 
application to the beads were used as input control.
Mutation of key residues within the putative calmodulin binding sites reduces NCX1.3 
activity
Five calmodulin binding sites were predicted within the mouse NCX1.3 with varying 
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prediction scores by in silico analysis using the Calmodulin Target Database.38 Since binding of 
calmodulin to the XIP region within NCX1 has never been demonstrated, this region was not 
further investigated.12,26 Two other sites were excluded, as these were localized in predicted 
transmembrane segments. Both remaining potential sites are conserved among species and 
NCX isoforms (Figure 5A). To study the role of these latter two potential calmodulin binding 
sites, predicted key residues were mutated as indicated in Figure 5A. NCX1.3 protein levels 
were slightly reduced by the different mutations (Figure 5B). Mutation of residues R362, R367 
and L696 reduced Ca2+ influx when compared to wild-type NCX1.3 at both low (0.1 mM) and 
physiological (1 mM) extracellular Ca2+ concentrations (Figure 5C,D). Interestingly, mutation of 
F683 into an aspartic acid significantly increased exchanger activity by 12±3% and 56±6% at 
0.1 and 1.0 mM Ca2+, respectively.
NCX1.3-L696D is unresponsive to calmodulin overexpression
To test whether the observed decrease in exchanger activity is indeed caused by 
(endogenous) calmodulin, we studied whether the observed stimulatory effect of calmodulin 
overexpression was affected by mutation of two of these potential key residues. NCX1.3-
R362E still showed increased activity due to overexpression of calmodulin at both low and 
physiological concentrations of Ca2+ (Figure 6A,B). Ca2+ influx was increased with 53±19% 
when overexpressing calmodulin, this as compared to 65±18% for wild-type at physiological 
Ca2+ concentrations. In contrast, stimulation of NCX1.3-L696D by calmodulin overexpression 
increased influx of Ca2+ with only 31±8% and 24±8% at Ca2+ concentrations of 0.1 and 1.0 
mM, respectively. Interestingly, the stabilizing effect of calmodulin on NCX1.3 protein levels 
was maintained for both mutants (Figure 6C). In addition, all four mutants were still able 
to bind calmodulin as assessed using calmodulin-coupled agarose beads (Figure 6D). No 
significant differences in binding of NCX1.3 mutants to calmodulin beads were observed from 
quantifications of immunoblots (Figure 6E).
Discussion
In this study, NCX1.2, NCX1.3 and NCX1.7 were cloned from mice kidney cDNA. NCX1.3 
was confirmed as the predominant NCX1 variant in murine kidney and DCT2/CNT nephron 
segments. Most importantly, we identified calmodulin as a positive regulator of NCX1.3 function 
as based on the following observations. Firstly, overexpression of calmodulin in HEK293T 
cells enhanced NCX1.3 protein abundance and increased exchanger activity as measured 
by influx of Ca2+ via reverse-mode function of the exchanger. Secondly, overexpression of 
calmodulin with mutations in its Ca2+-binding sites demonstrated that the observed effect is 
only partly dependent on Ca2+ binding to calmodulin. Thirdly, binding of calmodulin to NCX1.3 
was demonstrated using calmodulin-coupled agarose beads. Finally, a potential calmodulin 
binding site was identified in the NCX1.3 cytosolic loop in close proximity to residue L696. 
Interestingly, calmodulin was still able to increase protein levels of NCX1.3-L696D, suggesting 
that calmodulin also interacts with another binding site, which is responsible for the stabilizing 
effect of the NCX1.3 protein.
Murine NCX1.3 was cloned previously by Li et al. from mice osteoclasts but functional studies 
were never performed using this construct.39 Next to NCX1.3, being considered the main NCX1 
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in kidney, we also cloned NCX1.2 and NCX1.7 from mice kidney. This is in agreement with 
previous reports that NCX1.2 (BCD), NCX1.7 (BDF) and especially NCX1.3 (BD) are expressed 
in the kidney.15,16 For NCX1.2, not much is known about its role and regulation. NCX1.3 was 
previously reported to have a higher buffering capacity40 and is less susceptible to oxidative 
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Figure 6 – Identification of calmodulin binding sites within NCX1.3. A,B) NCX1.3 activity is determined using 
the 45Ca2+ reverse-mode assay in HEK293T cells co-expressing mock/NCX1.3 CTRL/NCX1.3-R362E/NCX1.3-L696D 
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immunoblot for NCX1, showing protein expression levels of the different NCX1.3 mutants in the absence/
presence of overexpressed CaM from HEK293T cells cultured in parallel to the cells used for 45Ca2+ uptake analysis 
(n=6). D) Binding of the different NCX1.3 mutants to CaM-coupled agarose beads as compared to wild-type 
(CTRL). NCX1.3 (CTRL) expressing HEK293T were lysed in the presence of Ca2+ (1 mM) or EGTA (2.5 mM), mock and 
NCX1.3 mutant expressing cells were all lysed in the presence of Ca2+. Protein lysates were used as input controls. 
E) Quantification of immunoblot densities for NCX1 binding to CaM beads, corrected for input and normalized 
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stress as compared to NCX1.7.41 Thereby NCX1.3 appears to be well suited as a high capacity 
extruder in the process of transcellular Ca2+ transport in the kidney. Also, NCX1.3 activity was 
reported to be elevated in response to PKC phosphorylation, which was not observed for 
NCX1.7.40,42 In contrast, the present results demonstrated no effect of PKC signaling on NCX1.3 
activity when activated using TPA. However, phosphorylation of NCX remains controversial 
and seems largely dependent on specific circumstances. For example, PKA phosphorylation 
of cardiac NCX1 was observed in both oocytes and rat ventricular cardiomyocytes, but this 
isoform was unresponsive to PKA activation when expressed in HEK293 cells.43 In addition, 
despite mutation of all PKC consensus sites within NCX1, the protein still appeared to be 
phosphorylated.33,43 Presumably, NCX1 is part of a macromolecular complex, containing 
kinases and phosphates, which might differ among tissues and different circumstances. Also, 
phosphorylation processes might indirectly affect NCX1 activity.43,44 Activation of NCX1 by PKA 
was only reported for NCX1.1 and not NCX1.3, consistent with the present results.45 
Although calmodulin was demonstrated to be involved in the regulation of renal transcellular 
Ca2+ transport by directly regulating the activity of TRPV5, which is responsible for Ca2+ influx,24 
as well as by activating the PMCAs enabling extrusion of Ca2+,25 regulation of NCX1.3 through 
calmodulin remained unknown. By applying the intracellular Ca2+ buffers BAPTA-AM and EGTA-
AM, we further substantiated that intracellular Ca2+ is of key importance for NCX1.3 activity.37,46 
Intracellular Ca2+ can potentially directly affect NCX1.3 function via its Ca2+-binding domains 
and indirectly via binding to calmodulin. Chelation of Ca2+ significantly decreased binding of 
NCX1 to calmodulin-coated agarose beads as observed in the presence of EGTA. Binding of 
calmodulin to NCX1.3 appeared to be largely Ca2+-dependent, although some binding was 
observed under Ca2+-free conditions. Increased binding in the presence of Ca2+ could be due 
to Ca2+-binding to calmodulin and/or Ca2+ binding to the CBDs of NCX1 itself. Additionally, 
presence of Ca2+ in the protein lysate resulted in the NCX1 protein to run lower (~115 kDa) on 
a SDS-gel. NCX1 is reported to be cleaved by Ca2+-dependent calpain or other Ca2+-sensitive 
proteases.10,47 Calpain, cleavage however, results in a much smaller band of about 80 kDa for 
NCX1.47,48 Also, no changes were observed upon application of high concentrations of protease 
inhibitors (leupeptin and calpeptin, data not shown). This observation can possibly be 
explained by the CBD1 being partially unstructured in the absence of Ca2+,49 therefore resulting 
in fully denatured NCX1.3 protein in Ca2+-free conditions only. Similar sizes were observed by 
Wanichawan et al., showing ~140 kDa bands in boiled samples and both sizes in unboiled 
samples.48
Most importantly, NCX1 activity was increased by co-expressing calmodulin in HEK293T 
cells. In addition, NCX1.3 protein levels were elevated, while mRNA levels were unaltered, 
suggesting that binding of calmodulin stabilizes the NCX1.3 protein. Calmodulin binding 
might structurally stabilize the NCX1.3 protein or could reduce accessibility for proteases 
such as calpain.10,47 The observed stabilizing effect on NCX1.3 protein levels was also observed 
for Δcalmodulin, a calmodulin mutant not able to bind any Ca2+ due to mutations in all four 
EF-hands.30 Activity of NCX1.3 was only partly enhanced by Δcalmodulin. This suggests that 
regulation of NCX1.3 exchanger activity by calmodulin is a partly Ca2+-dependent and partly 
Ca2+-independent process, the latter probably due to the effect on protein stability. Similar Ca2+-
independent/dependent effects of calmodulin have been observed for Small Conductance 
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Ca2+-Activated Potassium Channels (SK channels).30,31 These channels show Ca2+-independent 
binding of calmodulin to the channel and a Ca2+-dependent effect on channel gating.30 Ca2+-
free calmodulin was also shown to bind L-, N-, and P/Q-type voltage-gated Ca2+ channels.31,50,51
The so-called XIP region was previously identified as a potential calmodulin binding site, but 
calmodulin binding to this region within NCX1 could never be demonstrated.26 In contrast, the 
XIP peptide is now considered as an inhibitor of NCX as well as PMCA function.27 Therefore, 
we studied two additional predicted calmodulin binding sites. The site around residues F683/
L696, seems to contain important regulatory properties and probably is involved in binding of 
calmodulin. Mutation of NCX1.3 residue L696 into aspartic acid decreased transport activity, 
which was not stimulated by overexpression of calmodulin at physiological concentrations. 
However, since stabilization of the NCX1.3 protein by calmodulin was not impaired, the Ca2+-
independent process appears to remain intact, probably accounting for the small albeit not 
significant increase in NCX1.3-L696D activity in presence of calmodulin. The F683D mutation 
within the same predicted site increased NCX1.3 activity, suggesting that this site might 
also be a binding site for other interacting partners. This concept is in agreement with the 
previously proposed macromolecular complex, where depending on specific circumstances 
several factors could compete for similar binding sites. Comparable to L696D, mutation of 
residues R362 and R367 decreased NCX1.3 activity in the presence of endogenous calmodulin. 
However, NCX1.3-R362E activity could still be stimulated by calmodulin overexpression. Also, 
after mutation of the four individual residues, NCX1.3 was still able to bind calmodulin. This 
leads to the understanding that multiple calmodulin binding sites are involved in the process of 
enhancing NCX1.3 activity and protein stability. The predicted binding site involving residues 
R362/R367 could be a second calmodulin binding site, as possibly the introduced mutations 
were not sufficient to prevent binding of calmodulin to this site. 
In conclusion, the present study identifies NCX1.3 as the main NCX1 expressed in DCT2/CNT 
tubules facilitating transcellular Ca2+ reabsorption. For the first time NCX1.3 was demonstrated 
to bind the Ca2+-sensor calmodulin. Interestingly, the effects of calmodulin on NCX1.3 occur in 
both a Ca2+-dependent and Ca2+-independent fashion. We propose that binding of Ca2+-free 
calmodulin stabilizes the NCX1.3 protein, whereas Ca2+-calmodulin is required for activation 
of the NCX1.3 exchanger. Furthermore, stimulatory action of calmodulin on reverse-mode 
exchanger activity involves the predicted calmodulin binding site within the NCX1.3 cytosolic 
loop around residue L696.
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Introduction
Maintenance of calcium (Ca2+) homeostasis is of key importance for the human body. Ca2+ is 
a major constituent of bone, while intracellular Ca2+ is involved as second messenger in many 
physiological processes including muscle contraction and nerve excitation.1,2 Therefore, the 
Ca2+ balance must be tightly regulated. Ca2+ homeostasis is maintained via uptake in the 
intestine, storage in bone and reabsorption in the kidney.3 In the kidney, Ca2+ is reabsorbed 
along the nephron through paracellular transport in the proximal and thick ascending limb 
(TAL) segments. Final excretion of Ca2+ is determined by transcellular Ca2+ reabsorption in the 
distal convolution, comprising the second part of the distal convoluted tubule (DCT2) and 
connecting tubule (CNT).4 Here, the epithelial Ca2+ channel transient receptor potential vanilloid 
5 (TRPV5) is expressed, allowing the influx of Ca2+ into the cell.5 As a result, the TRPV5 channel is 
considered to be the “gatekeeper” of transcellular Ca2+ reabsorption. TRPV5 expression, plasma 
membrane abundance and channel activity are regulated by many factors including Ca2+, pH, 
several hormones, glycosidases and proteases.5-8 After apical entry via TRPV5, with the help of 
the Ca2+-buffer calbindin-D28k Ca
2+ is shuttled towards the basolateral membrane, where it is 
extruded towards the blood compartment by the concerted action of the plasma membrane 
Ca2+-ATPase (PMCA) and the Na+/Ca2+ exchanger type 1 (NCX1).5 
This thesis aimed to elucidate the molecular regulation of transcellular Ca2+ reabsorption in 
the distal convolution. Firstly, regulation of Ca2+ entry by the key player TRPV5 was further 
investigated. Secondly, a novel murine primary cell model for the distal convolution was 
developed, allowing studies of different components involved in transcellular Ca2+ transport. 
Finally, NCX1 was cloned from murine kidney to unravel its role and regulation as the main 
basolateral Ca2+ extruder.
The role and regulation of the epithelial Ca2+ channel TRPV5
Regulation of TRPV5 function by its N-terminal tail
As the gatekeeper of renal transcellular Ca2+ reabsorption,5,9 structure and regulation of 
the TRPV5 Ca2+ channel have been extensively studied. The TRPV5 C-terminal region and in 
particular its TRP domain has been implicated in the regulation of TRPV5 intrinsic activity as 
determined by channel open probability together with channel conductance, and plasma 
membrane abundance as regulated by trafficking processes.6,10,11 However, the role of the 
N-terminal region and especially its multiple ankyrin repeats remains largely elusive (Figure 
1). Ankyrin repeats are highly conserved helix-loop-helix structures of ~33 residues, that are 
involved in binding of several proteins/ligands, such as calmodulin and ATP.12-15 The TRPV5 
N-terminus is known to bind calmodulin,16 participates in the oligomerization of TRPV5 through 
the region L64-A7717 and is phosphorylated at the residues S144 and S299.7,18,19 In chapter 2 the 
role of the TRPV5 N-terminus was studied in the regulation of plasma membrane abundance 
and channel activity. Several N-terminal deletion mutants were generated, demonstrating an 
abolished TRPV5-mediated influx of Ca2+ when the first 38 amino acids were deleted. The well-
conserved residues Q31 and D34 were critical in this effect. Mutated channels were retained 
in the endoplasmic reticulum and lacked complex glycosylation. Some TRPV5 channels were 
present on the plasma membrane but proved non-functional and could not be internalized. 
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In the endoplasmic reticulum, misfolded proteins are recognized by the quality control 
machinery, retained and targeted for degradation.20,21 Our data suggest that some channels 
escaped from quality control and reached the plasma membrane, resulting in detectable 
amounts of TRPV5 channels on the plasma membrane as channels could not be properly 
internalized. Deletion of this N-terminal domain is associated with lack of glycosylation, 
which might cause inhibition of proper channel internalization. Glycosylation at residue N358 
is involved in channel internalization, a process that is modulated by klotho.22 Misfolding of 
TRPV5, due to deletion of residues M1-M38 or mutation of Q31/D34, was further evidenced by 
the rescue of TRPV5 activity in cells cultured at a lower temperature (30°C). In these conditions, 
proteins likely evade the quality control system and resume trafficking via the Golgi system. 
This in accordance to observations made for the cystic fibrosis transmembrane conductance 
regulator (CFTR), where misfolding and endoplasmic reticulum retention of the mutated 
chloride channel leads to cystic fibrosis.23 For TRPV5 Q31/D34 mutants, in addition to channel 
activity, complex glycosylation was restored as well, indicating that Golgi trafficking was indeed 
resumed. Moreover, the residues Q31/D34 are located within a predicted helix structure, 
suggesting that this helix is essential for folding of TRPV5 into a functional channel. Mutation 
of similar residues just after the predicted helix did not affect channel function. Hence, TRPV5 
N-terminal residues M1-M38 and in particular the residues Q31/D34 are essential for protein 
folding and thus a functional channel. The predicted helix structure within this N-terminal 
region appears to be a crucial structural feature within the TRPV5 channel. 
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Figure 1 - Focus on the TRPV5 N-terminus and the channel tetramer. The TRPV5 monomer consists of six 
putative transmembrane domains, a pore domain and large cytoplasmic N- and C-termini. An N-glycosylation 
site is present at residue N358. The N-terminal domain contains six highly conserved ankyrin repeats, the ankyrin 
repeat domain (ARD), of which ankyrin repeat 3 contains a PKC phosphorylation site (S114) and is involved in 
regulation by calmodulin (CaM). A second phosphorylation site (S299) is present in the linker region between 
the ARD and TM1. The N-terminal domain depicted in pink is crucial for proper channel folding, and contains 
a predicted helix structure implicated in this process. The TRPV5 tetramer is arranged around a central pore 
comprising the four individual pore domains, together allowing influx of Ca2+. The linker region between the 
ARD and TM1 interacts with ankyrin repeats 3/4 and the C-terminal domain of an adjacent TRPV5 protein.
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Interestingly, despite impaired protein folding, TRPV5 mutant channels were able to form 
tetramers, even when residues M1-R75 including the first ankyrin repeat were deleted. 
Assembly of misfolded ion channels has been demonstrated before, for example for 
the voltage-gated K+ channel.24 Since Golgi trafficking is abrogated, our results suggest 
that TRPV5 channel tetramerization takes place in the endoplasmic reticulum as is most 
commonly observed for plasma membrane proteins.25 Channel assembly in the endoplasmic 
reticulum was demonstrated earlier for TRPV4.26 The TRPV5 residues L64-A77 are essential for 
interactions between channel N-termini,17 indicating a role in channel oligomerization. These 
interactions, however, were demonstrated between bacterial derived and in vitro translated 
TRPV5 N-terminal domains, therefore not taking into account total protein structures.17 
Moreover, structural studies of TRPV6 ankyrin repeats did not demonstrate oligomerization,27 
while channel oligomerization was shown by interactions of transmembrane domains, N- 
and C-termini.28 This suggests that TRPV channel tetramerization is not solely dependent of 
N-terminal interactions, but an interplay of several domains.27 This is supported by recent 
structural data of TRPV1, demonstrating interactions between the ankyrin repeat domain 
(ARD, comprising all 6 ankyrin repeats), β-sheet structures within the linker region between 
the ARD and first transmembrane segment (TM1), and the C-terminus of an adjacent subunit 
within the channel tetramer.29 Hence, channel oligomerization probably is a result of several 
interactions within and between adjacent channel subunits. The present studies indicated that 
the region M1-R75 is not essential for channel tetramerization, but N-terminal interactions 
were not directly investigated. Therefore, ankyrin repeat 1 could still play a role in channel-
channel interactions and thus quaternary protein folding. 
The role of the six highly conserved ankyrin repeats in TRPV channels appears to be quite 
diverse.13 TRPV ankyrin repeats show an atypical sequence deviating from the consensus,13 
thereby making their function less predictable. As the first TRP channel, TRPV1 structural 
topology has been determined recently by electron cryo-microscopy.29 These data identify 
TRPV1 ankyrin repeats 3 and 4 as important structural features in overall channel folding and 
oligomerization, while ankyrin repeats 1 and 2 could not be detected probably due to high 
flexibility.29 In addition, ankyrin repeats 1 and 3 in TRPV4 and repeat 3 in TRPV6 are involved in 
channel tetramerization,26,30 suggesting a similar role for any of the ankyrin repeats within the 
TRPV5 N-terminus. Although it could be involved in channel-channel interactions,17 ankyrin 
repeat 1 was now demonstrated not to be essential for TRPV5 channel tetramerization. Due 
to high homology between TRPV5 and TRPV6, ankyrin repeat 3 might be a good candidate. 
Furthermore, TRPV1 ankyrin repeats are involved in binding of ATP and calmodulin,12 which is 
not conserved among other TRPV channels including its close homolog TRPV2.12,14 For TRPV5, 
ankyrin repeat 3 has recently been reported to bind calmodulin (region V133-R154).7,16,31 The 
N-terminal region preceding the ankyrin repeats is even less conserved among TRPV channels, 
predicting more divergence between the TRPV family members. In contrast to what we 
observed for the region M1-M38 in TRPV5, deletion of the first ~100 residues of TRPV1 had 
only small effects on channel function.32 Deletion of TRPV1 residues 1-114 abrogated channel 
function, but as opposed to TRPV5, its cellular localization was not changed. Hence, TRPV5 
residues M1-M38, preceding the first ankyrin repeat are required for channel folding, which 
is not conserved among TRPV channels. Function of the abundant ankyrin repeats and their 
role in channel oligomerization needs further investigation and probably involves interactions 
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with other structural aspects of the TRPV5 channel and interactions with auxiliary proteins.
Regulation of TRPV5 activity by β-adrenergic signaling
In addition to its many topological features and accompanying interactions, the TRPV5 
channel is also heavily regulated by several systemic factors such as hormones, glycosidases 
and proteases.6-8 The hormone epinephrine (adrenaline) has major effects in the body and in 
particular on the cardiovascular system.33 Cardiovascular effects are mediated by increases in 
intracellular Ca2+ levels, leading to vasoconstriction and increased heart rate.33 Epinephrine 
is present in the pro-urine due to filtration from blood, but a major fraction is secreted by 
the kidney itself.34 Epinephrine acts through binding to α- or β-adrenergic receptors.35 β1- 
(β1-AR) and β2-adrenergic receptors (β2-AR) are expressed in the distal convolution.36-38 The 
third β-adrenergic receptor (β3-AR) has not been detected in kidney and is mainly located in 
adipose tissue.39,40 The α-adrenergic receptors are expressed in kidney, but mainly in arterioles, 
proximal tubules and TAL.41-43 Thus, adrenergic agonists are present in pro-urine and blood, 
while β-ARs are expressed in the distal convolution. However, the role of adrenergic signaling 
in transcellular Ca2+ reabsorption in the kidney was not known. Therefore in chapter 3, the 
effect of β-AR signaling on TRPV5-mediated Ca2+ transport was studied. Expression of the β1-AR 
protein, but not β2-AR, was detected in the distal convolution. Furthermore, the synthetic β1-
AR agonist dobutamine enhanced transcellular Ca2+ transport in a murine distal convolution 
primary culture. 
The β-ARs are G-protein-coupled receptors (GPCRs),44 together with the Ca2+-sensing receptor 
(CaSR), parathyroid hormone receptor type 1 (PTH1R) and bradykinin receptor subtype 2 
(B2R), all reported to enhance the plasma membrane abundance and/or activity of the TRPV5 
channel.18,19,45,46 β1-AR stimulation activates the cAMP/protein kinase A (PKA) pathway, resulting 
in phosphorylation of several proteins involved in cardiac contraction, such as L-type Ca2+ 
channels, the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) and the ryanodine 
receptor (RyR),36,47,48 although adrenergic signals can also be mediated by PKC activation.49,50 
When treating TRPV5-expressing HEK293 cells with dobutamine, cAMP production and 
TRPV5 activity were increased. No changes in TRPV5 membrane abundance were observed. 
Hence, β1-AR signaling increases TRPV5 activity, mediated via a cAMP/PKA dependent 
pathway. As observed for PTH1R activation, this involves the phosphorylation of residue T709 
in the C-terminal tail of the TRPV5 channel.45 In contrast, stimulation of the GPCRs CaSR and 
B2R (activated by extracellular Ca2+ and tissue kallikrein, respectively) activates PKC, which 
subsequently phosphorylates residues S299/S654. This leads to increased plasma membrane 
abundance through delayed channel retrieval.19,46 Activation of PTH1R was shown to induce 
both PKC- and PKA-dependent pathways, subsequently phosphorylating the residues S299/
S654 and T709 respectively.18,45 The different GPCRs enhance TRPV5 function by increasing 
plasma membrane abundance through activation of PKC and subsequent phosphorylation of 
residues S299/S654 and/or by increasing intrinsic channel activity through phosphorylation 
of residue T709 by PKA. The plasmin activated protease-activated receptor-1 (PAR-1) is a GPCR 
as well. Here, activation of PAR-1 inhibits TRPV5 function via phosphorylation of residue S144 
by PKC.7 Thus, depending on the specific GPCR and respective G-protein signaling pathways, 
activation of the respective receptors could have similar or entirely different effects on TRPV5 
intrinsic channel activity and membrane abundance (Figure 2). 
99
General discussion
6
The observed increase of TRPV5 activity upon dobutamine stimulation highly suggests that 
β-adrenergic signaling enhances transcellular Ca2+ reabsorption in the distal convolution 
through activation of the TRPV5 channel. Activation of β1-AR, however, might also influence 
activity of other components involved in transcellular Ca2+ transport. β-AR signaling has 
been implicated in the regulation and expression of NCX1 in cardiomyocytes,47,51-54 where it is 
reported to increase NCX1 activity via phosphorylation by PKA47 and/or PKC50. However, due 
to the variability of the effects, the activation of NCX1 by β-AR signaling as well as the process 
of phosphorylation of NCX1 remains controversial.50,55 Action of β-AR signaling on renal NCX1 
might be dependent on specific environmental factors in different species or tissues and 
could be indirectly regulated via the participation of NCX1 in macromolecular complexes.50,55 
Further studies are required to determine the role of NCX1 in increases of renal transcellular 
Ca2+ transport as a result of β-AR signaling. In addition to the interplay between TRPV5 and 
NCX1 with respect to β-AR signaling, the effect of β-AR agonists and possibly antagonists on 
transcellular Ca2+ reabsorption should be studied in vivo. The β-AR agonist isoproterenol was 
demonstrated to enhance Ca2+ reabsorption in TAL,56 together with our results on the distal 
convolution this suggests significant effects on total renal Ca2+ handling in response to the 
different endogenous and pharmacological β-AR agonists.
The present study identified a novel calciotropic role of dobutamine in transcellular Ca2+ 
transport, proposing an effect of the different endogenously released and clinically applied 
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Figure 2 - Regulation of the TRPV5 channel. The TRPV5 C-terminus, important in many regulatory processes, 
contains the conserved TRP domain (in green) involved in regulation of channel activity and trafficking by 
binding of several factors, such as PIP2, S100A10, Rab11a, NHERF4 and calmodulin (CaM). Two calmodulin 
binding sites have been identified in the C-terminal domain and one within the N-terminus. The TRPV5 channel 
is regulated by PKA/PKC phosphorylation processes, so far all being initiated via signaling through several 
G-protein-coupled receptors (GPCRs). Depending on the specific site(s), TRPV5 phosphorylation leads to either 
increased or decreased intrinsic channel activity or enhanced membrane abundance.
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β1-AR agonists and antagonists on overall body Ca2+ balance. In addition to the agonist 
dobutamine generally used in treatment of acute heart failure, β-AR antagonists (β-blockers) 
are widely used in the clinic for treatment of congestive heart failure (CHF).57,58 CHF patients 
already commonly suffer from increased fecal and urinary Ca2+ excretion due to secondary 
aldosteronism.59 Thereby, the potential calciotropic effects of β-blockers might enhance the 
development of hypocalcaemia in these patients. β-blockers have already been used in the 
treatment of hyperthyroidism to resolve hypercalcaemia,60,61 and although the mechanism 
of action is unclear, effects of propranolol (nonselective β-blocker) on plasma Ca2+ levels are 
suggested to be caused by effects on Ca2+ handling in bone and/or kidney.61,62 Therefore, the 
increasingly used β-AR agonists and antagonists might have diverse and potentially adverse 
effects on the Ca2+ balance due to (dys)regulation of transcellular Ca2+ transport in the kidney 
and should be investigated further.
Coordinated control of renal transcellular Ca2+ transport
Regulation of TRPV5 function has mainly been studied in human embryonic kidney (HEK293) 
cells transiently expressing TRPV5. In order to study the role and regulation of TRPV5 in the 
process of transcellular Ca2+ transport and to study the interplay of TRPV5-mediated apical Ca2+ 
influx with intracellular shuttling and basolateral extrusion mechanisms, a polarized cell model 
harboring all characteristics of the distal convolution cell is required. Several cell models have 
been used in the past.63-66 Unfortunately, all exhibited significant limitations. Cell lines, such 
as the Madin-Darby canine kidney (MDCK) and murine distal convoluted tubule (mpkDCT), 
generally display low levels of Ca2+ transport indicating poor preservation of Ca2+ transport 
characteristics.63,65 On the other hand, manual microdissection of tubule segments provides 
a limited amount of material. Moreover, a model derived from mice would be much more 
valuable than the existing primary rabbit culture66 as mouse models are genetically much 
more defined, allowing detailed mRNA expression studies and the use of the several knockout 
animals to investigate the different components of Ca2+ transport. As demonstrated in chapter 
4 we developed a novel and unique murine primary distal convolution culture, demonstrating 
transcellular Ca2+ transport and preservation of important regulatory pathways. Distal 
convolution tubule fragments obtained from mice expressing enhanced Green Fluorescent 
Protein (EGFP) under the control of the TRPV5 promoter,67 were sorted based on fluorescence 
intensity using the Complex Object Parametric Analyzer and Sorter (COPAS), subsequently 
grown on permeable filter supports to maintain cell polarity and to enable transcellular Ca2+ 
transport. Interestingly, the sorting of tubule fragments, as opposed to single cells, proved 
crucial in the preservation of distal convolution characteristics. Likewise, for pancreatic cells it 
was demonstrated that sorting of a particular cell cluster size is essential to obtain viable cells, 
as smaller cell clusters showed many dead cells and reduced viability, while bigger particles 
suffer from necrosis in its central part.68 Also, for hepatocytes, extracellular matrix interactions 
have been demonstrated to be essential to regain cell polarity.69 Therefore, the favorable effects 
of isolation of tubule parts are probably due to maintenance of three-dimensional structures 
including extracellular matrices and cell polarity.
Initially, the novel distal convolution model was exploited to substantiate the role of TRPV5 as 
gatekeeper in transcellular Ca2+ transport, by generating TRPV5-/- primary distal convolution 
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cultures through crossbreeding of EGFP-expressing mice with TRPV5-/- animals.9 Subsequently, 
Na+-dependent basolateral Ca2+ extrusion was studied to assess the role of NCX1 in transcellular 
Ca2+ transport. Our data support the current understanding that NCX1 accounts for ~70% of 
Ca2+ efflux and PMCAs for the remaining fraction.5,70,71 Interestingly, mRNA expression levels 
of the key components of transcellular Ca2+ transport suggest that PMCA4, but not PMCA1, 
plays a key role in Ca2+ transport in the distal convolution. PMCA1 was previously considered 
to be the primary PMCA involved in this process.5 The components of renal transcellular 
Ca2+ transport are tightly co-regulated at the transcriptional level. Using the sorted distal 
convolution material we demonstrated enrichment of TRPV5, calbindin-D28k, NCX1 and PMCA4 
in this nephron segment, as well as reduced expression levels for all of these components in 
TRPV5-/- tubules. 1,25-dihydroxy vitamin D3 (1,25-(OH)2D3) is known to enhance the expression 
of the Ca2+ transport proteins identified  in the distal convolution including TRPV5, calbindin-
D28k, NCX1 and PMCA1.
64,72 However, in 1α-OHase-/- mice mRNA expression levels of PMCA1 
were unaltered, while the expression levels of the other Ca2+ transporters were significantly 
reduced.72 This suggests differential regulation of the PMCA1 gene by 1,25-(OH)2D3 as compared 
to the other key components. Interestingly, PTH has similar effects on the Ca2+ transporter 
expression levels as 1,25-(OH)2D3, but did not affect levels of PMCA1.
73 Other factors regulating 
protein transcription in the distal convolution are estrogen, testosterone, pH (metabolic 
acidosis/alkalosis), and dietary Na+ and Ca2+ 72,74-77. For estrogen, an increase in PMCA1 levels 
was reported as well.74 Currently, PMCA4 levels under influence of these factors are unknown 
and require further study in order to determine the role and interplay of PMCA1 and PMCA4. 
Thus, the Ca2+ transport proteins responsible for renal transcellular Ca2+ transport are tightly 
and coordinately regulated at the transcriptional level. Expression levels could be modulated 
by direct stimulation of the different promoter regions. Vitamin D-responsive elements (VDREs) 
have been identified in the calbindin-D28k promoter region and putative VDREs have been 
demonstrated for regulation of TRPV5.78-80 To our knowledge for PMCA and NCX1 no VDREs 
have been identified so far.81 Absence of specific promoter elements could also mean that 
transcriptional regulation is mediated via different pathways. In contrast to TRPV6 (responsible 
for Ca2+ influx in the intestine), estrogen response elements were not detected in the promoter 
region of TRPV5.80 However, the nuclear estrogen receptor is also known to regulate gene 
transcription via activator protein 1 (AP-1) binding sites or GC-rich stimulatory protein (Sp1) 
binding sites, which were identified in the TRPV5 promoter region.74 In addition to direct 
regulation of the different components, expression levels of calbindin-D28k, PMCAs and NCX1 
could also be directly regulated by influx of Ca2+ via TRPV5, again pointing to the significance 
of TRPV5 as key regulator of renal transcellular Ca2+ transport. Studies using PTH and TRPV5-/- 
animals suggest that Ca2+ itself controls the expression of other Ca2+ transport proteins.9,72,73,82 
Gene expression can be regulated by Ca2+ in several ways. For example, in the promoter region 
of the Ca2+-regulated gene c-fos, the cyclic AMP response element (CRE) and serum response 
element (SRE) were identified as Ca2+-responsive elements.82 In Purkinje cells, although cell 
specific, calbindin-D28k was regulated by a Ca
2+-sensitive element (PCE1).83 
By using the novel primary distal convolution cell model we were able to demonstrate the 
role of TRPV5 as gatekeeper, as well as to support the importance of NCX1 in the process of 
transcellular Ca2+ transport in the distal convolution. Also, we identified PMCA4 as the probable 
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PMCA involved in this process. The role of PMCA4 and possibly PMCA1 in transcellular Ca2+ 
transport requires further study. The novel primary cell model provides an excellent tool to 
investigate the functional role of the different PMCAs, for example by using different specific 
inhibitors or most favorably by crossbreeding with different knockout animals as was currently 
performed for TRPV5. After confirming the role of the individual components in Ca2+ transport, 
the interplay of these key transporters in the handling of Ca2+ needs to be elucidated on a 
functional level.
Basolateral extrusion of Ca2+: regulation of renal NCX1 
In addition to apical influx, basolateral extrusion of Ca2+ is crucial for transcellular Ca2+ transport 
as well. The importance of NCX1 was confirmed using the primary distal convolution culture, 
showing reduced levels of Ca2+ transport in the absence of extracellular Na+. Also, NCX1 was 
enriched ~20 times in distal convolution as compared to total kidney. In comparison, TRPV5 
is expressed specifically in the distal convolution and was enriched ~25 times. Therefore, 
in chapter 5, NCX1 was cloned from kidney cDNA and studied for its role and regulation 
in transcellular Ca2+ transport. We successfully cloned three NCX1 splice variants: NCX1.2 
(exons B,C,D), NCX1.3 (exons B,D) and NCX1.7 (exons B,D,F). The NCX1 protein consists of ten 
transmembrane domains and a large cytosolic loop with two Ca2+ binding domains (CBD1, 
CBD2), the latter containing the alternative splice region (Figure 3).50 Six exons (A-F) are present 
of which the first (A/B) are mutually exclusive, exon A generally being expressed in excitable 
tissues and exon B in non-excitable tissues such as the kidney. The other exons can all be 
spliced in or out, depending on the splice variant, although exon D was found to be present 
in all identified variants.50,84 In kidney NCX1.2, NCX1.3 and NCX1.7 variants are expressed.85-87 
NCX1.3 is the main NCX1 isoform in the kidney and is therefore often referred to as “the renal 
NCX1 variant”.86,88
Given its high kidney expression and enrichment in distal convolution segments, we focused 
our studies on the role and regulation of NCX1.3. NCX1.3 activity was studied by the uptake of 
Ca2+ via the reverse-mode function of the exchanger in transiently transfected HEK293 cells.50,89 
In our study, NCX1.3 activity was not regulated by PKA- and PKC-dependent phosphorylation. 
In agreement, phosphorylation by PKA was reported for the cardiac NCX1 (NCX1.1) but not 
for NCX1.3.84,88 In contrast, phosphorylation of NCX1.3 by PKC was demonstrated before.90,91 
Phosphorylation of NCX1 remains controversial, since it appears to be highly dependent on the 
specific circumstances. For example, cardiac NCX1 was activated by PKA phosphorylation in rat 
ventricular cardiomyocytes and Xenopus oocytes, but did not respond to PKA activation when 
expressed in HEK293 cells.51 Therefore, possibly NCX1 is not activated by phosphorylation in the 
kidney or the HEK293 model cell system lacks certain regulatory pathways or auxiliary proteins 
involving NCX1 activation. The current understanding is that NCX1 is part of a macromolecular 
complex, containing kinases and phosphatases, which arrangement differs among tissues and 
environment. Also, phosphorylation could affect NCX1 function indirectly by phosphorylation 
of interacting proteins.50,92 Further research is needed to identify the role of phosphorylation of 
NCX1 in the distal convolution. This is of particular interest when considering the possible role 
of β-AR signaling and subsequent PKA/PKC activation on NCX1 function as discussed earlier. 
When studying NCX1 activity in reverse-mode function as compared to its normal forward-
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mode in Ca2+ extrusion, potential dissimilarities in regulatory mechanism have to be taken into 
account as differences in the regulation of the reverse- and forward-mode of the exchanger 
have been observed earlier. For example, all current specific NCX1 inhibitors affect the function 
of the exchanger in the reverse-mode only.50,93
As NCX1.3 is likely part of a large macromolecular complex and as both TRPV5 and PMCAs are 
regulated by calmodulin, we hypothesized that calmodulin also binds to and regulates NCX1.3. 
The so-called exchanger inhibitory peptide (XIP) region located within the NCX1 cytosolic loop, 
was previously identified as a potential calmodulin binding site.94 The XIP peptide was shown 
to directly bind calmodulin, but an interaction of calmodulin with this NCX1 region was never 
demonstrated.94,95 Interestingly, XIP has later been characterized as an inhibitor of both NCX1 
and PMCA function.94,95 Using the Calmodulin Target Database,96 four additional potential 
binding sites were identified, of which two were excluded from further analysis given their 
significant overlap with transmembrane segments. We demonstrated binding of calmodulin 
to NCX1.3 in a Ca2+-dependent manner, as significantly less binding was observed in absence 
of Ca2+. Interestingly, calmodulin binding appeared to stabilize the NCX1.3 protein in a Ca2+-
independent manner, whereas NCX1.3 activity was enhanced primarily Ca2+-dependently. 
The region F683/L696 was confirmed as a potential calmodulin binding site, as calmodulin 
over-expression was not able to enhance activity of NCX1.3-L696D as was observed for wild-
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Figure 3 - Topology of NCX1 and the binding of calmodulin. NCX1 contains ten transmembrane domains, 
extracellular N- and C-termini and a large cytoplasmic domain between TM5-6. The cytoplasmic loop consists 
of two Ca2+ binding domains (CBD1 and CBD2), of which part of CBD2 is an alternative splicing region. A so-
called XIP region, previously indicated as a potential calmodulin (CaM) binding site, is located close to TM5 (in 
green). The present studies suggest that Ca2+-calmodulin binds to a region in proximity to CBD2 a process often 
mediated by the N-lobe of calmodulin, resulting in increased exchanger activity. Protein stability is increased 
Ca2+-independently, probably mediated by the C-lobe of Ca2+-free calmodulin
104
Chapter 6
6
type. Interestingly, although calmodulin no longer affected the activity of this NCX1.3 mutant, 
calmodulin was still able to bind and stabilize mutant proteins. These results suggest that 
calmodulin binding to NCX1.3 involves at least two binding sites, one comprising the residues 
F683/L696. In this regard, the other potential binding site surrounding residues R362/R367 
could not be confirmed as a calmodulin binding site.
Regulation of transport activity in a Ca2+-dependent and Ca2+-independent manner was shown 
previously for the small conductance Ca2+-activated potassium channels (SK) and voltage-
gated sodium channels.97,98 Here, the C-terminal lobe of calmodulin, containing two of the four 
Ca2+ binding EF-hands, is responsible for Ca2+-independent interactions, while binding of the 
calmodulin N-terminal lobe is required for Ca2+-dependent channel gating. The Ca2+-calmodulin 
binding domains are mostly found to bind to the canonical 1-8-14 calmodulin binding motif, 
while Ca2+-independent binding generally is to IQ motifs.97 Ca2+-independent calmodulin 
interactions have also been observed for L-type, P/Q-type and R-type voltage-dependent Ca2+ 
channels.99 For L-type channels similar differential interactions of calmodulin lobes have been 
observed as well.100 Hence, Ca2+-independent and dependent interactions of calmodulin with 
NCX1.3 could be mediated by binding of the calmodulin C- and N-lobes respectively, thereby 
involving multiple calmodulin binding sites. Of the five predicted calmodulin binding sites 
within NCX1.3 (including the XIP region),96 the region R362/R367 is the only to contain a motif 
resembling the IQ motif implicated in Ca2+-independent binding and should be investigated 
further.
Surprisingly, the potential calmodulin binding region F683/L696 likely plays a role in a different 
Ca2+-dependent regulatory mechanism as well, since NCX1.3-F683D demonstrates increased 
exchanger activity when compared to wild-type, which is much lower at low (0.1 mM) 
extracellular Ca2+ concentrations. Interestingly, this region in NCX1 contains several predicted 
PKA phosphorylation sites. In rat NCX1.1, phosphorylation of residue T731 (T694 in mouse 
NCX1.3) has been confirmed in vitro.92 For TRPV5, phosphorylation sites within calmodulin 
binding domains have been described twice: the region S696-H729 with residue T709 being 
phosphorylated in response to PTH and β-AR and the region V133-R154 where residue S144 
is phosphorylated in response to PAR-1 activation by plasmin.7,10 Since phosphorylation 
processes in NCX1 are still controversial, the role of phosphorylation on NCX1.3 function in the 
distal convolution has to be investigated first. 
Conclusions and future perspectives 
The aim of this thesis was to further characterize the regulation of transcellular Ca2+ transport 
in the distal convolution. The presented studies illustrate the coordinated regulation of the 
molecular components of renal transcellular Ca2+ transport, as well as the role and regulation 
of the individual elements, mainly focusing on the “gatekeeper” TRPV5 and the main extruder 
NCX1 (Figure 4). Deeper insight was obtained in the control of Ca2+ influx through TRPV5, by 
clarifying the role of its N-terminal region in channel folding. In addition, we demonstrated 
regulation of TRPV5 channel activity by the β1-AR agonist dobutamine, previously unknown 
as a regulator of renal transcellular Ca2+ transport. By modulating renal Ca2+ reabsorption, 
pharmacological β-AR agonists and antagonists (β-blockers) could greatly influence overall 
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Ca2+ homeostasis. The effect of these compounds on renal Ca2+ handling and total body Ca2+ 
balance needs to be studied in vivo. These studies would predict whether possible implications 
for treatment of patients with β-AR agonists and β-blockers should be investigated. 
Furthermore, regarding the characterization of basolateral Ca2+ extrusion, we cloned and 
characterized murine renal NCX1 (NCX1.3), and identified an important interacting partner: 
the Ca2+-sensor calmodulin, which regulates NCX1.3 protein stability and exchanger activity. 
In order to understand functioning of NCX1 in relation to transcellular Ca2+ transport, it is 
important to identify all key regulators of NCX1.3 activity. As a result, it is essential to determine 
the role of NCX1.3 phosphorylation, a process remaining controversial for NCX for a long time 
already. In addition, to understand functioning of NCX1 in renal transcellular Ca2+ transport, 
the role of the two other NCX variants, NCX1.2 and NCX1.7, in the distal convolution requires 
further investigations. 
ATPADP
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PMCA4NCX1
CB28k
TRPV5
Ca2+
Na+
Nucleus
ER
CaM
GPCR
dobutamine
channel activity  ↑
P 1
2
3
4
pro-urine
blood
Figure 4 - Overview of the key findings 
in renal transcellular Ca2+ transport. 
Firstly, the TRPV5 N-terminal region (M1-
M38) is implicated in channel folding, 
as absence of this segment results in 
endoplasmic reticulum (ER) retention. 
Secondly, TRPV5 channel activity is 
enhanced by the β1-AR (a GPCR) agonist 
dobutamine, a process mediated by 
channel phosphorylation. Thirdly, 
calmodulin (CaM) was demonstrated to 
bind NCX1 and to enhance exchanger 
activity and protein stability. Fourthly, 
based on transcriptional regulation 
PMCA4 and not PMCA1 was indicated as 
the key PMCA involved in transcellular 
Ca2+ transport.
In addition to studies on the regulation of the individual components TRPV5, NCX1 and 
possibly in the future PMCAs, to fully understand the process of transcellular Ca2+ transport it is 
essential to characterize the interplay of the different elements. Therefore, a highly innovative 
distal convolution cell model was developed. We confirmed the importance of TRPV5 in 
renal transcellular Ca2+ transport, as well as substantiated the role of NCX1 in this process. In 
addition, using the fluorescently sorted distal convolution material, we identified PMCA4 as an 
important and possibly the main PMCA involved in renal transcellular Ca2+ transport. The role 
and regulation of the different PMCAs in this process require further investigation. Additionally, 
the role, regulation and interplay of NCX1 and the PMCAs in basolateral extrusion of Ca2+ remain 
largely unknown. In this matter, the newly developed primary murine distal convolution cell 
model will enable several opportunities to study the regulation and interaction of the different 
components of renal transcellular Ca2+ transport, allowing study of the interplay of influx, 
shuttling and extrusion of Ca2+. Knowledge on regulation of the individual elements as well 
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as their interplay will enable the construction of a comprehensive model of renal transcellular 
Ca2+ transport. This will allow detailed computational studies and valuable predictions on 
total renal Ca2+ handling. New insights in the regulation of renal Ca2+ reabsorption will help 
to understand and solve disorders that are characterized by disturbances in the Ca2+ balance, 
such as idiopathic hypercalciuria. This is a condition displaying increased urinary Ca2+ excretion 
due to so far unknown causes, often leading to the development of kidney stones.101
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Chapter 1: Introduction
Calcium (Ca2+) plays a key role in many of our body’s physiological processes, such as bone 
formation, muscle contraction and blood coagulation. As a result, it is essential that Ca2+ levels 
are tightly regulated, both in blood and within cells. The overall Ca2+ balance is regulated 
by obtaining Ca2+ from food in the intestine, storage of Ca2+ in bone and by controlling Ca2+ 
excretion via the urine in the kidneys. Each kidney contains ~1 million functional elements, 
the nephrons. Each nephron in turn is composed of a glomerulus where the blood is filtered, 
followed by a long tubule where the filtered pro-urine is concentrated and important nutrients 
are reabsorbed back into the blood. To prevent loss of Ca2+ via the urine, ~99% of all filtered 
Ca2+ is reabsorbed along the nephron. The majority is taken up via the paracellular route, where 
Ca2+ is transported to the blood via so-called tight junctions. The final Ca2+ excretion via urine, 
however, is controlled by transcellular Ca2+ transport. This transcellular Ca2+ transport takes 
place in the distal part of the kidney tubule, the distal convolution. Here, tubular cells absorb 
Ca2+ from the pro-urine to extrude it again on the opposite side of the cell, towards the blood. 
Ca2+ entry into the cell is controlled by the epithelial Ca2+ channel transient receptor potential 
vanilloid 5 (TRPV5), after which the Ca2+-buffer calbindin-D28k guides it to the other end of the 
cell. There Ca2+ is transported to the blood by the Na+/Ca2+ exchanger, NCX1, and by the plasma 
membrane Ca2+-ATPase, PMCA.
To preserve the Ca2+ balance within our body, transcellular Ca2+ transport in the kidney is tightly 
regulated. Many different factors are involved, among which the calciotropic hormones such as 
vitamin D3 and parathyroid hormone (PTH). These hormones stimulate Ca
2+ reabsorption in the 
distal convolution, by increasing mRNA expression levels of TRPV5, calbindin-D28k and NCX1, 
resulting in a higher production of the corresponding proteins. In addition to the coordinated 
regulation of the mRNA and consequently protein expression levels, these transport proteins 
are also individually controlled by several local factors. These may for example specifically 
influence the intrinsic transport activity of TRPV5, NCX1 and PMCA, but could also affect their 
transport route within the cell, resulting in altered protein levels on the plasma membrane. 
Regulation of TRPV5 channel activity on the plasma membrane has been extensively 
investigated. TRPV5 acts as a gatekeeper by regulating the uptake of Ca2+ into the cell and 
is therefore considered as the most critical element in transcellular Ca2+ transport. The key 
role of TRPV5 in this process was revealed by studying mice lacking functional TRPV5 protein: 
TRPV5-/- mice. These animals reabsorb less Ca2+ in the distal convolution and therefore 
excrete more Ca2+ via their urine. The TRPV5 protein is a selective Ca2+ channel, comprising 
six transmembrane domains and large intracellular amino (N)- and carboxy (C)-termini. Four 
TRPV5 proteins, a tetramer, are required to form a functional Ca2+ channel. TRPV5 channel 
activity is controlled by many factors, among which are the intracellular and extracellular Ca2+ 
concentration, pH, hormones such as PTH, as well as many other factors present in the pro-
urine. The C-terminal domain of TRPV5, and especially the conserved TRP box domain, has 
an important role in these regulatory processes, as it binds many different proteins, such as 
the Ca2+-sensor calmodulin. Moreover, specific amino acids in the TRPV5 C-terminal domain 
can be phosphorylated, thereby raising the number of channels on the plasma membrane or 
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increasing the intrinsic channel activity. Both processes result in increased Ca2+ reabsorption 
from the pro-urine. After being taken up by TRPV5, Ca2+ is excreted on the other side of the 
cell by the interplay of NCX1 and PMCA. In contrast to the passive uptake of Ca2+ by TRPV5, 
being driven by the Ca2+-gradient over de plasma membrane, the transport of Ca2+ out of the 
cell is very energy consuming. The naturally occurring Na+-gradient that is important for NCX1 
function, is created by Na+-K+ ATPases, while the PMCAs are directly driven by ATP hydrolysis. 
Due to its high transport capacity, NCX1 is responsible for ~70% of Ca2+ excretion. PMCAs have 
a lower capacity, but do have a higher affinity for Ca2+, making them important for fine-tuning 
total Ca2+ export. In contrast to the TRPV5 dependent Ca2+ uptake, there is still only limited 
knowledge on the role and regulation of NCX1 and PMCA in renal Ca2+ transport. 
In this thesis the regulation of transcellular Ca2+ transport in the kidney is further investigated. 
Firstly, the regulation of the TRPV5 channel by i) the largely unknown TRPV5 N-terminal 
domain and ii) the effects of stress hormones via β-adrenergic receptor signaling, is studied. 
Secondly, by using an innovative approach, a novel primary distal convolution cell model was 
developed for detailed studies on the interplay of the different factors involved in transcellular 
Ca2+ transport. And finally, the regulation of the kidney-specific variant of the NCX1 protein 
was investigated.
Chapter 2: Role of the TRPV5 protein N-terminus in channel activity, tetramerization and 
trafficking
Unlike the TRPV5 C-terminus, the role of the N-terminal tail in the regulation of Ca2+ channel 
activity is still largely unknown. Like the other members of the TRPV family, the TRPV5 N-terminus 
contains six ankyrin domains. These are repeating domains consisting of conserved helix-loop-
helix structures of ~33 amino acids, which can bind different factors, as for example ATP. The 
first ankyrin domain is implicated in mutual interactions between different TRPV5 N-termini. 
Furthermore, it has been shown that calmodulin is able to bind the TRPV5 N-terminus. And 
finally, the N-terminus is phosphorylated by protein kinase C (PKC) on amino acids S144 and 
S299. To investigate the role of the N-terminus in TRPV5 function, different mutants were 
generated that lacked part of the N-terminus. When the first 38 amino acids are absent, 
more specifically when amino acids Q31/D34 are mutated, the TRPV5 channel lost its activity, 
remained unglycosylated and was localized primarily in the endoplasmic reticulum. Most 
likely this indicates that the protein is misfolded and therefore retained in the endoplasmic 
reticulum by the quality control mechanism, thereby blocking further transport to the Golgi 
apparatus. Moreover, the small amount of TRPV5 channels that escaped quality control and 
did reach the plasma membrane, could not be internalized. Interestingly, despite problems 
with protein folding, the TRPV5 channels were still able to form tetramers, even when the first 
75 amino acids and therefore the whole first ankyrin domain were missing. The critical amino 
acids Q31/D34 in the first part of the N-terminus are located in a possible helix structure, which 
appears to be essential for protein folding and thus functioning of the TRPV5 Ca2+ channel. 
Further investigations are required to clarify the role of the first ankyrin domain in mutual 
TRPV5 channel interactions. 
Chapter 3: β1-Adrenergic receptor signaling activates the epithelial Ca2+ channel TRPV5, via 
the protein kinase A pathway
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The stress hormones epinephrine and norepinephrine have different functions in the body, 
but mainly exert their effects on the cardiovascular system. They operate by binding to both 
α-adrenergic and β-adrenergic receptors (β-AR). Both hormones are not only present in the 
blood, but also in pro-urine. Additionally, β1-AR and β2-AR are located in the distal convolution, 
where TRPV5-mediated Ca2+ transport occurs. However, a possible effect of β-AR signaling on 
renal transcellular Ca2+ transport has never been described. The presence of β1-AR in the distal 
convolution was confirmed using immunohistochemistry, while β2-AR could not be detected. 
When primary distal convolution cultures were treated with the β1-AR agonist dobutamine, 
Ca2+ transport was clearly increased. β-AR receptors are G-protein coupled receptors, or 
GPCRs. Activation of other GPCRs such as the PTH receptor 1, the Ca2+ sensing receptor and 
the bradykinin receptor type 2, results in enhanced activity of the TRPV5 channel and/or an 
increased number of channels on the plasma membrane. Dobutamine-mediated activation of 
the β1-AR receptor in HEK293 cells transiently expressing TRPV5, resulted in increased TRPV5 
activity, while there was no increase in the presence of the channel on the plasma membrane. 
This effect was caused by phosphorylation of amino acid T709 by protein kinase A (PKA), 
in similarity to the response to PTH receptor activation. Endogenous and synthetic β1-AR 
agonists, and possibly antagonists such as the commonly used β-blockers, are likely to have 
an important role in maintaining the total body Ca2+ balance through their potential effect on 
total Ca2+ reabsorption in the kidney. 
Chapter 4: Coordinated regulation of TRPV5-mediated Ca2+ transport in primary distal 
convolution cultures
Studies into the molecular mechanism of transcellular Ca2+ transport in the distal convolution 
and especially the interplay of the different transport proteins, are seriously hindered by a 
suitable cell model. Several models have been developed in the past, but all harbor considerable 
limitations. Using a very innovative technique a novel primary cell model was developed to 
investigate the function of the distal convolution. The cell model described in this thesis makes 
use of transgenic mice expressing green fluorescent protein (GFP) from the TRPV5 promotor 
sequence. This allowed the use of the COPAS sorter to specifically isolate TRPV5 expressing 
kidney tubules (the distal convolution). Isolated tubular fragments were subsequently 
cultured on filters, to preserve the specific cellular characteristics. After seven days of culturing, 
the cells developed into a tight monolayer with all the typical Ca2+ transporting properties 
of the distal convolution. It is important to note that crucial regulatory pathways remained 
intact, such as regulation of gene expression by vitamin D3 or the increase in Ca
2+ transport 
after PTH treatment. By crossbreeding the GFP mice with TRPV5-/- mice, lacking any functional 
TRPV5, and subsequently culturing isolated TRPV5-/- tubule fragments, for the first time the key 
role of TRPV5 in transcellular Ca2+ transport was directly confirmed. Moreover, in the absence 
of the natural Na+-gradient, Ca2+ transport was decreased, confirming the role of NCX1 in 
this process. Furthermore, mRNA levels of the different proteins crucial for transcellular Ca2+ 
transport, TRPV5, calbindin-D28K and NCX1, were clearly enriched in the sorted kidney tubule 
fragments as compared to total kidney material before sorting. The same held true for PMCA4, 
but surprisingly not for PMCA1, which was previously considered the most important PMCA for 
transcellular Ca2+ transport. In addition, coordinated regulation of all these components was 
observed in the TRPV5-/- distal convolution, in which mRNA levels of calbindin-D28K, NCX1 and 
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PMCA4 were decreased. These results indicate an important role for PMCA4, but not PMCA1, in 
renal transcellular Ca2+ transport. The findings illustrate that this innovative primary cell model 
will allow the detailed study of the interplay between all the different components involved in 
renal transcellular Ca2+ transport.
Chapter 5: Regulation of the renal NCX1 variant by calmodulin
The Na+/Ca2+ exchanger 1 (NCX1) is responsible for excreting the majority of Ca2+ that has 
entered the cell via the TRPV5 channel. NCX1 consists of ten transmembrane domains, small 
extracellular N- and C-terminal domains and one large intracellular loop. This loop contains 
two Ca2+ binding domains (CBDs). Alternative splicing of NCX1 mRNA results in proteins 
with distinguishing characteristics that are expressed in different tissues. In the kidney, and 
especially in the distal convolution, the variants NCX1.2, NCX1.3 and NCX1.7 are present, of 
which NCX1.3 is commonly regarded as the most important NCX1 variant in the kidney. Both 
TRPV5 and PMCAs are regulated by calmodulin. Also, five calmodulin binding sites have been 
predicted in the NCX1 protein, among which the XIP domain. Previous studies have looked 
into the XIP domain as a potential calmodulin binding site, but actual binding has never 
been demonstrated. Two of the five potential binding sites are located within predicted 
transmembrane domains and were therefore not further pursued. The study described in this 
thesis demonstrates binding of calmodulin to NCX1.3. The strength of calmodulin binding 
was markedly increased in the presence of Ca2+, but occurred in Ca2+-free conditions as well. 
Overexpression of calmodulin together with NCX1.3 in HEK293T cells resulted in an increase 
in NCX1.3 activity and protein levels. The effect of calmodulin on NCX1.3 activity was largely 
dependent on Ca2+ binding to calmodulin, whereas the effect on protein levels seemed 
independent of Ca2+. The two remaining possible calmodulin binding sites were investigated 
by mutating critical amino acids within these regions. Mutation of amino acid R362 had little 
effect on stimulation of NCX1.3 by calmodulin, yet when amino acid L696 was mutated, 
calmodulin could no longer increase NCX1.3 activity. The effect on protein levels however was 
preserved, as was the binding of calmodulin to NCX1.3. In addition to the probable binding 
site around amino acid L696 that is involved in regulating NCX1.3 activity, a second binding 
site possibly exists, controlling NCX1.3 stability. Further studies are required to elucidate the 
Ca2+-independent regulation of NCX1.3 by calmodulin. 
Chapter 6: General discussion
The different studies described in this thesis provide additional insight into two essential 
components of transcellular Ca2+ transport in the kidney: the Ca2+ channel TRPV5 and the Na+/
Ca2+ exchanger NCX1.3. In addition, the novel primary cell model provides a very valuable 
basis to characterize the interplay of all the different components involved. The investigation 
into the regulation of the TRPV5 channel, has led to important insights into the structural role 
of its N-terminal tail and how it is involved in TRPV5 folding, and even more importantly to 
the finding that stress hormones are able to stimulate channel activity. The pharmacological 
compound dobutamine, part of the family of stress hormones such as epinephrine, has for 
the first time been implicated in the regulation of the TRPV5 channel and transcellular Ca2+ 
transport. In vivo studies are necessary to confirm the calciotropic role of dobutamine and 
other β-adrenergic agonists, but also antagonists (β-blockers), on renal Ca2+ resorption and 
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the total body Ca2+ balance.
On top of these findings, this thesis has made an important start in studying the regulation 
of the renal NCX1 variant. This protein, NCX1.3, has been cloned from kidney tissue in order 
to characterize its function in renal Ca2+ transport. For the first time it has been shown that 
calmodulin interacts with NCX1.3. Calmodulin has a crucial role in regulating TRPV5 and 
PMCA. It will be interesting to determine whether all other factors that are known to regulate 
TRPV5 in different ways, also affect NCX1.3 in a similar fashion. A prime example would be the 
role of β-adrenergic signaling, since regulation of NCX1 in the heart (splice variant NCX1.1) 
has previously been shown. To proceed in this direction, it is important to first clarify the 
controversial issue of NCX1 phosphorylation processes. Future investigations into the role and 
regulation of NCX1.3 will contribute significantly to the understanding of its function in renal 
transcellular Ca2+ transport.
In addition to studying TRPV5, NCX1.3 and in the future PMCA, individually, it will be essential to 
investigate how these different components function together. The development of the primary 
distal convolution cell model serves as an excellent basis for further studies. Crossbreeding 
with different mouse models will allow detailed study of all the different components involved 
in trancellular Ca2+ transport. Moreover, the primary cell model provides an opportunity 
to investigate the role of many known and unknown factors on Ca2+ reabsorption in an “ex 
vivo” setting. All together this should lead to a complete image on the interplay between all 
the different components, TRPV5, calbindin-D28k, PMCA4 and NCX1, and their regulation by 
different calciotropic factors, both known and unknown. Detailed insights into the regulation 
of renal transcellular Ca2+ transport will help to understand and treat several diseases where 
the Ca2+ balance has been disturbed, such as idiopathic hypercalciuria, for which the cause of 
the renal Ca2+ loss is still unknown. 
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Samenvatting
Hoofdstuk 1: Introductie
Calcium (Ca2+) speelt een sleutelrol in vele fysiologische processen in het lichaam, zoals bij 
de vorming van onze botten, spiercontracties en bloedstolling. Daarom is het essentieel dat 
de concentratie van Ca2+, zowel in het bloed als in de cel, nauwkeurig wordt gereguleerd. De 
Ca2+ balans wordt in evenwicht gehouden door een samenspel van verschillende organen. 
De darm is verantwoordelijk voor Ca2+ opname uit de voeding, het bot is belangrijk voor de 
opslag van Ca2+, terwijl de nier de uitscheiding van Ca2+ via de urine regelt. De nieren bestaan 
ieder uit ~1 miljoen functionele elementen, de nefronen. Ieder nefron is opgebouwd uit 
een glomerulus waar het bloed wordt gefiltreerd en een lange nierbuis waar de gefiltreerde 
voorurine vervolgens wordt geconcentreerd en belangrijke stoffen weer worden opgenomen 
in het bloed. Om verlies van Ca2+ via de urine te voorkomen, wordt in de nier ~99% van het Ca2+ 
uit de voorurine geresorbeerd. Het grootste deel wordt opgenomen via de paracellulaire route, 
waarbij Ca2+ tussen de cellen door via de zogenaamde “tight junctions” richting het bloed wordt 
getransporteerd. De uiteindelijke Ca2+ uitscheiding via de urine wordt echter bepaald door het 
transcellulaire transport. Hierbij wordt het Ca2+ uit de voorurine door de cel opgenomen om 
het aan de bloedkant weer af te geven. Dit proces van transcellulair transport vindt plaats 
in het laatste (distale) segment van de nierbuis, het zogenaamde distaal convoluut  en  de 
verbindingsbuis. De binnenkomst van Ca2+ in de cel wordt gereguleerd door het epitheliale 
Ca2+ kanaal transient receptor potential vanilloid 5 (TRPV5), waarna het door de Ca2+-buffer 
calbindine-D28k naar de andere kant van de cel wordt geleid. Hier wordt het Ca
2+ door de Na+/
Ca2+ uitwisselaar, NCX1, en door de plasmamembraan Ca2+-ATPase, PMCA, richting het bloed 
getransporteerd. 
Om de Ca2+ balans in het lichaam te behouden wordt het transcellulaire Ca2+ transport in 
de nier nauwkeurig geregeld. Vele factoren spelen hierbij een rol waaronder de calciotrope 
hormonen zoals vitamine D3 en parathormoon (PTH). In het distaal convoluut/verbindingsbuis 
van de nierbuis, stimuleren deze hormonen de Ca2+ resorptie door het verhogen van de mRNA 
expressieniveaus van TRPV5, calbinindine-D28k en NCX1, hetgeen resulteert in een hogere 
productie van de betreffende eiwitten. Naast het reguleren van de eiwitniveaus worden de 
elementen ook afzonderlijk gereguleerd door allerlei locale factoren. Deze factoren kunnen 
specifiek de intrinsieke activiteit van TRPV5, NCX1 en PMCA beïnvloeden, maar ook het 
transport en daarmee de hoeveelheid van deze eiwitten op de plasmamembraan. 
Regulatie van de activiteit van het epitheliale Ca2+ kanaal TRPV5 op de plasmamembraan 
is uitgebreid onderzocht. TRPV5 regelt de opname van Ca2+ in de cel, vervult een 
poortwachtersfunctie, en wordt daarom gezien als het meest kritische element in het 
transcellulaire Ca2+ transport. De sleutelrol van TRPV5 in dit proces is duidelijk geworden door 
onderzoek in muizen die geen functioneel TRPV5 eiwit bezitten, de TRPV5-/- muizen. Deze 
muizen hebben een verminderde Ca2+ resorptie in het distale segment van de nierbuis en 
verliezen daardoor meer Ca2+ via de urine. Het TRPV5 eiwit is een kanaal dat bestaat uit zes 
transmembraan segmenten en grote intracellulaire amino (N)- en carboxyl (C)- domeinen. Vier 
van deze TRPV5 eiwitten, de zogenaamde tetrameer, vormen samen een functioneel Ca2+ kanaal. 
De activiteit van het TRPV5 kanaal wordt bepaald door vele factoren, zoals de Ca2+ concentratie, 
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pH, verschillende hormonen waaronder PTH en allerlei andere stoffen die aanwezig zijn in de 
voorurine. Het C-terminale domein in TRPV5 en dan met name het geconserveerde TRP box 
domein speelt een belangrijke rol in deze regulatoire processen, doordat het domein allerlei 
eiwitten zoals bijvoorbeeld de Ca2+-sensor calmoduline bindt. Daarnaast kunnen specifieke 
aminozuren in het C-terminale domein van TRPV5 gefosforyleerd worden, waardoor het 
aantal kanalen op de plasmamembraan toeneemt of de intrinsieke kanaalactiviteit wordt 
verhoogd. Beiden leiden tot een hogere opname van Ca2+ uit de voorurine. Na opname door 
TRPV5, wordt het Ca2+ aan de andere kant van de cel uitgescheiden door een samenspel van 
NCX1 en PMCAs. In tegenstelling tot passieve opname van Ca2+ door het TRPV5 kanaal met 
de Ca2+-gradiënt mee, kost het transport van Ca2+ de cel uit juist veel energie. De van nature 
aanwezige Na+-gradiënt die van belang is voor het functioneren van NCX1 wordt gecreëerd 
door de Na+-K+ ATPases, terwijl de PMCAs direct worden aangedreven door hydrolyse van ATP. 
Vanwege zijn hoge transportcapaciteit is NCX1 verantwoordelijk voor ~70% van het uitgaande 
Ca2+ transport. PMCAs hebben een lagere capaciteit, maar een hoge affiniteit voor Ca2+, en zijn 
daarom belangrijk voor de fijnregeling van de Ca2+ uitscheiding. In tegenstelling tot opname 
van Ca2+ via TRPV5, is de functionele rol en regulatie van NCX1 en PMCA in het renale Ca2+ 
transport nog weinig bestudeerd. 
In dit proefschrift is de regulatie van het transcellulaire Ca2+ transport in de nier verder 
onderzocht. Daarbij is eerst de regulatie van het TRPV5 kanaal bestudeerd door i) het nog 
grotendeels onbekende TRPV5 N-terminale domein en ii) de  effecten van stresshormonen via 
β-adrenerge receptor signalering. Daarnaast is met behulp van een zeer innovatieve techniek 
een primair celmodel ontwikkeld om het samenspel van de verschillende componenten van 
het transcellulaire Ca2+ transport te kunnen bestuderen. Als laatste is onderzoek verricht naar 
de regulatie van de nier-specifieke variant van het NCX1 eiwit.
Hoofdstuk 2: De rol van de N-terminus in TRPV5 activiteit, tetramerisatie en transport
In tegenstelling tot de C-terminus, is de rol van de TRPV5 N-terminus in de regulatie van het Ca2+ 
kanaal nog weinig onderzocht. Net als de andere leden van de TRPV familie, bevat de TRPV5 
N-terminus zes ankyrine-domeinen. Dit zijn repeterende domeinen van geconserveerde helix-
lus-helix structuren, ieder ~33 aminozuren groot, die een rol spelen in het binden van allerlei 
factoren, zoals bijvoorbeeld ATP. Het eerste ankyrine-domein is betrokken bij onderlinge 
interacties tussen verschillende TRPV5 N-terminus domeinen. Daarnaast is binding van 
calmoduline aan de N-terminus aangetoond. Verder wordt de N-terminus door proteine kinase 
C (PKC) gefosforyleerd op de aminozuren S144 and S299. Om de functie van de N-terminus 
te onderzoeken, werden verschillende mutanten gegenereerd die een gedeelte van de 
N-terminus misten. In afwezigheid van de eerste 38 aminozuren en specifieker na mutatie 
van de aminozuren Q31/D34, was het TRPV5 kanaal niet actief, niet geglycosyleerd en was 
het voornamelijk aanwezig in het endoplasmatisch reticulum. Zeer waarschijnlijk betekent 
dit dat het eiwit niet goed kan worden gevouwen en door de kwaliteitscontrole van het 
endoplasmatisch reticulum wordt tegengehouden. Verder transport naar het Golgi-apparaat 
en uiteindelijk de plasmamembraan is hierdoor verstoord. Daarnaast konden de enkele 
TRPV5 kanalen die ontsnapten aan de kwaliteitscontrole en dus toch op de plasmamembraan 
aanwezig waren, niet meer op de gebruikelijke manier worden geïnternaliseerd. Ondanks dat 
de eiwitvouwing verstoord was, konden de TRPV5 kanalen nog wel tetrameren vormen, zelfs 
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als de eerste 75 aminozuren en dus ook het eerste ankyrine-domein ontbraken. De kritische 
aminozuren Q31/D34 in het eerste deel van de N-terminus bevinden zich in een mogelijke helix 
structuur, deze helix is dus waarschijnlijk essentieel voor de vouwing en dus het functioneren 
van het TRPV5 Ca2+ kanaal. Verder onderzoek is nodig om de rol van het eerste ankyrine-
domein in interacties tussen TRPV5 kanalen te verduidelijken.
Hoofdstuk 3: β1-Adrenerge signalering activeert het epitheliale Ca2+ kanaal TRPV5 
De stresshormonen epinefrine en norepinefrine hebben verschillende functies in het lichaam, 
en reguleren met name de werking van het hart en de bloedvaten. De hormonen werken door 
te binden aan α-adrenerge receptoren en β-adrenerge receptoren (β-AR). Beide hormonen zijn 
niet alleen in het bloed, maar ook in de voorurine aanwezig. Daarnaast zijn de β1-AR en β2-AR 
aanwezig in het distale gedeelte van de nierbuis, waar TRPV5-gemedieerd transcellulair Ca2+ 
transport plaatsvindt. Echter, een mogelijke rol van β-AR signalering op renaal transcellulair Ca2+ 
transport is nooit eerder beschreven. Met behulp van immunohistochemie is de aanwezigheid 
van β1-AR in het distaal convoluut/verbindingsbuis bevestigd, terwijl β2-AR niet kon worden 
aangetoond. Wanneer primaire niercellen van het distaal convoluut/verbindingsbuis met de 
β1-AR agonist dobutamine werden behandeld, was het Ca2+ transport duidelijk verhoogd. 
De β-AR receptoren zijn G-proteïne gekoppelde receptoren (G-protein coupled receptors, 
GPCRs). Activatie van verschillende GPCRs zoals de PTH receptor 1, de Ca2+ sensing receptor 
en de bradykinin receptor type 2, resulteert in TRPV5 kanaalactivatie of verhoogde expressie 
van het kanaal op de plasmamembraan. Activatie van de β1-AR receptor door dobutamine in 
een HEK293 cel systeem dat TRPV5 tot expressie brengt, leidde tot verhoogde TRPV5 activiteit 
terwijl het aantal kanalen op de plasmamembraan onveranderd bleef. Dit werd veroorzaakt 
door fosforylatie van aminozuur T709 door proteine kinase A (PKA); een effect dat ook 
optreedt door activatie van de PTH receptor. Endogene en farmacologische β1-AR agonisten 
en mogelijk ook antagonisten zoals de veelgebruikte β-blokkers hebben door hun potentiële 
effect op de totale Ca2+ resorptie in de nier dus zeer waarschijnlijk een belangrijk effect op de 
Ca2+ balans in het lichaam.
Hoofdstuk 4: Gecoördineerde regulatie van TRPV5-gemedieerd Ca2+ transport in primaire 
cultures van distaal convoluut/verbindingsbuis
Studies naar het moleculaire mechanisme van transcellulair Ca2+ transport in het distale 
deel van het nefron, en dan met name het samenspel van de betrokken componenten, 
worden ernstig belemmerd door het gebrek aan een geschikt celmodel. In het verleden 
zijn verschillende modellen ontwikkeld, maar deze hebben allen significante beperkingen. 
Met behulp van een zeer innovatieve techniek is een nieuw celmodel ontwikkeld voor 
studies naar de werking van het distaal convoluut/verbindingsbuis. Het in dit proefschrift 
beschreven celmodel maakt gebruik van muizen die een groen fluorescerend eiwit (green 
fluorescent protein, GFP) tot expressie brengen vanaf de TRPV5 promotersequentie. Hierdoor 
konden met gebruik van de COPAS sorteerder specifiek de nierbuisjes die TRPV5 bevatten 
(distaal convoluut/verbindingsbuis) worden geïsoleerd. Deze nierbuisfragmenten werden 
vervolgens gekweekt op speciale filters, zodat de specifieke eigenschappen van de cellen 
bewaard bleven. Op deze manier werd na zeven dagen kweken, een celmonolaag met de 
typische Ca2+-transporterende karakteristieken van het distaal convoluut/verbindingsbuis 
verkregen. Cruciaal is ook dat de belangrijkste regulatoire routes intact waren, zoals regulatie 
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van genexpressie door vitamine D3 en de snelle verhoging van het Ca
2+ transport als reactie 
op behandeling met PTH. Door het kruisen van de GFP-muizen met TRPV5-/- muizen die geen 
functioneel TRPV5 bevatten, en vervolgens het kweken van de gesorteerde TRPV5-/- nierbuis 
fragmenten, werd voor de eerste keer de sleutelrol van het TRPV5 kanaal in het transcellulaire 
Ca2+ transport bevestigd. Daarnaast was het Ca2+ transport verlaagd in de afwezigheid van de 
natuurlijke Na+-gradient, hetgeen de rol van NCX1 in dit proces aantoont. De mRNA niveaus van 
de verschillende componenten die een rol spelen in het transcellulaire Ca2+ transport, namelijk 
TRPV5, calbindine-D28k en NCX1, waren duidelijk verrijkt in gesorteerde tubulussegmenten 
wanneer dit werd vergeleken met het niermateriaal voor sorteren. Dit geldt ook voor PMCA4, 
maar niet voor PMCA1 dat voorheen werd gezien als de belangrijkste PMCA in het proces 
van transcellulair Ca2+ transport. Soortgelijke co-regulatie van deze componenten werd 
waargenomen in TRPV5-/- distaal convoluut/verbindingsbuis, waar de mRNA niveaus van 
calbindine-D28k, NCX1, PMCA4 zijn verlaagd. Deze resultaten duiden op een belangrijke rol 
van PMCA4, en niet PMCA1, in renaal transcellulair Ca2+ transport. De bevindingen illustreren 
dat met behulp van dit innovatieve celmodel in de toekomst de regulatie, en voor het eerst 
ook het samenspel van de verschillende componenten, in het transcellulaire Ca2+ transport 
nauwkeurig zal kunnen worden bestudeerd. 
Hoofdstuk 5: Regulatie van de renale Na+/Ca2+ uitwisselaar 1 (NCX1) door calmoduline
De Na+/Ca2+ uitwisselaar 1 (NCX1) is verantwoordelijk voor het uitscheiden van het grootste 
deel van het via TRPV5 opgenomen Ca2+. NCX1 bestaat uit tien transmembraan domeinen, 
kleine extracellulaire N- en C-terminale domeinen en een grote intracellulaire lus. Deze lus 
bevat twee Ca2+-bindende domeinen (CBDs).  De tweede CBD is een plaats voor alternatieve 
splicing, waardoor verschillende NCX1 varianten bestaan. Alternatieve splicing van NCX1 leidt 
tot eiwitten met onderscheidende eigenschappen die in verschillende weefsels in het lichaam 
tot expressie komen. In de nier, en met name in het distaal convoluut/verbindingsbuis, zijn 
de varianten NCX1.2, NCX1.3 en NCX1.7 aanwezig, waarvan NCX1.3 het meest tot expressie 
komt en dan ook vaak als de belangrijkste NCX1 variant in de nier wordt beschouwd. Zowel 
TRPV5 als de PMCAs worden gereguleerd door calmoduline. Voor NCX1 werden vijf mogelijke 
bindingsplaatsen voor calmoduline voorspeld, waaronder het zogenaamde XIP domein. Dit 
domein is al eerder onderzocht als potentiële calmoduline bindingsplaats, maar binding is nooit 
aangetoond. Twee andere voorspelde bindingsplaatsen vielen samen met transmembraan 
domeinen en zijn daarom niet verder onderzocht. De in dit proefschrift beschreven studie 
laat binding van calmoduline aan NCX1.3 zien. Deze calmoduline binding was veel sterker 
in de aanwezigheid van Ca2+, maar trad ook op onder Ca2+-vrije condities. Overexpressie van 
calmoduline samen met NCX1.3 in een HEK293T celmodel, resulteerde in een verhoogde NCX1.3 
activiteit en eiwitexpressie. Het effect van calmoduline op de NCX1.3 activiteit was grotendeels 
afhankelijk van het binden van Ca2+ aan calmoduline, terwijl het effect op de eiwitniveaus Ca2+-
onafhankelijk was. De twee mogelijke calmoduline bindingsplaatsen werden onderzocht door 
het muteren van kritische aminozuren binnen deze regio’s. Mutatie van het aminozuur R362 
had weinig effect op de stimulatie van NCX1 door calmoduline, echter wanneer het aminozuur 
L696 werd gemuteerd, kon calmoduline de NCX1.3 activiteit niet verder verhogen. Het effect 
op de eiwitniveaus bleef wel bestaan, evenals binding van calmoduline aan NCX1.3. Naast 
de waarschijnlijke bindingsplaats rond aminozuur L696, die een rol speelt in de regulatie van 
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NCX1.3 activiteit is er dus vermoedelijk een tweede bindingsplaats die zorgt voor stabilisatie 
van het NCX1.3 eiwit. Nader onderzoek is nodig om het mechanisme van Ca2+-onafhankelijke 
regulatie van NCX1.3 door calmoduline te verhelderen. 
Hoofdstuk 6: Algemene discussie
De studies beschreven in dit proefschrift geven meer inzicht in twee essentiële componenten 
van het transcellulaire Ca2+ transport in nier: het Ca2+ kanaal TRPV5 en de Na+/Ca2+ uitwisselaar 
NCX1.3. Daarnaast leggen zij een belangrijke basis om het samenspel van de verschillende 
componenten nauwkeurig te kunnen karakteriseren. Het onderzoek naar de regulatie van 
TRPV5 heeft geleid tot belangrijke structurele kennis over de rol van het N-terminale domein 
in eiwitvouwing en nog belangrijker het ontdekken van de stimulerende effecten van 
zogenaamde stresshormonen op de kanaalactiviteit. De farmacologische stof dobutamine, uit 
de familie van stresshormonen zoals epinefrine, is voor het eerst in verband gebracht met de 
regulatie van het TRPV5 kanaal en het transcellulaire Ca2+ transport. In vivo studies zijn nodig 
om de calciotrope rol van dobutamine en andere β-adrenerge agonisten en ook antagonisten 
(β-blokkers) op renale Ca2+ resorptie en de totale Ca2+ balans te onderzoeken.
Vervolgens is met dit proefschrift een belangrijk begin gemaakt in het bestuderen van de 
regulatie van de renale NCX1 variant. Dit eiwit, NCX1.3, is gekloneerd uit de nier, om het 
daarna te karakteriseren. Hierbij is voor het eerst een interactie tussen NCX1.3 en calmoduline 
aangetoond. Calmoduline speelt een onmisbare rol in het functioneren van TRPV5 en PMCA. 
Het is interessant om te onderzoeken of de vele andere factoren die een effect hebben op 
TRPV5, ook een rol spelen in de regulatie van NCX1.3. Een goed voorbeeld is het effect van 
β-adrenerge signalering, omdat regulatie van NCX1 in het hart (splice variant NCX1.1) al in 
eerdere studies is beschreven. Hiervoor is het van groot belang eerst het nog controversiële 
onderwerp van fosforylatie van NCX1 helder te krijgen. Het onderzoek naar de rol en regulatie 
van NCX1.3 zal een grote bijdrage leveren aan het begrip van de functie van deze Ca2+ 
transporteur in het transcellulaire Ca2+ transport in de nier. 
Naast het individueel bestuderen van TRPV5, NCX1.3 en in de toekomst ook PMCA, is het van 
essentieel belang om het samenspel van de verschillende componenten te onderzoeken. Met 
de ontwikkeling van een celmodel voor het distaal convoluut/verbindingsbuis, is hiervoor 
een cruciale basis gelegd. Door het kruisen met verschillende muismodellen zullen de 
verschillende componenten tot in detail kunnen worden bestudeerd. Daarnaast biedt het 
celmodel de kans om voor allerlei bekende en onbekende factoren hun rol op de Ca2+ resorptie 
“ex vivo” te kunnen bestuderen. Dit tezamen zal leiden tot een compleet beeld van de rol en 
het samenspel van de verschillende elementen, TRPV5, calbindine-D28k, PMCA4 en NCX1, en 
regulatie door verschillende bekende en nog onbekende calciotrope factoren. Inzicht in de 
precieze regulatie van het transcellulair Ca2+ transport in de nier zal helpen in het begrijpen 
en oplossen van verschillende ziektes waar de Ca2+ balans is verstoord, zoals met name bij 
idiopathische hypercalciurie, waar de oorzaak van het renale Ca2+ verlies nog onbekend is.
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List of abbreviations 
1,25-(OH)2D3 1,25-dihydroxyvitamin D3 
1α-OHase 25-hydroxyvitamin-D3-1α-hydroxylase
[Ca2+]I   intracellular Ca
2+ concentration
β-AR  β-adrenergic receptor 
AQP2  aquaporin 2 
ARD  ankyrin repeat domain
ATP  adenosine 5’-triphosphate
a.u.  arbitrary unit
B2R  bradykinin receptor subtype 2
BAPTA-AM 1,2-Bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid tetrakis(acetoxy- 
  methyl ester)
bp  base pair
BSA  bovine serum albumin
Ca2+  calcium ion
CaCl2  calcium chloride
CaM  calmodulin
cAMP  3’- 5’-cyclic adenosine monophosphate 
CaSR  Ca2+-sensing receptor
CBD  Ca2+ binding domain
CB28k  calbindin-D28k 
cDNA  complement DNA
CHF  congestive heart failure
CNT  connecting tubule
COPAS  complex object parameter analyzer and sorter
C-terminus carboxy terminus
DAG  diacylglycerol
DCT   distal convoluted tubule
DMEM  dulbecco’s modified eagle medium
DMSO  dimethylsulphoxide
EDTA  ethylenediamine tetraacetic acid
EGFP   enhanced green fluorescent protein
EGTA  ethyleneglycol-bis-(β-aminoethylether)-N,N,N’,N’-tetraacetic acid
ENaC  epithelial sodium channel
Epi  epinephrine
ER  endoplasmic reticulum
fors  forskolin
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GAPDH   glyceraldehyde-3-phosphate dehydrogenase
GFP   green fluorescent protein
GPCR  G protein-coupled receptor
GSDB  goat serum dilution buffer 
HEK293  human embryonic kidney 293 cells
HRP  horseradish peroxidase
HCl  hydrochloric acid
IC50   50% inhibitory concentration
IP  immunoprecipitation
IP3  inositol trisphosphate
IRES  internal ribosome entry site
KD  dissociation constant
K+  potassium ion
KCl  potassium chloride
kDa   kilo dalton
KHB  KREBS-Henseleit
LaCl3   lanthanum chloride
MDCK  Madin-Darby canine kidney
mpkDCT  murine renal distal convoluted tubule
mesna  2-mercaptoethanesulfonic acid sodium salt
MgCl2  magnesium chloride
Mg2+  magnesium ion
mRNA  messenger RNA
n  sample size
NaCl   sodium chloride
NaOH  sodium hydroxide
Na+  sodium ion
NCC  Na+-Cl- cotransporter
NCX  Na+/Ca2+ exchanger
NE  norepinephrine
NHERF  Na+/H+ exchanger regulatory factor
NKCC2  Na-K-2Cl cotransporter
NMDG   N-methyl-D-glucamine
N-terminus amino terminus
PAGE   polyacrylamide gel electrophoresis
PAR-1  protease-activated receptor-1
PBS  phosphate-buffered saline 
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PEI   polyethylenimine
PFO  perfluorooctanoic acid
PIP2   phosphatidylinositol 4,5-bisphosphate
PKA   protein kinase A 
PKC   protein kinase C 
PLC   phospholipase C
PMA  phorbol-12-myristate-13-acetate
PMCA  plasma membrane Ca2+ ATPase
PMSF  phenylmethanesulfonylfluoride
PSS  physiological salt solution
PT   proximal tubule
PTH   parathyroid hormone
PTH1R  parahyroid hormone receptor type 1
PV  parvalbumin
RR   ruthenium red
SE  standard error
SERCA  sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
SGK1  serum- and glucocorticoid-induced kinase 1
TAL  thick ascending loop of Henle
TEER  transepithelial electrical resistance
TM  transmembrane
TPA  12-O-tetradecanoylphorbol-13-acetaat
TRPV  transient receptor potential vanilloid
TRPV5-/-  TRPV5 knockout
VDR  vitamin D receptor
VDRE  vitamin D-responsive element
WNK  with no lysine (K)
WT   wild-type
XIP   exchanger inhibitor peptide
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Dankwoord
Na bijna 5 jaar bloed, zweet en tranen, ik vrees zowel letterlijk als figuurlijk, is het na het schrijven 
van dit stukje toch echt bijna af! Het proefschrift waar het de afgelopen 5 jaar allemaal om 
draaide. Ondanks dat niet alles helemaal liep zoals gepland of gehoopt, ben ik heel blij en trots 
op het uiteindelijke resultaat! Dit heb ik natuurlijk niet alleen gedaan, en daarom wil ik hier 
heel graag iedereen bedanken die direct of meer indirect aan dit boekje hebben bijgedragen.
Daarbij wil ik natuurlijk beginnen met mijn promotoren prof. dr. Joost Hoenderop en prof. 
dr. René Bindels, zonder de kans die jullie me hebben gegeven om als PhD student 4 jaar 
op jullie succesvolle en goed georganiseerde afdeling te werken, was dit boekje er natuurlijk 
nooit geweest. Ik heb ontzettend veel geleerd van jullie manier van schrijven en presenteren. 
Bedankt voor alle mogelijkheden die ik heb gekregen.
Daarna wil ik heel graag Sjoerd bedanken, vanaf dag 1 was je betrokken bij mijn onderzoek, 
super fijn om iemand te hebben om mee te kunnen discussiëren over resultaten, technieken 
en nieuwe mogelijkheden. Je had altijd wel weer een geweldig (of soms wat minder geweldig) 
nieuw idee om te gaan onderzoeken. Zonder jou was dit boekje zeker niet zo mooi geweest, 
jouw invloeden en experimenten zijn in ieder hoofdstuk zichtbaar! Ik ben dan ook heel blij dat 
je me bij wilt staan als paranimf.
Ook wil ik Theun bedanken, ontzettend fijn dat ik met jou mijn eerste publicatie kon verwerven. 
De kritische discussies met jou en Sjoerd waren ontzettend leerzaam en productief, precies 
zoals het in mijn ogen zou moeten gaan. Ook na je “verhuizing” naar osmoregulatie heb ik 
altijd nog veel aan je adviezen gehad.
Kukiat, great that we succeeded to get the β-adrenergic story to the publication that it is now, 
the last requirement for us both to deliver a PhD thesis. Hopelijk ben je al je Nederlands nog 
niet verleerd als je terugkomt om te verdedigen.
Dan wil ik heel graag het “COPAS team” bedanken: AnneMiete voor alle essentiële muizen 
kennis en kunde, en Hans, Marla en Femke, als ik al die tubules zelf had moeten sorteren 
was het allemaal nooit gelukt. Ik weet hoe ontzettend geestdodend en frustrerend het werk 
is en ben jullie ontzettend dankbaar dat jullie hierin zoveel hebben kunnen helpen. Daarbij 
wil ik in het speciaal Femke bedanken, jij was vanaf het begin betrokken bij de COPAS en 
hebt daardoor het langst en het meest afgezien, gelukkig was het allemaal niet voor niets en 
hebben we een mooi verhaal af kunnen leveren en gaat het sorteren steeds ietsje makkelijker 
en beter! Marla, ook al kwam je later bij het “COPAS team”, je kritische blik en onnavolgbare 
handigheid hebben het leven met de COPAS ontzettend verbeterd! En natuurlijk heel erg 
bedankt voor alle mooie stainings en de laatste transport assay resultaten.
Irene, onmisbaar in het lab, jouw “magische handen” die apparaten als vanzelf weer laten 
draaien, maar het meest natuurlijk om de geweldige organisatie die ervoor zorgt dat alles blijft 
werken en er nooit iets mist. En natuurlijk heel erg bedankt met de hulp bij het verkrijgen van 
al die lastige stofjes en niet te vergeten voor de gezelligheid bij de lunch.
Jeroen, na ¾ jaar afzien aan de “koude kant” van het lab, kwam er een zonnetje binnengelopen. 
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Al was je vrolijke geklets niet altijd even handig, het was ontzettend fijn in zo’n plezierige 
sfeer te mogen werken, dit kwam de productiviteit zeker ten goede! En ondanks dat we nooit 
hebben samengewerkt, was je altijd bereid mee te denken over wetenschappelijke en meer 
diplomatieke oplossingen, in beiden ben je onzettend goed, ik ben heel erg benieuwd waar 
dat toe gaat leiden. 
Anke, raar eigenlijk dat we elkaar (voor mijn gevoel) pas zo laat echt tegen kwamen, toen ik 
verhuisde naar de “warme kant” van het lab. Ik gun niemand wetenschappelijke tegenslag en 
jij met al je kennis, kunde en enthousiasme verdient dat al helemaal niet, maar stiekem was 
het voor mij een hoopgevend voorbeeld om te zien hoe je uiteindelijk toch zo’n mooi resultaat 
hebt weten te behalen. Het is ons gelukt!
Liz en Ellen, ik kan er niet omheen om jullie samen te noemen, als doldwaze duo met jullie 
(zelfverzonnen) liedjes en ik moet toegeven dat ondanks dat het niet echt om aan te horen 
is, misschien juist daarom toveren jullie een lach op ieders gezicht. Maar jullie zijn vooral ook 
ontzettend verschillend. Liz, ik heb ontzettend veel bewondering voor je efficiënte manier 
van werken en hoe je op je doel af gaat, je bent er bijna! Ellen, als student bij Sjoerd hebben 
we al veel en fijn samengewerkt aan het FGF23/Klotho verhaal, helemaal leuk toen je besloot 
als PhD student verder te gaan. Voor mij super dat juist jij voortzet wat ik heb achtergelaten, 
vooral het NCX1 stuk maar ook de PMCAs. Hopelijk gaat het jou ook een mooi proefschrift 
brengen, ik heb er het volste vertrouwen in! 
Lauriane, after moving around in the lab, I ended up in the “NCX unit” with you, my only fellow 
NCX colleague. I much enjoyed our discussions, you were of great help. I also want to thank 
you, together with Maxime, for critically reading the last parts of this thesis. 
Mijn studenten: Sanne, Marga, Jali, Britta. Heel erg bedankt voor alle mooie resultaten en 
leuke discussies, hopelijk hebben jullie veel geleerd, ik zeker ook van jullie! 
Annelies, onze treinreizen terug naar Arnhem en avonden bij de PhD retreat waren altijd 
gezellig, en fijn ook dat ik bij late feestjes mee terug kon met de auto!  
Ofcourse, also, I would like to thank all other colleagues that made the work so much fun! 
Thanks for the nice chats during breaks, visits to the aesculaaf, helpful discussions, etc, etc. 
Dan wil ik nu graag diegenen bedanken die buiten het lab hebben bijgedragen aan dit boekje 
door morele steun, het tonen van interesse en het bieden van de nodige afleiding. 
Jaarclubgenootjes, de gezellige BBQs, weekeindjes naar Cochem en Norwich en andere 
geslaagde uitjes waren een zeer welkome afwisseling! En ja, ik weet het, nu ben ik aan de beurt 
om iets leuks te regelen, RAM!
Lieve Ruud, Dinie, Thomas, Laura, David en Pauline, bedankt voor alle gezellige BBQs, 
etentjes, bezoekjes en het tonen van jullie interesse, ontzettend fijn!
Papa, Mama, Rob, Marloes, het was niet altijd makkelijk als enige “beta” in het gezin, misschien 
juist dankzij jullie vaak skeptische opmerkingen ben ik stug doorgegaan met het bestuderen 
van die “molecuultjes”, hopelijk zijn jullie ook trots op het resultaat! En natuurlijk heel erg 
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bedankt voor alle gezelligheid bij de verschillende etentjes, uitjes, feestjes etc. Daarbij wil ik 
ook zeker Helle en Aerent niet vergeten! Bedankt ook voor de interesse in het wel en wee van 
het onderzoek gedurende al die jaren. Papa, Mama, jullie staan altijd klaar met raad en daad, 
niets is te gek om het ons zo goed mogelijk te maken. Zonder alle kansen en mogelijkheden 
die jullie mij hebben gegeven had ik dit nooit kunnen bereiken, bedankt!
Lieve Remco, jij hebt deze tijd met al zijn ups en downs natuurlijk van het dichtstbij 
meegemaakt. Bij jou kan ik altijd tot rust komen na een dag hard werken, eentje vol frustraties 
of juist de succesjes vieren. Helemaal geweldig dat we dit zo samen hebben kunnen doen. Nu 
samen op naar een nieuw avontuur! 


